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1. Characteristics of adipose tissue 
1.1. Structure of adipose tissue 
Adipose tissue represents a loose connective tissue mainly consisting of mature lipid-filled 
adipocytes and, a variety of other cell types such as stromal vascular cells including blood 
cells, endothelial cells, pericytes, adipose precursor cells, and fibroblasts as well as immune 
cells [1-3]. The mature adipocytes are closely arranged within the tissue resulting in a 
hexagonal configuration. Spaces between the cells are filled by a specific fiber network 
referred to as extracellular matrix (ECM) which is interspersed with capillaries. Not only due 
to its color, adipose tissue is classified into two subtypes, white adipose tissue (WAT) and 
brown adipose tissue (BAT), which differ in their abundance and function in humans [4]. 
BAT is principally found in neonates and only marginally in the adult body and is specialized 
for heat production by adaptive non-shivering thermogenesis [4-6]. The BAT is extremely 
well vascularized and the adipocytes are characterized by densely packed mitochondria as 
well as by the accumulation of triglycerides (TGs) in multiple small lipid droplets [4,7]. 
However, this work focuses only on WAT as it is the major object of the current adipose 
research. WAT is the predominant type of fat tissue in adult humans and is widely distributed 
in multiple depots in the body. The total fat mass is locally classified into subcutaneous 
(~ 80%) and internal (~ 20%) adipose compartments. The internal fat depots include visceral 
and nonvisceral fat as well as other small fat depots [4]. White fat acts as the major energy 
reservoir by storing TGs in periods of energy excess and releasing free fatty acids during 
energy deprivation. The growth of WAT results from increased adipocyte number 
(hyperplasia) and, respectively, adipocyte size (hypertrophy) [2]. Due to the accumulation of 
lipids, adipocytes reach sizes ranging from 20 µm to 200 µm in diameter [4]. The mature 
unilocular adipocyte contains a large single droplet surrounded by a thin rim of cytoplasm, 
and a nucleus located peripherally which gives the cell a so called signet-ring form [8]. 
However, developing adipocytes temporarily contain multiple lipid droplets, before these 
finally coalesce into a single large droplet. Multilocular appearance is also present at periods 
of nutrient deprivation due to mobilization of TGs. 
1.2. Functions of adipose tissue 
Until the 1980s, the most important functions of fat seemed to be heat insulation, mechanical 
cushion, and of course, a source of energy. Adipose tissue stores energy in times of nutritional 
excess in the form of TGs and release free fatty acids and glycerol when energy is required 
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[9,10]. However, during the last two decades, particularly through the identification of leptin 
in 1994 [11], it became increasingly clear that the fat tissue also has active roles in 
physiological processes by mediating endocrine, paracrine, and autocrine signals. Aside from 
the primary function as energy reservoir, the WAT is also described as a highly active 
metabolic and endocrine organ secreting a large number of protein factors and signals termed 
as adipokines [5,12,13]. Adipokines and other adipocyte-secreted factors include leptin, 
adiponectin, resistin, visfatin, apelin, and inflammatory cytokines like tumor necrosis factor 
alpha (TNF-α), monocyte chemoattractant protein-1 (MCP-1), and plasminogen activator 
inhibitor protein (PAI) as well as growth factors, enzymes, complement factors, and matrix 
proteins [4,6]. These factors act as mediators for multiple physiological processes, i.e., energy 
homeostasis, insulin sensitivity, lipid metabolism, inflammatory and immunological 
responses, angiogenesis, blood pressure, and reproductive function [14,15]. A large body of 
evidence indicates that many factors secreted by adipocytes are dysregulated in obesity 
contributing to hyperglycemia, hyperlipidemia, chronic inflammation, and insulin resistance 
[9,16-18]. Thus, WAT dysfunction is involved in the pathogenesis of type 2 diabetes and 
other metabolic diseases, such as atherosclerosis. Particularly leptin, a hormone that is 
primarily synthesized and secreted by mature adipocytes is elevated in human obesity and in 
animal models of obesity. Different roles of leptin are suggested including regulation of body 
fat mass, modulation of insulin action in liver, production of steroids in ovary, and direct 
effects on adrenocortical steroidogenesis. Another adipokine, the cytokine TNF-α, is 
upregulated in obesity which contributes to insulin resistance by the inhibition of the insulin 
receptor signalling through the insulin receptor substrate 1 (IRS-1) [19,20]. 
The two vascular function-related proteins angiotensinogen and plasminogen activator 
inhibitor type I (PAI-1) are responsible for mediating vasoregulatory functions of adipose 
tissue such as blood supply and fatty acid efflux from fat [21]. Angiotensin II, the cleavage 
product of angiotensinogen, increases lipogenesis in adipocytes and, thus, angiotensin II may 
play a role in the control of adiposity through regulation of lipid synthesis and storage in 
adipocytes [22]. Higher levels of PAI-1, a fibrinolytic protein, have been reported in obesity. 
Therefore, PAI-1 is assumed to be involved in the development of cardiovascular diseases 
associated with obesity [23,24].  
Taken together, multiple studies from literature have clearly shown that adipose tissue can be 
regarded as endocrine organ which is involved in various physiological processes in addition 
to its main role in regulation of energy balance.  
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1.3. Adipocyte differentiation 
The adipose lineage arises from a pluripotent stem cell population of mesodermal origin 
which has the capacity to differentiate into various cell types such as adipocytes, 
chondrocytes, osteoblasts, and myocytes [9]. These multipotential precursor cells reside in the 
stromal vascular compartment of adipose tissue and undergo a commitment step, in which 
cells become restricted to the adipocyte lineage. Figure 1 illustrates an overview of the 
different stages of adipocyte development [9].  
 
 
Figure 1: Overview of the adipocyte development (from Gregoire et al. [9]).  
Abbreviations: C/EBP=CCAAT/enhancer binding protein, PPAR=peroxisome proliferator-activated 
receptor, pref-1=preadipocyte factor 1, ECM=extracellular matrix. 
Adipocyte differentiation is induced on the molecular level by a coordinated transcriptional 
program resulting in lipid-laden and insulin-responsive adipocytes. The cellular and 
molecular mechanisms of adipogenesis have been extensively studied using model 
preadipocytes, notably 3T3-L1, 3T3-F442A, C3H10T1/2 and NIH 3T3 cell lines [25]. 
Adipogenesis of preadipocytes is stimulated by a combination of adipogenic inducers in vitro. 
Commonly used combinations mainly consist of glucocorticoids, agonists which increase 
intracellular cyclic adenosine monophosphate (cAMP) levels, insulin which stimulates 
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insulin-like growth factor-I receptors, and thiazolidinediones known as peroxisome 
proliferator-activated receptor gamma (PPARγ) ligands [26]. Upon induction of confluent 
preadipocytes with the cocktail of differentiation inducers, the cells synchronously re-enter 
the cell cycle and undergo last rounds of cell division, referred to as mitotic clonal expansion 
before they enter a unique growth-arrested state of the cell cycle which is required for 
terminal differentiation [27]. It was reported that both clonal expansion and growth arrest are 
prerequisites for adipogenesis [9,28,29]. Subsequently, a cascade of transcription factors is 
induced which activate the expression of adipocyte genes and ultimately produce the 
adipocyte phenotype. An overview of the genetic cascade is shown in Figure 2 [26].  
 
Figure 2: Genetic cascade of adipogenesis leading to the adipogenic phenotype.  
Abbreviations: C/EBP=CCAAT/enhancer binding protein, PPAR=peroxisome proliferator-activated 
receptor, SREBP-1/ADD-1=sterol regulatory element binding protein 1/adipocyte differentiation and 
determination factor 1. The figure was modified from MacDougald et al. [26]. 
First of all, the early regulators of preadipocyte differentiation C/EBPβ and δ are induced 
which are responsible for subsequent activation of the master adipogenic transcription factors 
C/EBPα and PPARγ [26,30]. PPARγ, the central regulator of adipogenesis, is necessary and 
sufficient for the adipogenic process in vitro and in vivo [31,32], whereas C/EBPα is required 
for insulin-dependent glucose uptake in mature adipocytes [30]. Once C/EBPα and PPARγ 
are expressed, the differentiation state is maintained through autoactivation of their expression 
[28,33] and, additionally, they positively regulate each other’s expression [15,34]. 
Furthermore, C/EBPα and PPARγ, along with the sterol regulatory element binding 
protein 1/adipocyte differentiation and determination factor 1 (SREBP-1/ADD-1), 
coordinately activate the transcription of adipocyte-specific genes including adipocyte fatty 
acid binding protein and lipid-metabolizing enzymes that produce and maintain the adipocyte 
phenotype [35]. However, besides C/EBPβ, δ, α and PPARγ, adipogenesis is also regulated by 
other transcription factors. Some factors such as T cell-specific transcription factor/lymphoid 
enhancer-binding factor (TCF/LEF), GATA2/3, retinoic acid receptor α or SMAD6/7 are 
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described as negative regulators of adipogenesis, whereas active cAMP-responsive element 
binding protein (CREB) induces adipogenesis [26].  
Recent studies have identified that many other factors, e.g., cell cycle proteins, clock proteins, 
interferon-regulatory factors (IRFs) and various proteins in the external environment are 
involved in the regulation of the adipogenic process [9,36-38]. 
1.4. Adipocyte metabolism 
TGs are an efficient form to accumulate fatty acids as energy reservoirs or as building blocks 
for membrane lipid synthesis. In adipose tissue, TGs are continuously synthesized and 
simultaneously mobilized. In times of energy excess, free fatty acids (FFAs) are assimilated 
into TG-rich lipid droplets resulting in an increase of the fat cell size.  
The fatty acids are mainly synthesized in the liver, a process referred to as lipogenesis, 
whereas only small amounts are synthesized in the adipocytes. After synthesis of the fatty 
acids in the liver, they are esterified to TGs that are packaged into very low density 
lipoproteins (VLDL). The TG-rich lipoproteins are secreted into the blood followed by the 
hydrolysis of TGs by the lipoprotein lipase. The fatty acids are transported via blood 
circulation to the adipose tissue for storage [39]. Their uptake through the adipocyte plasma 
membrane is regulated by fatty acid transporters. Within the adipocytes, the fatty acids 
together with glycerol are immediately reesterified to TGs. 
Lipolysis is the chemical decomposition of adipose tissue under fasting conditions or in 
periods of increased energy demand to provide fuel to other organs and to deliver substrates 
to the liver for gluconeogenesis and lipoprotein synthesis [40]. Regarding pathophysiology, 
dysregulations of lipolysis are involved in obesity, insulin resistance in type 2 diabetes and 
related disorders [41-44]. During lipolysis, the TGs stored in adipocytes are hydrolyzed by 
different lipases into glycerol and FFAs which are released into the circulation and 
transported to other tissues (Figure 3). The adipose triglyceride lipase (ATGL) is 
predominantly responsible for the initial hydrolysis of TGs into diglycerides (DGs). Although 
hormone-sensitive lipase (HSL) is able to hydrolyze TGs, DGs, and monoglycerides (MGs) in 
vitro, HSL acts preferentially on DGs [45-47,47]. Finally, the hydrolysis of MGs into FFAs 
and glycerol is catalyzed by the monoglyceride lipase [47]. Subsequently, FFAs leave the 
adipose tissue bound to albumin or other carrier proteins [48] and are transported via the 
blood circulation to target tissues such as skeletal as well as cardiac muscle and liver in order 
to be metabolized. However, some FFAs never leave the adipocyte but are reesterified to new 
TGs after food intake [49].  
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Lipolysis in adipocytes is intensively regulated by hormones. In humans, the major hormones 
are catecholamines, the most abundant lipolytic hormones, and insulin, the most potent 
antilipolytic hormone [40]. The lipolysis-regulating action of these hormones have been 
extensively studied with regard to HSL [50,51]. HSL is stimulated by the natural 
catecholamines adrenaline and noradrenaline which bind to β-adrenergic receptors resulting in 
the activation of adenylyl cyclase via a stimulatory G-protein (Figure 3). This leads to 
increased levels of cAMP and subsequent activation of the protein kinase A which induces 
lipolysis by phosphorylation of several proteins in the lipolytic cascade, primarily HSL and 
perilipin A. Perilipin is an abundant structural protein covering the surface of adipocyte lipid 
droplets. In the non-phosphorylated state, perilipin protects the lipid store from hydrolysis by 
blocking access of the lipases to the droplet [52,53]. Phosphorylation of this protein induces 
reorganization of the lipid droplet coating which facilitates the translocation of HSL from the 
cytosol to the surface of the lipid droplet where efficient hydrolysis occurs [45,54]. 
Subsequently, binding of HSL to adipocyte lipid binding protein favors the export of the 
released FFAs [54].  
 
Figure 3: Stimulatory lipolysis pathway in human adipose tissue. 
Abbreviations: AC=adenylyl cyclase, AR=adrenoreceptor, ATGL=adipose triglyceride lipase, 
cAMP=cyclic adenosine monophosphate, cGMP=cyclic guanosine monophosphate, DG=diglyceride, 
FA=fatty acid, GC=guanylate cyclase, Gs=stimulatory GTP-binding protein, HSL=hormone-sensitive 
lipase, MG=monoglyceride, MGL=monoglyceride lipase, NPRA=natriuretic peptide receptor A, 
PKA=protein kinase A, PKG=protein kinase G, TG=triglyceride. 
Reprinted with permission from Langin et al. [54]. ©2010 Elsevier B.V. 
Additionally, catecholamines which bind to α2-adrenoreceptors have been reported to result 
in antilipolytic effects. The stimulation of the α2-adrenoreceptor leads to decreased cAMP-
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levels through the activation of inhibitory G-proteins [55]. Similar antilipolytic effects are 
caused by insulin inhibiting HSL. Insulin stimulates the phosphodiesterase 3B resulting in 
reduced cAMP levels and in turn inhibits protein kinase A activity which leads to reduced 
phosphorylation of HSL [56].  
However, the regulation of adipocyte lipolysis is additionally modulated by numerous other 
lipolytic and antilipolytic factors and (adipo)cytokines such as growth hormones, 
glucocorticoids, atrial and brain natriuretic peptide, leptin, resistin, adrenomedullin, TNF-α, 
IL-6, and adiponectin [50,54,57]. 
Up to now, the molecular mechanisms and pathways that regulate lipolysis in response to 
these factors are not fully understood. Natriuretic peptides induce a signal transduction 
pathway which is distinct from catecholamines (Figure 3). They activate their corresponding 
receptor A which possesses intrinsic guanylyl cyclase activity leading to an increase in cyclic 
guanosine monophosphate (cGMP) level and an activation of protein kinase G which induces 
phosphorylation and activation of HSL [58]. Regarding TNF-α, it is supposed that this 
cytokine stimulates lipolysis by decreasing the perilipin level at the surface of lipid droplets 
[59]. Furthermore, TNFα induces lipolysis by downregulation of inhibitory G-proteins [60] as 
well as phosphodiesterase 3B that are responsible for the degradation of cAMP [61,62]. 
2. The adipocyte extracellular matrix  
2.1. The extracellular matrix composition of adipose tissue 
Structural integrity and functionality in tissues are determined by a highly organized 
architecture of the ECM which is generated by residing cells. Thereby, the ECM is not only 
giving shape and physical support for cells, but it is also a reservoir of growth factors, 
enzymes, and plasma proteins and it is involved in complex cell-matrix interactions. This 
microenvironment influences various cell functions such as cell differentiation, proliferation, 
adhesion, migration, and polarization and hence, it is implicated in biological processes such 
as development, tissue maintenance, regeneration, and repair, as well as in various 
pathological processes such as tumor growth and metastasis. The ECM comprises 
glycosaminoglycans (GAGs), proteoglycans, collagens and further non-collagenous 
components. Although the ECM constituents are similar in different tissues, their composition 
and organization vary according to tissue-specific requirements. Furthermore, changes occur 
within the same tissue depending on developmental stage, viability, and subtype of the cells 
[63]. 
Chapter 1  Introduction 
- 11 - 
The ECM of adipose tissue is a thick matrix network referred to as basement membrane [64]. 
This network structure represents a close arrangement of collagen fibrils and fibrillar bundles 
as detected by scanning electron microscopy (SEM) [65]. However, differences are described 
between the ECM composition of WAT and BAT resulting from the distinct characteristics of 
monovacuolated and multivacuolated adipocytes. The basement membrane of WAT is mainly 
composed of collagen IV and laminin, whereas heparan sulfate proteoglycan and fibronectin 
were less abundant, in contrast to BAT in which all components are present [66]. 
Previous in vitro studies using immunological techniques have identified several ECM 
molecules being present in adipose culture. Currently, with the emerging usage of microarray 
and proteomic techniques, novel proteins were discovered that seem to be constituent parts of 
the adipocyte ECM [67-72]. Mariman et al. have summarized various components being a 
part of the ECM in different adipocyte models [73]. Distinct proteoglycans, a variety of 
collagens, fibulins, fibronectin, different isoforms of laminin, nidogens and versican, for 
example, are counted among these matrix components. Different families of ECM molecules 
in adipocytes are separately discussed in the following sections. 
2.1.1. Proteoglycans 
GAGs are linear unbranched polymers of repeating disaccharides composed of a hexosamine 
and an uronic acid. The abundance of carboxyl, hydroxyl, and sulfate groups in these 
molecules divides them into chondroitin-, dermatin-, keratin-, and heparin-sulfate GAGs and 
gives them distinct physical properties [63]. One or more GAG chains are covalently linked to 
core proteins resulting in the formation of proteoglycans [74]. The structure and function of 
proteoglycans in cartilage have been extensively studied by many researchers [75-77], but 
much less attention has been given to proteoglycans in adipose tissue.  
The major proteoglycans expressed by mature adipocytes are of high molecular weight and 
contain a large amount of heparan and chondroitin sulfates [78]. Particularly, the chondroitin 
sulfate proteoglycan versican and hyaluronan were detected in mature 3T3-L1 adipocytes 
[79,80]. Furthermore, it was reported that the proteoglycans decorin and biglycan were 
expressed in differentiated 3T3-L1 adipocytes although the level was decreased in 
comparison to preadipocytes [81]. Decorin was also identified in vivo in adipose tissue, 
primarily adjacent to blood vessels [82]. Additionally, aggrecan was investigated during 
adipose tissue development in mice. At early differentiation stages, high levels of this 
chondroitin sulphate/keratin sulphate proteoglycan were observed but during adipocyte 
maturation, this component was degraded [83]. Another specific proteoglycan which is 
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distributed in adipose tissue is syndecan-4, a transmembrane heparan sulfate proteoglycan 
which mediates cell binding [84]. In agreement to this, syndecan-4 and also syndecan-1 
expression was shown in 3T3-L1 and 3T3-F442A adipocytes [85,86]. 
2.1.2. Non-collagenous glycoproteins 
During development of adipose cells, the adipocyte ECM converts from a fibronectin-rich 
stroma to a laminin-rich basal lamina. Laminins together with collagen IV form the main 
networks of the basement membrane which are connected via nidogen/entactin bridges 
(Figure 4). These components, i.e., collagen IV, laminin complexes, and nidogen/entactin 
have been identified in the ECM of murine 3T3-L1 adipocytes by Aratani et al. [87]. 
Alexander et al. have also reported nidogen-1/entactin as a prominent component of 
adipocyte basement membranes [88]. 
 
Figure 4: Scaffold formation of the basement membrane. Reprinted with permission from Kalluri et 
al. [89]. ©2010 Nature Publishing Group. 
A) Inside the cell, the basement membrane components are assembled into functional units and then 
secreted into the extracellular space. B) Laminins which are anchored to the cells via receptor proteins 
(integrins, dystroglycans) polymerize and initiate the scaffold formation. C) Laminin and collagen 
type IV networks are connected via nidogen/entactin bridges. The other components interact with this 
main network resulting in a functional basement membrane.  
Another important component of the ECM is fibronectin, a high molecular weight 
glycoprotein. Previous in vitro studies from Pierleoni et al. demonstrated that fibronectin is 
not expressed around mature subcutaneous adipocytes in contrast to laminin [64]. However, 
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in differentiated bovine intramuscular preadipocytes (BIP), fibronectin and also laminin were 
detected in the ECM [90].  
2.1.3. Collagens 
The collagens represent a large and complex family of structurally diverse ECM molecules 
and are the most abundant proteins in the human body [91]. All collagen molecules are 
composed of three polypeptide chains referred to as α-chains which are characterized by 
unique Gly-X-Y motifs. The amino acids hydroxyproline and hydroxylysine are mainly found 
at the X and Y position [92]. These Gly-X-Y sequences including the hydroxylated forms of 
proline and lysine are essential for the formation and stability of the triple helix consisting of 
three identical or different α-chains.  
Up to date, 28 different collagens are known which can be classified into several subgroups 
based on their structure and assemblies [91,93,94]. The different subgroups are presented in 
Table 1. Collagen XXVIII does not easily fit into any category. 
Table 1: Members of the collagen family. The table was modified from Myllyharju et al. and Kielty et 
al. [91,94]. 
A – Fibrillar collagens  
Fibril-forming collagens Type I, II, III, V, XI, XXIV, XXVII 
B – Non-fibrillar collagens  
Basement membrane collagens Type IV, VII 
Short-chain collagens Type VI, VIII, X 
Fibril associated collagens with 
interrupted triple helices (FACIT) 
Type IX, XII, XIV, XVI, XIX, XX, XXI, XXII, 
XXVI 
Transmembrane collagens Type XIII, XVII, XXIII, XXV 
Multiplexin collagens Type XV, XVIII 
 
The large number of collagen types and their structural diversity implies that they play an 
important role in numerous different biological functions including adipocyte differentiation 
[90,92,94,95].  
Synthesis of fibril-forming collagens involves many posttranslational modifications that 
require different modifying enzymes such as hydroxylases, glycosyltransferases, proteinases, 
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isomerases, and the lysyl oxidase [92,96-99]. At first, the proline and lysine residues are 
hydroxylated by specific hydroxylases. Notably, collagen-4-prolyl hydroxlase located in the 
lumen of the endoplasmic reticulum plays a crucial role in collagen synthesis since the 
4-hydroxyprolines are essential for the formation of the triple helical molecule [96]. 
Subsequently, several glycosylation reactions occur at some hydroxylysine and asparagine 
residues before the three alpha chains assemble to a triple helix which is stabilized by intra- 
and intermolecular disulfide bonds. Afterwards, the triple helical procollagen molecules are 
transported from the endoplasmic reticulum through the Golgi stacks into the extracellular 
space. After cleavage of the C- and N-propeptides from the soluble procollagen molecule, the 
resulting insoluble collagen molecules self-assemble into fibrils which are covalently cross-
linked by oxidation of the amino group in certain lysine and hydroxylysine residues 
[91,92,94].  
Up to date, 20 subunits of 12 different collagen types (type I-VI, XI, XII, XIV, XV, XVIII, 
and XXIII) have been identified in the adipocyte ECM from rodent cells [73]. A lot of studies 
showed the presence of the main basement membrane collagen type IV around adipocytes in 
in vivo adipose tissue [64] as well as in in vitro adipocyte cultures of different species [87,90]. 
Additionally to collagen IV, Nakajima et al. detected collagen type I, II, III, V, and VI in 
differentiated BIP preadipocytes, whereas collagen type II was much less abundant [90]. 
Especially collagen VI which is highly enriched in adipocytes seems to be a specific factor in 
the adipocyte ECM structure. Collagen VI binds to many cell types and also interacts with 
other matrix proteins, such as collagen type I, II and IV, fibronectin, hyaluronan, decorin, and 
biglycan [73,100-104]. Therefore, collagen VI is proposed to be an adaptor molecule which 
mediates anchoring of the basement membrane to surrounding cells [105].  
2.2. Extracellular matrix dynamics during adipogenesis 
During adipogenesis, spindle-shaped preadipocytes change their morphology into sphere-
shaped adipocytes due to the accumulation of lipids which is accompanied by extensive ECM 
remodeling, changes in cell-ECM interactions, and cytoskeletal rearrangement. The 
continuous reorganization of the ECM is primarily regulated by matrix metalloproteinases 
(MMPs), specific enzymes implicated in the degradation of matrix molecules, and also by 
tissue inhibitors of MMPs (TIMPs) [106,107]. In human adipose tissue, MMP-2 and -9 are 
highly expressed and secreted. For the murine 3T3-F442A cell line, a differentiation-
dependent secretion of these proteins was demonstrated [108].  
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The specific structural organization of the ECM components is crucial for the differentiation 
and maintenance of unilocular adipocytes [65]. However, only few studies focused on the 
components of the ECM that are associated with the development of the adipocytes and many 
discrepancies are reported in the literature. One of the first ultrastructural changes is the 
increase in the levels of laminins, entactin, and GAGs [87,109-111]. Additionally, decreased 
amounts of cell-associated fibronectin were detected during differentiation of 3T3-L1 and 
3T3-F442A resulting in degradation of the fibronectin network [65,87,112,113]. Collagens, 
the most abundant and best-characterized proteins of the ECM, have also been implicated in 
the differentiation of adipocytes. Green et al. demonstrated that collagens were synthesized at 
substantial levels in 3T3-L1 preadipocytes [114]. During differentiation of 3T3-L1 
preadipocytes into adipocytes, the gene expression of the fibrillar collagens type I and III 
declined [111], whereas the gene expression of the basement membrane collagen type IV 
increased [87,111]. However, Dijan et al. reported that the levels of collagen type I mRNA 
were not altered during differentiation of 3T3-F442A adipocytes [115]. Studies from Renes et 
al. confirmed the increased expression of collagen IV during adipogenesis of 3T3-L1 on 
protein level and additionally, they determined an enhanced collagen V expression [72]. 
However, concerning collagen I and III, they did not agree with Weiner et al. [72,111]. Renes 
et al. suggested a biphasic expression pattern of collagen I, III, and VI during the adipogenic 
differentiation. Firstly, the expression of collagen I and III decreased, before it increased 
again at later differentiation stages. A contrary pattern was observed for collagen VI whose 
expression was initially enhanced and then decreased at later differentiation time points. 
However, the collagen VI level was finally increased compared to the preadipocyte state [72]. 
Biphasic expression patterns of various ECM components including collagen VI were also 
described by other research groups [70]. However, controversial results were presented by 
Dani et al. who described collagen VI as a marker of the preadipose state which is 
downregulated during adipogenesis [116]. Interestingly, Nakajima et al. showed changes in 
the network structure of this type of collagen. They elucidated that collagen V and VI altered 
their network structure during the differentiation process from fine and spiny fibrils to a rough 
and thick network [90]. Kubo et al. have also investigated the changes of the collagen 
network during adipocyte differentiation using stromal vascular cells from mouse adipose 
tissue [65]. As detected by SEM, collagen networks of type I, III, V, and VI developed and 
remained well organized through the stages of adipocyte differentiation, whereas the network 
structure of collagen IV was degraded during adipogenesis [65].  
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These controversial results from literature reflect the complexity of the adipocyte ECM. In 
summary, the expression and synthesis of various matrix molecules, particularly collagens, 
seem to underlay strong changes during adipogenesis that are accompanied by alterations of 
the structural ECM organization. This specific development and remodeling of the ECM 
during adipocyte differentiation likely is of crucial significance for adipocyte functions. Thus, 
disruption of the specifically organized matrix structure, e.g., through inhibition of the 
collagen synthesis by ethyl-3,4-dihydroxybenzoate (EDHB), results in loss of adipocyte 
development [90,95].  
2.3. Novel culture systems for the investigation of the extracellular matrix 
Three-dimensional (3-D) culture systems which create a microenvironment including cell-cell 
and cell-ECM interactions provide new possibilities to study the complex mechanisms of 
adipose development and function. Tissue-inherent factors have been recently found to exert 
influence on cell adhesion, proliferation, differentiation, signal transduction, and other 
biological responses in various tissues [117] [118]. Many studies showed notable differences 
in cell morphology, function, and behavior between 2-D and 3-D cell culture systems [118-
126] and have demonstrated that cells behave more in vivo-like when cultured in 3-D 
environments [127] [128]. The most currently used adipogenic 3-D constructs, mainly for 
tissue engineering approaches, consist of polymeric or natural cell carriers in which cells are 
distributed. However, these 3-D model systems exhibit several drawbacks for the use in basic 
research. Particularly, the cellular inhomogeneity within the construct due to their size and the 
resulting insufficient nutrient and oxygen supply constitutes a severe impairment. 
Furthermore, most of the 3-D constructs contain exogenous materials as scaffolds which may 
affect the behavior and functions of the cells. Moreover, the cell carrier in which the cells are 
initially situated separately, prevents the formation of a coherent cellular context, at least at 
early stages of the culture, resulting in limited cell-cell and cell-matrix interactions [123,129-
132]. For other cell types, a novel 3-D model system based on the generation of cellular 
aggregates was developed which is suggested to form a more homogeneous tissue-like 
construct [133,134]. These multicellular spheroids are generated according to the liquid 
overlay technique by seeding adherent cells onto non-adherent surfaces. As a consequence, 
cells are forced to aggregate to multicellular spheroids. Thus, from the beginning of the 
culture, the cells are closely connected and secrete their own ECM resulting in a coherent 
tissue-like context. Recently, an adipogenic spheroid model with 3T3-L1 cells was developed 
by our group [135]. Additionally, Wang et al. have introduced a similar adipogenic spheroid 
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model with multipotent mesenchymal stem cells. However, their spheroid culture technique 
was based on photolithography and micropatterning techniques [136].  
3. Adipocyte culture in reconstructive and plastic surgery 
3.1. Injection Lipolysis 
The subcutaneous injection of phosphatidylcholine into adipose tissue is an increasingly 
popular therapy for aesthetic approaches to reduce the volume of smaller fat depositions such 
as accumulations on the waist and hip, lower eyelid fat herniation, and lipomas [137-140]. 
This fat dissolution therapy is often referred to as injection lipolysis and is instructed in 
Germany by the “Network Lipolysis” [137]. Notably, injection lipolysis is restricted to small 
fat accumulations and is not a slimming treatment for obese humans. Soy-derived PC which is 
available as Lipostabil®  (Natterman & Cie GmbH, Köln, Germany) is often used for the 
treatment of localized fat accumulation by this procedure [138,139,141-144]. Originally, 
Lipostabil® was approved as an intravenous therapy to treat hyperlipidemia, peripheral 
vascular disease, cardiac ischemia, and liver disease [145-150]. However, to date, the 
subcutaneous injection of Lipostabil® is not licensed and, therefore, injection lipolysis is used 
as an “off-label” practice which means the use of Lipostabil® aside from its initial field of 
application. 
The Lipostabil® formula is mainly composed of PC and sodium deoxycholate (DC) which is 
responsible for the aqueous solubility of PC by forming mixed micelles [142,151,152]. 
Benzyl alcohol is supplemented as a preservative into the formula. In injection lipolysis 
therapy, many physicians combine the Lipostabil® preparation with various additives, e.g., 
vasodilators, aminophylline, vitamins or lidocaine in order to increase the fat reducing effect 
and, respectively, to minimize side effect [153].  
The mechanisms by which Lipostabil® causes localized fat reduction are unknown so far. 
Both PC and DC are proposed to be the actively fat-dissolving component in the Lipostabil® 
formula. PC has a large influence on the regulation of lipid homeostasis. It has effects on 
lowering TG and cholesterol levels, increases high density lipoproteins in the cholesterol 
metabolism, and dissolves atherosclerotic plaques [137,154]. Bobkova et al. have 
demonstrated that PC also influences the receptor properties of cell membranes accompanied 
by increased insulin sensitivity and lipolysis [149]. In injection lipolysis, it is supposed that 
one mechanism of action of PC is related to compromising the adipocyte membrane resulting 
in the secretion of triglyceride-rich lipoproteins [137,140]. Furthermore, PC is proposed to 
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have a lipolytic action by stimulating the activity of lipases. The resulting monoglycerides are 
emulsified by PC and further transported to the liver and metabolized by beta-oxidation 
[137,142,155]. However, Rotunda et al. have taken the view that DC is responsible for the 
fat-dissolving effect by its detergent action [140]. As other detergents, bile salts including DC 
act as potent solubilizers of lipid bilayers [151,156-158]. Recently, it has been demonstrated 
that DC caused nonspecific cell membrane lysis in cultured cells in vitro [140]. Rotunda et al. 
have also shown that the injection of DC into human lipomas induced focal necrosis, acute 
inflammation, and hemorrhage as detected histologically [159]. Moreover, in tissue biopsies, 
the architectural organization of fat and muscle tissue was strongly affected by DC in contrast 
to epidermis and dermis on which DC had less profound effects [140]. A cytolytic effect of 
Lipostabil® on various cell types, i.e., preadipocytes, vascular smooth muscle cells, skeletal 
myotubes, and renal epithelial cells was additionally demonstrated in other studies [160,161]. 
Histological evaluation of lipomas exhibited that the necrosis of fat cells after treatment with 
Lipostabil® was accompanied by an inflammatory reaction similar to panniculitis [162]. The 
local inflammation was characterized by the infiltration of granulocytes, lymphocytes as well 
as macrophages and an increased expression of pro-inflammatory cytokines such as TNF-α, 
interferon-γ (INF-γ), and several interleukins (e.g. interleukin 6, 8 and 10) [163].  
Nevertheless, to date, the subcutaneous injection of Lipostabil® has not been associated with 
serious adverse effects. The observed complications were relatively rare, mild, and temporary 
[164]. The most frequently observed side effects after injection included transient burning, 
edema and erythema at the injection site, swelling, persistent pain beyond two weeks, late 
itching, hyperpigmentation, hives, bacterial infections, and skin contour deformities 
[141,143,153]. Lipid, liver and renal profiles did not change after treatment with PC [142]. 
No patients were reported to die or need hospitalization. It has been shown that the fat 
deposits did not return for approximately four years, but if necessary, the application may be 
repeated [141].  
However, due to lack of scientific studies, the safety and efficacy of injection lipolysis has 
still remained ambiguous to many patients and physicians. Thus, in order to further establish 
injection lipolysis as a serious option in plastic surgery, investigations into the mechanisms of 
action are indispensable. 
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3.2. Adipose tissue engineering 
3.2.1. Clinical need for adipose tissue augmentation 
Largely defected adipose tissue caused by congenital abnormalities, tumor resections or 
traumas such as large burns or chronically open wounds does not regenerate spontaneously 
and requires tissue reconstruction. Increasingly, transplantable and, ideally, biologically 
functional adipose tissue substitutes appear promising to restore a variety of soft tissue defects 
in reconstructive and plastic surgery. Cosmetic and aesthetic surgeons are also interested in 
natural adipose tissue grafts in order to compensate disfigurement. Thereby, the generated 
substitutes should be equivalent to native adipose tissue concerning its cellular and 
extracellular composition and organization as well as its biological functions to guarantee 
integration of the engineered construct into the host tissue including rapid and sufficient 
vascularization. 
3.2.2. Strategies for adipose tissue augmentation 
Currently, different strategies are used to augment soft tissue defects in clinical practice. One 
strategy to treat smaller deformities is the single-cell injection of mature adipocytes which, 
however, is an out-dated method for tissue augmentation without promising outcome. The 
exposure of the fragile adipocytes to the mechanical forces of liposuction results in about 90% 
traumatized adipocytes leading to cyst formation and localized necrosis after injection 
[165,166].  
Another strategy, especially for reconstruction of larger tissue defects, e.g. after breast tumor 
resection, includes the implantation of autologous fat tissue. Even if this implant seems to be 
ideal in terms of biocompatibility and immune response, graft resorption due to insufficient 
neovascularization limits its application [167]. 
A third strategy for adipose tissue augmentation is the induction of de novo adipogenesis in 
vivo. Without the application of exogenous cells, adipose tissue-inducing substances or/and 
materials are administered which supports the development of adipose tissue in vivo. This 
acellular approach avoids the time- and cost-intensive in vitro cell culture and, additionally, 
the problem of immunological compatibility of the cells [167].  
Tissue engineering represents a new promising alternative to augment adipose tissue. For 
engineering 3-D adipose tissue constructs, cells are isolated from the donor tissue and, 
subsequently, propagated in vitro until a sufficient number is available (Figure 5). Afterwards, 
the scaffold is seeded with the propagated cells which can be differentiated in vitro, before the 
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cell-containing construct is re-implanted into the host. The several components of tissue 
engineering strategies, i.e., cells, cell carriers and tissue-inducing substances are discussed in 
detail in the following sections. 
 
 
Figure 5: Strategy of cell-based tissue engineering approaches. Cells are isolated from the donor, 
expanded in monolayer culture in vitro and then seeded onto or into cell carriers. The cell-containing 
construct can be directly re-implanted or after previous in vitro cultivation.  
3.2.3. Components needed for adipose tissue engineering 
3.2.3.1 Cell sources 
The use of suitable cells is crucial for successful transplantation of adipose tissue engineered 
substitutes. The cells have to be autologous or nonimmunogenic, and also have to be available 
in sufficient quantities. The abundance of some cells, e.g. bone marrow derived mesenchymal 
stem cells (BMSCs) is very low after isolation and, therefore, requires an in vitro expansion to 
obtain sufficient cell quantities for clinical therapies [168]. However, the propagation of cells 
is sometimes accompanied by the decline of their proliferation and differentiation potential, 
which, therefore, has to be monitored [169,170]. Furthermore, the harvest of cells should 
occur with minimally invasive procedures that are standardized as well as the processing 
procedures. 
Mature adipocytes 
The characteristics of mature adipocytes make them an inapplicable source for regenerative 
medicine. Due to their high lipid content, these cells are very fragile resulting in a vast 
majority of traumatized adipocytes during isolation and processing procedures [165]. Even if 
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these cells can principally be cultured in vitro, culturing is difficult to perform because of the 
buoyancy of the lipid-filled cells [171,172] and the incapability to proliferate due to their 
terminal differentiation state [165].  
Preadipocyte cell lines 
Murine preadipocyte cell lines such as the 3T3-L1 and 3T3-F442A preadipocytes are widely 
used in basic research and also for characterization of adipose tissue engineering principles 
[123,129,130,166,173]. These preadipocyte cell lines have the advantage that they are well 
characterized, easily to expand and uniform in their differentiation potential. However, for 
clinical therapies, cell lines are not beneficial due to their aneuploid status and xenogeneic 
origin [167]. 
Embryonic stem cells 
The tremendous proliferation and differentiation potential suggest the embryonic stem cells to 
be a highly promising cell source for repair of soft tissue defects [174,175]. However, up to 
date, only a limited number of studies are performed for adipose tissue engineering [131,176], 
primarily due to ethical concerns and legal constraints which limit the application and 
availability of human embryonic stem cells. Nevertheless, embryonic stem cell lines from 
other species, such as mouse models are available and are used for basic research.  
Adipose-derived stem cells 
Adipose tissue is an abundant and easily obtained tissue and was previously identified as an 
alternative cell source of autologous stem cells for engineering tissues. The stromal vascular 
fraction of adipose tissue can be easily harvested in a large quantity by enzymatic digestion of 
lipoaspirates or liposections and, subsequently, cultured, expanded and differentiated in vitro 
[177]. This cell fraction represents a heterogeneous cell pool containing, among others, 
noncommitted multipotent stem cells that have the capacity to differentiate into several 
mesenchymal lineages including adipocytes [178,179]. A lot of different designations, such as 
adipose-derived stem cells, adipose-derived stromal cells, stromal vascular fraction, 
preadipocytes etc. are used in literature for this isolated cell population. In accordance to the 
International Fat Applied Technology Society (IFATS) [180], this cell pool is denominated 
adipose-derived stem cells (ADSCs) in this work. ADSCs can be expanded in vitro over 
several passages without senescing or loosing their adipogenic differentiation potential 
[177,181]. Previous studies have reported that yield, growth, and differentiation 
characteristics are influenced by the handling of the cells including isolation and harvest but 
also by the age, sex, and health status of the donor as well as by the donor site (epididymal, 
mammary, subcutaneous, omentum, etc.) [182-185]. 
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Bone marrow-derived stem cells 
Mesenchymal stem cells can also be isolated from bone marrow aspirates derived from the 
iliac crest or bone marrow biopsies [186] and were accordingly designated bone marrow-
derived stem cells (BMSCs). Similar to ADSCs, BMSCs have a high self-renewal potential 
and are able to differentiate into adipocytes, chondrocytes, osteoblasts, neurons, and 
myoblasts in vitro and in vivo [168,187]. Unfortunately, in contrast to ADSCs, the use of 
BMSCs is limited because of their invasive isolation procedure and the low yield of stem cells 
being present in bone marrow [168,188,189]. Therefore, significant in vitro propagation of 
BMSCs is necessary resulting in the decrease of their proliferation and multilineage 
differentiation capacity [168-170,190,191].  
The properties of ADSCs and BMSCs are highly similar regarding to morphology, 
differentiation capacity, expression of main marker genes, gene expression, and cytokine 
profiles [192-194]. However, based on gene expression studies, BMSCs have been reported to 
show a higher capacity to differentiate into osteoblasts and chondrocytes compared to ADSCs 
whose differentiation ability towards adipocytes appears to be slightly better [195].  
In conclusion, although both ADSCs and BMSCs are appropriate cell sources for adipose 
tissue engineering approaches, ADSCs currently appear to be the most promising cell source 
for clinical therapies due to their easy harvesting conditions, high abundance, and adipogenic 
differentiation capacity [167,196,197].  
3.2.3.2 Cell carriers 
Cells can be seeded onto or into an artificial structure referred to as scaffold which mainly 
gives mechanical support for the formation of a 3-D tissue engineered construct that is 
subsequently implanted into the host tissue. For successful repair of soft tissue defects, the 
scaffold materials have to meet different requirements such as biocompatibility and 
biodegradability. Furthermore, the material has to provide a structure and chemistry allowing 
cell attachment, distribution as well as differentiation and supporting the maintenance of the 
biological functions of the cells. For this, the structure of the scaffold must be highly porous 
and interconnective and additionally facilitates capillary ingrowth, nutrient, and oxygen 
supply [167]. Especially for adipose tissue constructs, large pore sizes within the scaffolds are 
required to enable enlargement of the adipocytes during their maturation [198]. During recent 
years, novel cell carrier principles have been developed. Aside from the implantable porous 
scaffolds, injectable sytems such as hydrogels or microspheres in which the cells are 
encapsulated or to which they are attached, have been used.  
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Implantable porous scaffolds 
In many previous studies of different adipose tissue engineering approaches, the used scaffold 
materials consisted of synthetic polymers, such as polylactic acid (PLA), polyglycolic acid 
(PGA), and poly(lactic-co-glycolic) acid (PLGA) [123,199,200]. However, possible 
limitations may be caused by their acidic degradation products affecting cell functions and the 
lack of chemically reactive groups which makes the polymers easily accessible for surface 
modifications. Recent studies have reported that modifications of these scaffolds such as 
electrospun nanofibrous PLA scaffolds or PLGA hollow fiber scaffolds encapsulated within 
hydrogel capsules promote the adipogenic development of the engineered substitutes in vitro 
and in vivo [201,202]. 
Other synthetic scaffolds that were used for characterization of adipose tissue engineering 
approaches are composed of polyethylene terephthalate or electrospun polycaprolactone 
[130,131]. However, the seeding and culturing of these two cell carriers with adipogenic 
precursor cells did not result in the formation of a coherent adipose tissue.   
Scaffolds do not have to be made of synthetic origin, they also can be composed of natural 
materials, e.g. silk. Mauney et al. have recently investigated the adipogenic development of 
human ADSCs and BMSCs integrated in silk fibroin-derived scaffolds in vitro [203]. Even if 
further in vivo studies have shown that the development of adipose tissue was marginal four 
weeks after implantation, the silk scaffolds proved to be resistant to degradation and thus, 
guaranteed a longer-term integrity compared to collagen or PLA scaffolds.  
For creating a cellular environment more resembling the one within adipose tissue, porous 
scaffolds composed of ECM compounds are used which are additionally characterized by low 
toxicity. Besides the application of collagen and hyaluronic acid esters sponges for adipose 
reconstruction [198,204,205], it is also possible to use autologous ECM materials derived 
from diverse tissues, e.g., adipose tissue ECM or placental ECM, resulting in minimized 
immunological response [206-208].  
Injectable hydrogels and microspheres 
Hydrogels represent an alternative type of cell carrier as they are less invasive resulting in a 
reduced risk of infections and scarring. Hydrogels can be applied as injectables which is 
advantageous for filling irregularly shaped defect sites and as implants if gelling occurs in 
advance in vitro. In both cases, the cells are encapsulated within the gel during formation.  
Similar to porous scaffolds, hydrogels can be composed of synthetic materials such as 
polyethylene glycol (PEG), PEG-diacrylate and Pluronic F-127 [176,209-211] or natural 
materials like alginate [212]. Additionally, hydrogels consisting of various ECM components 
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such as collagen, hyaluronan or fibrin have been successfully used in adipose tissue 
engineering [213-218]. Among these, fibrin glue is already approved by the Food and Drug 
Administration (FDA) for a variety of clinical applications. A specialized ECM hydrogel 
represents Matrigel, an ECM extract derived from Engelbreth-Holm-Swarm mouse sarcoma. 
This gel contains the main components of basement membranes, i.e., proteoglycans, laminin, 
collagen type IV as well as nidogen/entactin, and additionally various growth factors such as 
platelet-derived growth factor (PDGF), transforming growth factor β (TGF-β), and basic 
fibroblast growth factor (bFGF). It was reported that this hydrogel has a promoting effect on 
adipogenesis and angiogenesis in vivo [219,220]. Unfortunately, Matrigel is a mouse tumor 
product and therefore, its clinical use is limited. A promising alternative to Matrigel that is 
comparably rich in ECM components is the recently developed Myogel and an adipose 
protein-derived as well as dermis-derived gel [221-223]. However, their utility for clinical 
applications has not been extensively studied, yet.  
Another injectable application strategy is the use of microspheres to which adipogenic 
precursor cells are attached. Different kinds of microspheres such as PLGA microspheres 
[224-227], alginate beads [228], porous collagenous microbeads [229], human ECM powders 
derived from adipose tissue [230] or particulate small intestinal submoca microparticles [231] 
were investigated with regard to their utility for adipose tissue engineering.  
3.2.3.3 Adipose tissue-inducing substances 
Adipose tissue-inducing substances include a variety of growth factors as well as biological 
and pharmaceutical agents promoting adipogenesis in vitro and in vivo. 
As mentioned above, the generation of adipose tissue substitutes often requires the in vitro 
expansion of adipogenic precursor cells. Several growth factors such as insulin-like growth 
factors (IGF-1, IGF-2), acidic FGF, bFGF, epidermal growth factor (EGF), and PDGF were 
identified to stimulate the proliferation of ADSCs and BMSCs. However, some of these 
growth factors are also able to influence the adipogenesis of precursor cells. Basic FGF was 
reported to be a positive stimulator for the adipogenic conversion of BMSCs [200] and 
ADSCs [232] whereas the effect of this growth factor is controversially discussed in 
literature. Gregoire et al. have reported that bFGF acts as an adipogenic inhibitor in 
preadipocyte cell lines and ADSCs [9]. Basic FGF or other inducing substances such as IGF-1 
or insulin have been repeatedly applied in combination with distinct biomaterials, such as 
Matrigel or microspheres to induce de novo adipogenesis in vivo [220,233-238]. With regard 
to adipose tissue development, the combination of the substances was more effective than 
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when applied alone. So far, it is unclear whether bFGF modulates adipogenesis by directly 
affecting the adipocytes or whether it modulates adipogenesis indirectly through its 
angiogenic effect. 
 
In conclusion, during the recent years, many promising approaches have emerged in adipose 
tissue engineering to reconstruct fat substitutes for reconstructive and plastic surgery as well 
as for basic science. Various types of cell carriers and cell sources enabling adipose tissue 
development have been characterized. Several studies have shown that a long-term survival of 
distinct engineered construct was successful over a period of six months and beyond. 
However, the size of generated constructs still rarely exceeds one milliliter. Thus, further 
improvements are required regarding long-term maintenance and optimal vascularization to 
finally generate a standardized, coherent, and functional adipose tissue graft of considerable 
size which can be successfully used for clinical applications.  
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1. Two-dimensional (2-D) adipocyte culture 
To develop therapeutic strategies, for the treatment of fat-related diseases or for reconstructive 
and aesthetic surgery, it is of prime importance to understand adipocyte biology and function. 
Hereby, for many questions, 2-D culture of differentiating preadipocytes still is an adequate 
model system to study adipocyte biology in vitro.  
1.1. Investigation of therapeutic substances used for injection lipolysis 
In the first part of this thesis, 2-D adipocyte culture was used for in vitro studies of therapeutic 
substances applied in injection lipolysis. Injection lipolysis is a therapeutical strategy to 
reduce localized fat accumulation in humans. By this treatment, soy-derived PC which is 
available as Lipostabil® is injected subcutaneously into fat deposits [1,2]. However, the 
mechanisms by which Lipostabil® induces fat dissolution are controversially discussed and a 
lipolytic activity of this substance has not yet been investigated. Therefore, the aim of this 
study was to investigate the action of Lipostabil® and its single components 
phosphatidylcholine and sodium deoxycholate on adipocytes concerning toxic and lipolytic 
effects. For a first approach, we used a well established cell line, the murine 3T3-L1 cells 
(Chapter 4). As an additional human cell source, adipose-derived stem cells (ADSCs) were 
utilized. ADSCs can be differentiated into various lineages including adipocytes [3]. 
However, many factors such as harvesting and culture conditions have been described to 
influence the adipocyte culture. Therefore, we tested different isolation procedures and 
induction media stimulating the adipogenic differentiation to optimize the adipogenic 
differentiation rate (Chapter 3). The established adipocyte model system was further used for 
the in vitro studies of Lipostabil® (Chapter 4).  
2. Three-dimensional (3-D) adipocyte culture 
To study tissue-inherent factors such as cell-cell and cell-matrix interactions, the 2-D culture 
system is limited and cannot fully capture the relevant complexity of in vivo adipose tissue. In 
contrast, a 3-D tissue-like model system likely is more appropriate attempting to mimic the in 
vivo tissue environment as closely as possible. Furthermore, for tissue reconstruction, the use 
of 3-D substitutes is inevitable.  
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2.1. Investigation of collagens in adipogenesis in vitro 
During the last decades, it was shown that the adipocyte function is strongly influenced by the 
surroundings of the cells [4,5]. Various studies have described the regulation of several 
extracellular matrix (ECM) components during adipogenic differentiation [6-10]. 
Nevertheless, the composition of the ECM in adipose tissue as well as its role in adipogenesis 
has not been fully understood. To study the influence of various ECM components on 
adipogenic differentiation in vitro, we have previously developed a 3-D adipocyte culture 
system based on the formation of spheroids [11]. In contrast to scaffold- or gel-based 3-D 
constructs, this 3-D model system provides a coherent adipose tissue-like context including 
direct cell-cell and cell-matrix interactions and represents an adequate model for studying the 
importance of the ECM for adipocyte development. Thereby, the role of collagens in 
adipogenesis is of major interest since these ECM components are the most abundant 
molecules in the matrix. However, the role of collagens in adipogenesis has not been 
investigated in a 3-D tissue-like context so far. As the well organized matrix structure of 3-D 
adipose tissue seems to modulate adipocyte differentiation, we hypothesized that the 
inhibition of the collagen synthesis by a prolyl hydroxylase inhibitor has more profound 
effects in 3-D spheroids compared to 2-D culture. Therefore, we examined the influence of 
collagens on the adipogenesis of 3T3-L1 cells as well as ADSCs cultured in 3-D spheroids 
and 2-D culture by using ethyl-3,4-dihydroxybenzoate (EDHB) as an inhibitor of collagen 
synthesis (Chapter 5).  
In general, it is known that the expression of collagens, particularly fibrillar collagens, is 
regulated during adipose conversion [5,8,10]. However, the organization of the collagen 
network through interactions of the molecules during adipogenesis is not well characterized. 
The so-called fibril-associated collagens with interrupted triple helices (FACIT) are important 
for the structure of the ECM network. Members of the FACIT family are localized on the 
surface of major collagen fibrils and act as molecular bridges that arrange the structural 
integrity of the ECM. Therefore, we supposed that FACITs may be involved in adipocyte 
differentiation. So far, FACITs have not been investigated during adipocyte development. 
One member of the FACIT sub-family is collagen XVI which is mainly expressed in skin and 
cartilage in humans [12,13]. As collagen XVI mediates anchoring processes and remodelling 
of the ECM [14,15], we hypothesized that this FACIT collagen is also involved in adipose 
conversion. Therefore, we investigated the expression of collagen XVI during the in vitro 
adipogenesis of 3T3-L1 preadipocytes and ADSCs in 2-D and 3-D culture (Chapter 6). 
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2.2. Novel hydrogels for adipose tissue engineering 
Besides the benefit of 3-D culture systems in basic research, 3-D adipose substitutes are 
required for clinical applications to augment soft tissue defects, e.g., after traumatic injuries or 
tumor resections. However, reviewing currently used adipose engineering strategies, it 
becomes evident that cell carriers that are more adipose-specific are desirable. Hydrogels 
represent a promising 3-D scaffold for adipose tissue engineering due to effective cell 
encapsulation and unrestricted diffusion of nutrients and metabolites. Recently, a novel 
biodegradable poly(ethylene glycol) (PEG)-based hydrogel has been developed by our group 
[16]. The gel-forming polymers were functionalized with a synthetic tetrapeptide which 
enables proteolytic degradation of the hydrogel by cell secreted proteases. Furthermore, the 
hydrogel provides an elastic microenvironment which mimics the properties of native ECM. 
Another promising approach of this gel system is the possibility to functionalize the hydrogel 
with adhesion molecules, hormones or growth factors to promote the formation of a coherent 
adipose tissue. The aim of this study was to investigate the suitability of this novel 
biointeractive PEG-based hydrogel for adipose tissue engineering. To this end, the hydrogels 
were seeded and cultured with 3T3-L1 preadipocytes to study the influence of substrate 
stiffness, adhesiveness, and degradability on cell proliferation and adipogenic differentiation 
in vitro (Chapter 7).  
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1. Abstract 
Adipose-derived stem cells (ADSCs) have an equal potential to differentiate into several cell 
lineages including adipocytes which makes them to a promising cell source for basic research 
and clinical applications. The aim of this study was to evaluate a two-dimensional (2-D) in 
vitro adipocyte culture system with human ADSCs by optimization of the isolation procedure 
as well as culture conditions by addition of various factors such as human plasma, basic 
fibroblast growth factor (bFGF) and ascorbic acid (AA). ADSCs were isolated from 
subcutaneous adipose tissue, propagated and, subsequently, hormonally induced to undergo 
adipogenesis. It was shown that modification of the isolation procedure by introduction of two 
additional filtration steps led to an increased adipogenic differentiation rate within ADSCs, 
whereas an additional erythrocyte lysis step did not influence the adipogenesis. Similarly, 
supplementation of human plasma into the culture medium did not enhance the adipogenic 
differentiation after hormonal induction. However, the addition of bFGF into the medium 
exerted increased adipogenic conversion of ADSCs, in contrast to AA that strongly inhibited 
the adipogenic differentiation capacity of ADSCs. We have established an in vitro adipocyte 
culture system with human ADSCs which can be used as model system for the study of the 
effect of substances used for injection lipolysis as described in chapter 4 (Page 71). 
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2. Introduction 
Adipose tissue was identified as an alternative cell source of autologous stem cells which are 
found in the stromal vascular fraction (SVF) of subcutaneous adipose tissue and which are 
referred to as adipose-derived stem cells (ADSCs) in this work. Recently, interest has rapidly 
grown in ADSCs for use in adipocyte culture in vitro and in tissue repair in vivo. ADSCs have 
been classified as mesenchymal stem cells (MSCs) with differentiation abilities and surface 
marker proteins comparable to those of bone marrow-derived stem cells (BMSCs) [1-4]. 
However, in contrast to BMSCs, ADSCs are more advantageous by virtue of the unique 
accessibility from adipose tissue in a less-invasive manner, the easy harvest in a large quantity 
from abdominoplasties or lipoaspirates by enzymatic digestion, the extensive expansion 
capacity in vitro and the capability to differentiate into multiple cell lineages upon induction 
cues [5-8]. ADSCs represent a heterogeneous cell population containing fibroblasts, smooth 
muscle cells, pericytes, endothelial cells, monocytes/macrophages, lymphocytes, mature 
adipocytes, and also progenitor cells of adipocytes [9-11]. Depending on the inducing stimuli 
and specific growth factors, these cells are able to undergo osteogenesis, adipogenesis, 
chondrogenesis, neurogenesis, and myogenesis [1,4]. For a successful in vitro adipocyte 
culture, extensive expansion and adipogenic differentiation of ADSCs is necessary to obtain a 
sufficient rate of differentiated adipocytes for following research. Thus, it is of great interest 
to achieve a significant fraction of cells differentiating into adipocytes within the 
heterogeneous cell population.  
A wide variety of exogenous supplements, including serum from different species, low 
molecular weight drugs and growth factors, has been found to influence proliferation and 
adipogenesis of ADSCs [12-16]. Previously, it has been shown that long proliferation periods 
in fetal calf serum (FCS)-supplemented medium markedly reduce the capability for 
adipogenic differentiation which is most likely caused by serum factors in the FCS [17,18]. 
Therefore, FCS is mostly missing in the adipogenic differentiation medium of ADSCs. 
However, some studies have revealed that in contrast to FCS, horse, rabbit, murine, and 
human serum or human plasma enhances the proliferation and the adipogenesis of MSCs in 
vitro [18-23]. In some cases, the serum or plasma replaced the adipogenic induction cocktail 
[20,21], whereas in other studies, the serum is supplemented to the induction medium [18,23]. 
The commonly used adipogenic induction medium contains agents such as insulin, 
glucocorticoids, 3-isobutyl-methylxanthine (IBMX), and ligands of peroxisome proliferator- 
activated receptor γ (PPARγ) such as troglitazone. In addition, growth factors like epidermal 
growth factor (EGF) or bFGF have been shown to modulate the adipogenic induction process 
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of MSCs and preadipocytes [12,24]. Basic FGF has been identified to act as a mitogen and 
chemoattractant that enhances angiogenesis, migration and adipogenic differentiation of both 
ADSCs and BMSCs [12,25-29].  
In addition to growth hormones, antioxidants such as AA are also known to stimulate the in 
vitro proliferation and differentiation of several mesenchymal cell types [30-34]. A few basic 
studies reported that AA also enhances adipogenesis of 3T3-L1 and BMSCs [35-38]. These 
stimulatory effects likely resulted, at least in part, from the essential role of AA in collagen 
synthesis [36,37]. AA is an essential cofactor for the enzyme prolyl hydroxylase which is 
responsible for post-translational modification of collagen molecules [39]. 
Nevertheless, there is an extensive inconsistency among laboratories concerning the isolation 
procedure, the culture media, and the addition of supplementary factors for the successful 
expansion and adipogenic differentiation of ADSCs.  
The aim of this chapter was to evaluate the isolation and culture procedures for ADSCs 
finally leading to a new in vitro model for the study of the effect of substances used for 
injection lipolysis as described in chapter 4 (Page 71). Initially, we advanced the isolation of 
ADSCs from human adipose tissue to optimize the rate of differentiating adipocytes by 
varying different steps of the isolation procedure such as filtration or lysis of erythrocytes. 
Secondly, we searched for improved culture conditions by addition of supplementary factors 
such as human plasma, bFGF or AA to reach effective adipogenic differentiation of ADSCs.  
3. Materials and Methods 
Materials 
ADSCs were isolated from human abdominoplasties or lipoaspirates obtained from cosmetic 
surgery. Dulbecco’s Modified Eagle’s Medium (DMEM) and Dulbecco’s Modified Eagle’s 
Medium Ham’sF12 (DMEM Ham’sF12) were purchased from Biochrom (Berlin, Germany). 
Fetal bovine serum (FBS, Lot. No. 40A0044K), phosphate buffered saline (PBS), 0.25% 
trypsin-EDTA solution, and penicillin-streptomycin solution were from Invitrogen 
(Karlsruhe, Germany). Collagenase NB4 and IBMX were bought from Serva Electrophoresis 
(Heidelberg, Germany). Papainase was from Worthington (Lakewood, NJ, USA). Bovine 
insulin was kindly provided by Sanofi-Aventis (Frankfurt a. M., Germany). Cortisol, 
transferrin, biotin, pantothenate, troglitazone, triiodothyronine, glucose, bovine serum 
albumin, cysteine, bovine DNA, 2-mercaptoethanol, Tris base, dihydroxyacetone phosphate 
(DHAP), dimethylsulfoxide (DMSO), AA, Nile Red, and oil red O were obtained from 
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Sigma-Aldrich (Taufkirchen, Germany). Hoechst 33258 dye was obtained from Polysciences 
(Warrington, PA, USA). Nicotinamide adenine dinucleotide (NADH) was from Roche 
(Mannheim, Germany). Thesit was obtained from Gepepharm GmbH (Siegburg, Germany). 
Basic FGF was obtained from R&D Systems (Minneapolis, MN, USA). If not stated 
otherwise, all other chemicals were from Merck KGaA (Darmstadt, Germany). Deionized 
water was obtained using a Milli-Q water purification system from Millipore (Schwalbach, 
Germany). All cell culture plastics were purchased from Corning (Bodenheim, Germany).  
Methods 
3.1. Isolation of ADSCs from human adipose tissue 
ADSCs were isolated from human subcutaneous adipose tissue obtained during 
abdominoplastic surgery or liposuctions from healthy women or men aged 17-69 years as 
described by Schling et al. [40,41]. Briefly, after removal of connective tissue and blood 
vessels, adipose tissue was subjected to enzymatic digestion using a 0.1% collagenase 
solution at 37°C for 4 hours on an orbital shaker at 150 rpm (Heidolph, Schwabach, 
Germany) in order to obtain a single-cell suspension. Lipoaspirates were directly transferred 
to the collagenase solution containing 1 mg/ml collagenase NB4, 15 mg/ml bovine serum 
albumin, 100 mM 2-[-4-(2-hydroxyethyl)1-piperazinyl]-ethan-sulfonic acid (HEPES), pH 7.4, 
120 mM NaCl, 50 mM KCl, 1mM CaCl2, and 5 mM glucose. The suspension was filtrated 
twice through a 100 µm nylon filter (BD Biosciences, San Jose, CA, USA) and centrifuged at 
700 g for 7 minutes. The resulting pellet, termed the SVF, was resuspended in basal medium 
consisting of DMEM/DMEM Ham’sF12-Medium (1:1), 10% FBS, penicillin (100 U/ml), 
streptomycin (100 µg/ml), 1 µM insulin, 2 µg/ml transferrin, 1 µM biotin, and 17 µM 
pantothenate [41]. Cells were seeded in T75 culture flasks and cultured in a humidified 
atmosphere at 37°C and 5% CO2 or were cryopreserved in liquid nitrogen. Cryopreservation 
medium consisted of basal medium supplemented with 10% DMSO. In the case of following 
cultivation, cells were allowed to adhere to the substratum for one day. The flasks were rinsed 
twice with PBS in order to remove erythrocytes and other non-adherent cells. In the following 
experiments, cells were expanded (proliferation phase) with basal media up to passage 3. 
Cyropreserved cells were similarly expanded up to passage 3 after thawing.  
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3.2. 2-D cell culture of ADSCs 
For conventional 2-D monolayer cultures, cells were seeded in basal medium 
(DMEM/DMEM Ham’sF12-Medium (1:1), 10% FBS, penicillin (100 U/ml), streptomycin 
(100 µg/ml), 1 µM insulin, 2 µg/ml transferrin, 1 µM biotin, and 17 µM pantothenate) into 
tissue-culture polystyrene well plates (Corning, Bodenheim, Germany) at a density of 30,000 
cells/cm2 if not stated otherwise. At confluence, cells were induced to undergo adipogenesis 
by supplementing basal media (without FBS) with 100 nM cortisol, 500 µM IBMX, 1 nM 
triiodothyronine and 500 nM troglitazone [41] named as induction medium. The time point of 
induction was referred to as day 0 throughout all experiments. At day 2, the medium was 
exchanged with differentiation medium (basal medium without FBS, 100 nM cortisol, 1 nM 
triiodothyronine and 500 nM troglitazone). During the entire culture period, medium was 
exchanged every two days and cells were incubated in a humidified atmosphere at 37°C and 
5% CO2. 
3.3. Oil red O staining 
In order to visualize accumulated cytoplasmic triglyceride droplets, oil red O staining was 
performed at day 12 after hormonal induction of adipogenesis. For this purpose, cells were 
washed once with PBS, fixed in 10% PBS-buffered formalin overnight and then stained with 
oil red O (3 mg/ml solution in 60% isopropanol) for 4 hours [42,43]. Excess dye was removed 
by washing three times with PBS. Microscopical bright field pictures were acquired at 20x 
and 4x magnification using an inverted microscope (Leica DM IRB, Leica Microsystems, 
Wetzlar, Germany) equipped with a CCD camera (DS-5M, Nikon, Düsseldorf, Germany) and 
the software Eclipse Net (Laboratory Imaging, Praha, Czech Republic). 
3.4. Quantitative analysis of intracellular triglyceride (TG) accumulation 
For analysis of the intracellular TG content, 2-D monolayers were washed twice with PBS 
and harvested in 0.5% aqueous thesit solution. After sonication with a digital sonifier 
(Branson Ultrasonic Corporation, Danburg, CT, USA), the spectroscopic quantification of TG 
was performed using the enzymatic serum triglyceride determination kit from Sigma-Aldrich 
(Taufkirchen, Germany) according to the manufacturer’s instructions. Measurements were 
done in three biological replicates; one replicate was derived from one well. The amount of 
TG per well was calculated and normalized to the DNA content of the samples as determined 
by the DNA assay.  
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3.5. Determination of the glycerol-3-phosphate dehydrogenase (GPDH) activity 
GPDH activity was measured according to a protocol adapted from Pairault and Green [44]. 
Briefly, after washing with PBS, cells were harvested in lysis buffer (50 mM Tris, 1 mM 
EDTA, 1 mM 2-mercaptoethanol, pH 7.5), sonicated with a digital sonifier (Branson 
Ultrasonic Corporation, Danburg, CT, USA) and centrifuged (16,000 g, 5 minutes). GPDH 
activity was measured by adding an aliquot of the lysate supernatant to the substrate buffer 
(0.1 M triethanolamine, 2.5 mM EDTA, 0.5 mM 2-mercaptoethanol, 0.12 mM NADH, 2 mM 
DHAP) and monitoring the consumption of NADH photometrically at 340 nm for 
4.2 minutes. Measurements were done in three biological replicates; one replicate was derived 
from one well. GPDH activities were normalized to the DNA content of the samples as 
determined by the DNA assay. 
3.6. Determination of the DNA content with DNA assay 
After washing with PBS, cells were harvested in lysis buffer (50 mM Tris, 1 mM EDTA, 
1 mM 2-mercaptoethanol, pH 7.5) and sonicated with a digital sonifier (Branson Ultrasonic 
Corporation, Danburg, CT, USA). Aliquots of the cell lysates were digested with papainase 
(3.2 U/ml in 0.1 M Na2HPO4 buffer, pH 6.5 containing 1 mM Na2EDTA and 2.5 mM 
cysteine) for 16 hours at 60°C, and the DNA content was determined using the intercalating 
Hoechst 33258 dye (0.1 µg/ml in 0.1 M NaCl containing 1 mM Na2EDTA, 10 mM Tris, pH 
7.4) [45]. Fluorescence intensities were determined at 365 nm excitation wavelength and 
458 nm emission wavelength on a LS 55 Fluorescence Spectrometer (PerkinElmer, 
Wiesbaden, Germany) and correlated to DNA contents using standard dilutions of double-
stranded DNA (from calf thymus). 
3.7. Flow Cytometry 
This method was carried out using a protocol adapted from Gimble et al. [46]. ADSCs were 
carefully harvested by treatment with 0.25% trypsin/EDTA and centrifuged at 200 g at 4°C 
for 5 minutes. After washing the pellet with PBS, cells were centrifuged as described above 
and resuspended in PBS containing the lipophilic fluorescent dye Nile Red. Cells were 
incubated for 30 minutes on ice. Samples were analyzed with a FACSCalibur flow cytometer 
(Becton Dickinson, Heidelberg, Germany). Nile Red fluorescence was measured on the FL2 
emission channel through a 585±21 nm band pass filter, following excitation with an argon 
ion laser source at 488 nm. For each sample, a selection marker M1 was set in histograms and 
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the amount of adipocytes was assessed by determining the percentage of cells within the M1 
region. The M1 region was adjusted according to unstained differentiated ADSCs taking into 
account the autofluorescence of each sample.  
3.8. Statistics 
All quantitative results are presented as mean value ± standard deviation. Significances were 
determined using GraphPadPrism v.5 (GraphPad Software, La Jolla, CA, USA). Differences 
between groups were analyzed for significance using unpaired Student’s t-test. A value of 
p<0.05 was regarded as statistically significant. 
4. Results 
4.1. Evaluation of the isolation procedure of ADSCs from adipose tissue 
The initial methods to isolate cells from rat adipose tissue were pioneered by Rodbell et al. in 
the 1960s [47,48]. They minced rat fat pads, washed extensively to remove contaminating 
hematopoietic stem cells, incubated the tissue fragments with collagenase, and centrifuged the 
digest, thereby separating the floating population of mature adipocytes from the pelleted SVF. 
In our studies, this procedure has been modified according to the method published by 
Schling et al., which included additional filtration steps after digestion [40]. The additional 
filtration steps were performed in order to purify the SVF of the digested tissue from residual 
connective tissue and other matrix components as well as large mature adipocytes. In a first 
experiment, we compared the two different procedures with regard to the ability of ADSCs to 
differentiate into adipocytes. Isolation 1 was performed according to the method of Rodbell as 
described above, whereas isolation 2 was modified by introducing two filtration steps through 
a filter of 100 µm pore size. The first filtration was performed after digestion of the tissue 
with collagenase. Subsequently, the floated mature adipocytes were aspirated carefully 
followed by another filtration step and centrifugation afterwards. The pelletized cell fraction 
was seeded into culture flasks and after one day, non-adhered cells and cell debris were 
removed by washing with PBS. After expansion in basal medium, the adhered ADSCs were 
induced by a hormonal cocktail consisting of 100 nM cortisol, 500 µM IBMX, 1 nM 
triiodothyronine, and 500 nM troglitazone to undergo adipogenic differentiation. At day 12 
after induction, adipogenic potential of ADSCs was determined by staining of the lipid 
droplets within adipocytes with oil red O (Figure 1). The additional filtration steps in 
isolation 2 resulted in increased removal of connective tissue remnants and other matrix 
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components as well as large cells such as mature adipocytes. After seeding of the SVF of 
isolation 2 into flasks, less erythrocytes and other non-adhered cells were existing in the 
culture medium compared to the fraction of isolation 1. After adipogenic induction, ADSCs 
isolated according to procedure 2 clearly differentiated into adipocytes and even at higher 
rates than the ADSCs of isolation 1 did.  
 
 
Figure 1: Oil red O staining of adipocytes at day 12 after induction within the heterogeneous 
population of ADSCs which were isolated according to different procedures. Isolation 1: After 
digestion of adipose tissue with collagenase, the cell suspension was centrifuged without prior 
filtration steps. Isolation 2: After digestion of adipose tissue with collagenase, the cell suspension was 
filtrated twice through a filter with 100 µm pore size followed by the centrifugation step. Bar=100 µm. 
In a second experiment, a final lysis of erythrocytes after the centrifugation was introduced in 
the isolation procedure 2 referred to as isolation 3. This was supposed to further purify the 
heterogeneous cell population. Erythrocytes were removed by resuspending the pelletized 
SVF in erythrocyte lysis buffer (0.16 M NH4Cl) for 10 minutes at room temperature. 
Subsequently, the cell suspension was centrifuged again and the obtained cell pellet was 
seeded into flasks. After expansion, the ADSCs were seeded at a density of 20,000 cells per 
cm2 into well plates and at confluence, the cells were hormonally induced to undergo 
adipogenesis. The adipogenic differentiation capacity of ADSCs was determined at day 12 
after induction by oil red O staining. The lysis of erythrocytes did not influence the purity and 
the growth of ADSCs (Figure 2). The differentiation capacity was not altered by the 
additional lysis step in isolation procedure 3. Apparently, washing of the cells with PBS one 
day after attachment, as performed in the first experiment, did remove erythrocytes in a 
similar manner than lysis did, as performed in the second experiment. 
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Figure 2: Oil red O staining of adipocytes at day 12 after induction within the heterogeneous 
population of ADSCs which were isolated according to different procedures. Isolation 2: After 
digestion of adipose tissue with collagenase, the cell suspension was filtrated twice through a filter 
with 100 µm pore size followed by the centrifugation step. Isolation 3: After digestion of adipose 
tissue with collagenase, the cell suspension was filtrated twice through a filter with 100 µm pore size 
followed by the centrifugation step. Subsequently, the pelletized cell fraction was treated with 
erythrocyte lysis buffer for 10 minutes at room temperature. Bar=500 µm. 
4.2. Adipogenic differentiation capacity is dependent on donors  
We isolated ADSCs from adipose tissue of eleven different donors. Hereby, we detected 
differences of the adipogenic differentiation capacity of ADSCs dependent on the distinct 
donors. In this study, exemplarily for two extreme examples, we illustrated the differential 
adipogenic potential of ADSCs obtained from human adipose tissue of two different donors. 
To determine the rate of differentiated adipocytes in the heterogeneous cell population, 
samples were analyzed by flow cytometry using the lipophilic dye Nile Red at day 12 after 
adipogenic induction. Cell size and granularity were assessed using forward- and side-scatter 
settings. Samples were corrected for nonspecific fluorescence and autofluorescence. The 
number of positive events for Nile Red stained cells was expressed as percentage of the total 
cell number of ADSCs. Consistent with microscopic brightfield pictures (Figure 3 A), the 
fraction of ADSCs from donor 1 (64.91 ± 11.60%) contained distinctly more adipocytes than 
the one from donor 2 (11.13 ± 3.94%) (Figure 3 B). Non-induced ADSCs served as control 
for undifferentiated cells. No lipid droplets were observed in undifferentiated cells and, 
accordingly, no adipocytes were detected by flow cytometry.  
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Figure 3: Adipogenic differentiation capacity of ADSCs isolated from adipose tissues of two different 
donors. A) Microscopic brightfield images of undifferentiated and differentiated ADSCs at day 12 
after induction are shown. Bar=200 µm. B) Flow cytometry data from undifferentiated and 
differentiated ADSCs at day 12 after induction are presented. To determine the number of adipocytes 
within ADSC population the samples were incubated with the lipophilic dye Nile red. The table 
represents the number of differentiated cells expressed as a percentage of total cells in culture. Data 
represent means ± standard deviation of three biological replicates. The group designated as 
“undifferentiated” were cultivated without induction by the hormonal cocktail. 
4.3. Effect of human plasma on adipogenesis of ADSCs  
Previous studies have shown that a medium supplemented with murine or human plasma 
promoted the propagation of BMSCs and preserved the differentiation capacity of the cells 
[21,22]. Thus, we assumed that the addition of human plasma into both the growth and the 
induction medium may promote the adipogenic differentiation potential of ADSCs. 
Human plasma was obtained by pooling blood collected from healthy volunteers using EDTA 
as anticoagulant. Blood was then centrifuged and the supernatant was stored frozen until use. 
First, ADSCs were cultured in basal media supplemented with 5% human plasma in which 
the concentration was adapted to conditions from literature [21] and afterwards, ADSCs were 
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hormonally induced to undergo adipogenesis in the presence of human plasma. At day 12 
after induction, adipogenic conversion was detected by oil red O staining and the percentage 
of cells undergoing adipogenesis was calculated by microscopic inspection (Figure 4 A). The 
number of adipocytes in a field staining positive with oil red O for lipid droplets were 
determined as a percentage relative to the total number of the cells in the field (Figure 4 B). 
Oil red O staining revealed that the addition of human plasma did not increase the number of 
adipocytes. The calculated adipocyte fraction did not vary in cultures differentiated in the 
presence or absence of human plasma (Figure 4 B).  
 
 
Figure 4: Adipogenic differentiation capacity of ADSCs cultured with or without human plasma.      
A) Oil red O staining of adipocytes within the heterogeneous population of ADSCs at day 12 after 
adipogenic induction. Bar=200 µm. B) Quantification of adipocytes at day 12 after adipogenic 
induction by microscopic inspection. The number of cells in a field staining positive with oil red O for 
lipid droplets were determined as a percentage relative to the total number of the cells in the field. The 
number of adipocytes from three images, each of a different biological replicate, was evaluated.  
4.4. Effect of bFGF-supplemented media on adipogenesis of ADSCs  
The use of bFGF as a potent mitogen for human MSCs, while maintaining their 
differentiation potential, has previously been reported in various culture systems [49-52]. 
With regard to adipogenesis, Neubauer et al. have previously shown that bFGF enhances the 
adipogenic differentiation of BMSCs in 2-D and 3-D cell culture [29,53]. Therefore, we 
supposed an enhancing effect of bFGF on the adipocyte differentiation of ADSCs as well. 
ADSCs were seeded at a density of 30,000 cells/cm2 in basal medium supplemented with 
3 ng/ml bFGF and cells grew to confluence within two days. At this time, cell densities were 
comparable between the groups with or without addition of bFGF as observed by microscopy 
(data not shown). Subsequently, adipogenic differentiation was induced with induction 
medium supplemented with 3 ng/ml bFGF. The adipogenic potential after induction of 
ADSCs was clearly enhanced in the presence of bFGF compared to control. At day 12 after 
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induction, the number of oil red O stained cells was strongly increased by addition of bFGF 
(Figure 5 A). This observation was verified by measurement of the intracellular TG content 
(Figure 5 B) as well as the GPDH activity (Figure 5 C). 
 
 
Figure 5: Effect of bFGF on the TG accumulation of ADSCs. ADSCs were expanded and, 
subsequently, induced to undergo adipogenesis in the absence or presence of 3 ng/ml bFGF. TG 
accumulation was determined at day 12 after induction. A) Oil red O staining of intracellular lipid 
droplets. Bar=200 µm. B) Quantification of intracellular TG content (n=3). TG contents were 
normalized to DNA contents. C) Measurement of specific GPDH activity (n=3). Enzyme activity was 
normalized to DNA contents. * indicates statistically significant differences to the control group 
(p<0.05). 
4.5. Effect of AA-supplemented media on adipogenesis of ADSCs  
A promoting effect of AA on adipogenesis of BMSCs was previously reported by Weiser et 
al. [37]. Accordingly, we tested the influence of AA on the adipogenic conversion of ADSCs. 
For this purpose, expansion, induction and differentiation of ADSCs were performed in the 
presence of 50 µg/ml AA. Afterwards, adipogenic differentiation of ADSCs was monitored at 
day 12 after induction (Figure 6). Oil red O staining revealed that AA supplementation 
remarkably decreased the number of differentiated ADSCs when compared to the respective 
group propagated without AA (Figure 6 A), whereas the proliferation of ADSCs was 
increased in presence of AA (Figure 6 A, right). The reduced adipogenic potential of ADSCs 
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in the presence of AA was confirmed by quantification of the intracellular TG (Figure 6 B) 
and by measurement of the GPDH activity (Figure 6 C).  
 
 
Figure 6: Effect of AA on the TG accumulation of ADSCs. ADSCs were expanded and, subsequently, 
induced to undergo adipogenesis in the absence or presence of 50 µg/ml AA. TG accumulation was 
determined at day 12 after induction. A) Oil red O staining of intracellular lipid droplets. Bar=200 µm. 
B) Quantification of intracellular TG content (n=3). TG contents were normalized to DNA contents. 
C) Measurement of specific GPDH activity (n=3). Enzyme activity was normalized to DNA contents. 
* indicates statistically significant differences to the control group (p<0.05). 
5. Discussion 
ADSCs are an attractive in vitro model system to study adipocyte biology or adipose-related 
diseases such as obesity or type 2 diabetes. The major advantages of ADSCs are their easy 
harvest in a large quantity as well as their expansion and differentiation capacity in vitro. 
However, to date, studies using ADSCs in different models have yielded varying results. 
Variability may reflect differences between individual donors as well as differences in 
isolation, culturing, and expansion methods.  
In this study we tested different conditions for ADSC isolation and in vitro expansion as well 
as adipogenic differentiation, some of them already being used in experimental protocols. 
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Evaluation of the isolation procedure 
The standard protocol for isolation of ADSCs from adipose tissue introduced by Rodbell et al. 
and broadly applied by most scientists is performed by enzymatic digestion and subsequent 
centrifugation [47,48]. We modified this standard isolation procedure according to Rodbell et 
al. as well as Schling et al. [54] to improve the yield of isolated ADSCs and their adipogenic 
differentiation potential. Firstly, we introduced two filtration steps after the digestion and 
tested the effect on adipogenic differentiation of ADSCs. The additional filtrations enhanced 
the purity of the cell suspension. Debris of digested connective tissue and other ECM 
components as well as mature adipocytes were removed. Thus, the percentage of adipogenic 
progenitors within the heterogeneous cell population was enriched and, accordingly, the 
differentiation efficiency as well. Some protocols reported in literature have implemented the 
lysis of erythrocytes after the centrifugation [55,56] which is another possibility to advance 
the purity of ADSCs. In our studies, the erythrocyte lysis did not affect the adipogenic 
capacity of the cells. Washing of the cells one day after seeding apparently also removed non-
adherent cells including erythrocytes, and therefore, it had the same effect than erythrocyte 
lysis. Besides the modifications in isolation procedure that we have performed, the recovery 
of ADSCs can be improved further by manipulating the centrifugation speed [57]. 
Nevertheless, even if we observed an influence of the isolation procedure on adipogenic 
differentiation, Mizuno et al. have described that the immunophenotype of ADSCs was 
relatively constant regardless of differences in isolation and culture procedures [8]. 
In conclusion, we modified the standard isolation procedure from Rodbell et al. by 
introduction of two additional filtration steps which was proven to be beneficial for ADSC 
adipocyte culture. In contrast, the lysis of erythrocytes was not effective and, therefore, not 
implemented in the protocol.  
Differences in adipogenic potential of ADSCs from multiple donors 
We have observed that ADSCs isolated from eleven individual human donors showed varying 
adipogenic differentiation capacity in response to adipogenic stimulation in vitro. 
Microscopic inspection as well as flow cytometry examining lipid accumulation revealed that 
the fraction of cells within the heterogeneous cell population which was able to differentiate 
into adipocytes under adipogenic conditions differed extensively between the tested donors. 
The variability found in ADSC cultures is commonly known. Bunnell et al. have previously 
reported that the percentage of preadipocytes obtained from the SVF after digestion is patient-
dependent and, therefore, the differentiation efficiency as well [58]. Various factors such as 
age, gender or disease state of the donor are discussed to be responsible for the heterogeneous 
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behavior of ADSCs in vitro [9,59-61]. Additionally, different genetic constitution of the 
donors may play a role for the patient-to-patient variability [62]. Furthermore, different 
characteristics of ADSCs isolated from different regions of the body have been reported 
[59,63-66]. For example, human subcutaneous adipose tissue contained more ADSCs 
compared to omental adipose tissue, and the ADSCs from subcutaneous tissue had a higher 
adipogenic differentiation capacity [65].  
In independent studies, we investigated whether the method to obtain adipose tissue has an 
influence on the differentiation potential of ADSCs. We compared ADSCs obtained from 
abdominoplasties and lipoaspirates of the same donor regarding their adipogenic 
differentiation capacity. The different procedures did not influence the yield as well as the 
adipogenic potential of isolated ADSCs (data not shown). Differences in ADSC culture 
depending on the fat harvesting technique used are controversially discussed in literature. 
Some studies reported that lipoaspiration yielded more isolated ADSCs with better 
proliferation and adipogenic differentiation rate [67-69], whereas, in contrast, Yoshimura et 
al. reported that disruption of cells was caused in ultrasound-assisted liposuction and the 
number of isolated ADSC as well as their proliferative capacity was reduced [70]. In turn, 
other researchers reported that the type of surgical procedure did not affect the total number of 
viable cells that can be obtained from the SVF [71-73].  
Addition of human plasma 
It was supposed that human plasma contains multiple components with the potential to 
promote adipogenic differentiation of ADSCs. However, we have observed that the 
supplementation of human plasma into the medium during the entire culture period did not 
enhance the adipogenic potential of ADSCs. In other studies, a positive effect of human 
plasma on adipogenesis of various cells was reported. Lin et al. have shown that a medium 
supplemented with 10% human plasma promoted the propagation of BMSCs and preserved 
the adipogenic differentiation capacity of the cells [22]. Furthermore, it was reported that 
differentiation capacity depended on the concentration of plasma and adult serum as well as 
the species the plasma was derived from [21,74]. However, comparisons with data from 
literature are difficult due to different cell species, human plasma, and cultivation conditions.  
Addition of bFGF 
Under our culture conditions, bFGF did not affect proliferation of ADSCs, whereas 
adipogenic conversion was significantly increased in the presence of bFGF. The absent effect 
of bFGF on the proliferation of ADSCs was somehow unexpected since in literature an 
increasing proliferation was described [75,76]. Different culture conditions including varying 
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bFGF concentrations could be the reason for this inconsistency. With regard to adipogenesis, 
a promoting effect of bFGF has previously been reported in BMSCs [29]. Simultaneously to 
our experiments, Kakudo et al. also investigated the effect of bFGF on the adipogenic 
differentiation of ADSCs and they also observed an enhanced adipogenesis [75]. 
Additionally, recent studies from Lee et al. revealed that ADSCs which were expanded in 
vitro with bFGF and dexamethasone exhibited a higher tendency to differentiate into both 
osteoblasts and adipocytes [77]. 
The underlying mechanisms by which bFGF influences proliferation and differentiation of 
MSCs are poorly characterized. Different hypotheses for this are discussed in literature. It has 
been reported that bFGF modulates the cell morphology via alterations of the cytoskeletal and 
ECM organization [78,79] and it is known that matrix remodeling is important for adipocyte 
conversion during which adipocytes change their morphology from a spread to a spherical 
shape [80]. Another discussed theory includes bFGF as mitogen for a distinct subset of MSCs 
[52,79]. Basic FGF is assumed to stimulate the proliferation of a subpopulation of ADSCs 
within the heterogeneous cell pool which preferentially differentiates into adipocytes. This 
hypothesis has to be further investigated by culturing single cell clones of ADSCs. Finally, 
bFGF could influence the adipogenesis of ADSCs on the molecular level. In 3T3-L1, bFGF 
directly increased the expression of adipogenic key transcription factors like PPARγ and 
CCAAT/enhancer-binding protein α (C/EBPα) via the MEK/ERK signaling pathways 
[75,81]. 
In conclusion, the addition of bFGF was found to be suitable for ADSC culture, most notably 
due to its enhancing effect on adipogenic differentiation. 
Addition of AA 
We have demonstrated that AA increased the proliferation of ADSCs, whereas the adipogenic 
differentiation potential was decreased. However, our findings are inconsistent with data from 
literature in which AA stimulated both the proliferation and the adipogenic differentiation of 
various cell types such as 3T3-L1, BMSCs or ADSCs [35,37,38,67]. However, different cell 
systems as well as culture conditions make the comparison of our results with literature 
difficult. 
We assumed that AA promoted the proliferation of a subpopulation within the heterogeneous 
cell population that was not capable of undergoing adipogenesis, similar to the hypothesis for 
bFGF as discussed above. Consequently, the percentage of adipogenic progenitors would be 
reduced resulting in a decreased adipogenic differentiation rate. The effect of AA is often 
linked to collagen synthesis and secretion [36,67,82]. AA is an important cofactor for the 
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activity of prolyl hydroxylase which is responsible for the hydroxylation of proline and lysine 
residues [39,83]. These hydroxylations are essential for the assembly of collagens into triple 
helices and subsequent secretion. Although the importance of matrix remodeling including 
alterations in collagen structures in adipogenesis was previously reported [80,84], we suppose 
that increased collagen synthesis may be obstructive for the expansion of lipid droplets. 
During maturation, adipocytes storing TGs within lipid droplets demand flexible surroundings 
for their development and expansion. Khan et al. have reported if the rigidity of the ECM 
surrounding adipocytes increased, the adipocytes were constricted to further expand due to 
massive pressure on the plasma membrane [85]. Thus, the correct assembly of the ECM 
during differentiation is important for adipocyte conversion. Finally, it cannot be excluded 
that other actions or mechanisms triggered by AA are responsible for the decreased 
adipogenic differentiation.  
In conclusion, we determined an isolation procedure as well as culture conditions for the 
adipogenic differentiation of ADSCs in vitro. Concerning the isolation procedure, we 
introduced two additional filtration steps resulting in a more purified SVF. Subsequently, the 
adipogenic culture of the ADSCs was advanced by addition of bFGF into the conventionally 
used growth, induction, and differentiation media. The developed in vitro adipocyte model 
system with human ADSCs was used for the study of the effect of substances used for 
injection lipolysis in the following chapter. 
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1. Abstract 
In the last years, the interest in non-invasive aesthetic procedures to reduce localized 
subcutaneous fat deposits has globally increased. Injections with Lipostabil®, a 
phosphatidylcholine (PC) and sodium deoxycholate (DC) containing agent have been 
developed to a practicable application for reduction of the volume of small, localized fat 
deposits and lipomas. The underlying mechanisms are mostly unknown to date. It is 
controversially discussed which ingredient of the Lipostabil® formula is the active one. 
Whereas cytolytic actions caused by DC have been already reported, the induction of lipolytic 
activity by PC, DC or Lipostabil® has not been investigated so far. Therefore, we studied the 
cellular effects caused by the single components DC and PC as well as by Lipostabil® itself 
on adipocytes by using in vitro cell model systems. In vitro dose-response relationships of 
these three substances were determined for adipocytes derived from 3T3-L1 and human 
adipose-derived stem cells (ADSCs). Additionally, effective doses of buflomedil and 
pentoxifyllin, both vasodilators which were supplemented to the injection compound of 
Lipostabil®, were investigated on 3T3-L1 cells. Changes in cell membrane integrity were 
evaluated microscopically. In addition, cell viability was determined with dimethyl thiazolyl 
diphenyl tetrazolium (MTT) assay and lipolytic activity was analyzed by measurement of the 
glycerol amount as a biochemical lipolysis substrate. Cell membrane lysis resulting in a 
significant loss of cell viability was seen in differentiated adipocytes treated with different 
concentrations of isolated DC. In comparison to DC, Lipostabil caused similar effects. In 
contrast, adipocytes only treated with PC did not show any cytotoxic effects. Furthermore, no 
membrane and cell damaging effects were caused by the vasodilators. Neither DC, nor PC, 
nor Lipostabil® led to an induction of lipolytic activity. Further experiments revealed that high 
concentrations of PC were able to protect cells against the cytotoxic effects caused by DC.  
In conclusion, our results suggest that Lipostabil® which is used for injection lipolysis does 
not induce the lipolytic pathway. On the contrary, the reduction of adipose tissue volume is 
attributed to disruption of the cell membrane integrity caused by the detergent action of DC.
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2. Introduction 
Injection lipolysis, also named fat dissolution, describes a procedure in aesthetic medicine for 
reduction of localized fat accumulations by subcutaneous injection of substances that induce 
destruction of adipocytes [1-3]. Soy-derived PC which is available as Lipostabil®  (Natterman 
& Cie GmbH, Köln, Germany) is frequently used to treat fat deposits by this procedure [2-7]. 
However, to date, the subcutaneous injection of Lipostabil® is not licensed, in contrast to oral 
and intravenous administration of Lipostabil® which is permitted in several countries as 
therapies for hyperlipidemia, peripheral vascular disease, cardiac ischemia, and liver disease 
[8-13]. 
The Lipostabil® formula mainly consists of PC and DC [5]. The bile salt DC is used to 
dissolve PC by forming mixed micelles [14,15]. For decades, the combination of intravenous 
medications with bile salts is commonly used to improve the aqueous solubility [16-19]. 
Many of the physicians supplement the Lipostabil® formula with various additives such as 
aminophylline, vasodilators, multivitamins, collagenase, hyualuronidase, and lidocaine to 
increase the efficacy of the formula [20]. The commonly used mixture which is instructed by 
the “Network-Lipolysis” for injection lipolysis consists of Lipostabil® (50 mg/ml PC) 
supplemented with 0.9% sodium chloride as diluent (50%), 5% buflomedil as vasodilator, and 
1% vitamin B complexes.  
The mechanism of Lipostabil® causing localized fat reduction is unknown so far. Several 
authors described PC as the active component of the subcutaneous injection of Lipostabil®, 
presumably due to its known lipid-lowering effect in serum following oral and parenteral 
administration [3,5,21]. Stimulation of lipase activity, emulsification and transport of 
triglycerides, and detergent effects were suggested as underlying mechanisms of action of PC 
[1,5,21]. However, some authors proposed that DC was responsible for the reduction of fat 
deposits by its detergent action [22]. Like other physiologic bile salts, DC possesses detergent 
properties with polar lipids [23,24]. This detergent action was recently shown to cause 
nonspecific lysis of cell membranes [22,25]. Injection of DC also reduces sizes of human 
lipomas which is accompanied by focal necrosis, acute inflammation, and hemorrhage as 
detected histologically [26]. Other recent studies showed that injection of Lipostabil® affected 
adipose tissue by disruption of fat cells following an inflammatory reaction similar to 
panniculitis [2,27]. Investigations of the expression of different pro-inflammatory cytokines 
after injection of Lipostabil® into lipomas showed changes of the cytokine profile including 
increased expression of tumor-necrosis factor-α (TNF-α), interferon-γ (INF-γ), and several 
interleukins (e.g. interleukin 6, 8, and 10) [28]. 
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Nevertheless, complications following injection of Lipostabil® were relatively rare, mild, and 
temporary [29]. The most frequently observed side effects were transient burning, edema and 
erythema at the injection site, swelling immediately after injection, persistent pain beyond two 
weeks, late itching, hyperpigmentation, hives, bacterial infections, and skin contour 
deformities. Lipid, liver, and renal profiles were not altered after treatment with PC [5]. No 
patients were reported to die or need hospitalization. Nevertheless, due to lack of scientific 
studies, the safety and efficacy of this injection lipolysis remain ambiguous to most patients 
and physicians. The use of Lipostabil® or PC compounds for injection lipolysis is still an “off-
label” use which means an application aside from its initial description. For a widely 
approved use of injection lipolysis, scientific data concerning the mechanism of action and 
safety are necessary.  
Therefore, the aim of our study was to investigate cellular effects of Lipostabil® and the 
particular components DC and PC on differentiated adipocytes in vitro. Different doses and 
exposure times of Lipostabil®, PC, and DC were analyzed. Furthermore, the concentration-
dependent effects of the vasodilators buflomedil and pentoxifyllin were investigated. The 
murine 3T3-L1 preadipocyte cell line, a widely utilized model system for characterization of 
adipocyte biology [30-32], was initially used in this study. In addition, further studies were 
done with adipogenically induced ADSCs as a model system for human cells [33-37]. Finally, 
we investigated whether the different substances stimulate simple cell death or a lipolytic 
pathway within the adipocytes by using enzymatic assays and propidium iodide staining. 
3. Materials and Methods 
Materials 
Murine 3T3-L1 preadipocytes were obtained from ATCC (Manassas, VA, USA). ADSCs 
were isolated from human abdomen lipoaspirate obtained from cosmetic surgery as described 
in detail in chapter 3 (Page 47). Dulbecco’s Modified Eagle’s Medium (DMEM) and 
Dulbecco’s Modified Eagle’s Medium Ham’sF12 (DMEM Ham’sF12) were purchased from 
Biochrom (Berlin, Germany). Fetal bovine serum (FBS, Lot. No. 40A0044K), phosphate 
buffered saline (PBS), 0.25% trypsin-EDTA solution, and penicillin-streptomycin solution 
were from Invitrogen (Karlsruhe, Germany). Collagenase NB4 and 3-isobutyl-methylxanthine 
(IBMX) were bought from Serva Electrophoresis (Heidelberg, Germany). Papainase was from 
Worthington (Lakewood, NJ, USA). Bovine insulin was kindly provided by Sanofi-Aventis 
(Frankfurt a. M., Germany). Minimum Essential Medium alpha modification (α-MEM), 
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cortisol, dexamethasone, corticosterone, indomethacin, transferrin, biotin, pantothenic acid, 
glucose, fatty acid-free bovine serum albumin, cysteine, bovine DNA, 2-mercaptoethanol, 
dimethylsulfoxide (DMSO), isoproterenol, MTT, DC, propidium iodide, and oil red O were 
obtained from Sigma-Aldrich (Taufkirchen, Germany). Hoechst 33258 dye was obtained from 
Polysciences (Warrington, PA, USA). Basic FGF was from R&D Systems (Minneapolis, MN, 
USA). Pure PC was acquired from Lipoid GmbH (Ludwigshafen, Germany). If not stated 
otherwise, all other chemicals were from Merck KGaA (Darmstadt, Germany). Deionized 
water was obtained using a Milli-Q water purification system from Millipore (Schwalbach, 
Germany). All cell culture plastics were purchased from Corning (Bodenheim, Germany). 
Lipostabil® was obtained from Nattermann Pharma (Köln, Germany). The exact composition 
is given in Table 1. 
Table 1: Composition of Lipostabil®  




Sodium deoxycholate 25.3 mg 
Benzyl alcohol 9 mg 
Sodium chloride 3.6 mg 
Sodium hydroxide 2.53 mg 
DL-α-tocopherol 0.15 mg 
Ethanol 3 mg 
Sterile water 907.8 mg 
 
3.1. Cell culture 
3.1.1. Expansion and differentiation of 3T3-L1 
3T3-L1 is a mouse embryonic fibroblast cell line. These cells are derived from the original 
line 3T3-Swiss albino and are used as an in vitro model of adipocytes [32]. 3T3-L1 
preadipocytes were expanded in DMEM supplemented with 10% FBS, penicillin (100 U/ml), 
and streptomycin (100 µg/ml) [30,31]. Preadipocytes were seeded in basal medium (α-MEM, 
10% FBS, penicillin (100 U/ml), and streptomycin (100 µg/ml)) into tissue-culture 
polystyrene well plates at a density of 40,000 cells/cm2. This high seeding density guaranteed 
that two-dimensional (2-D) cultures grew to confluence within two days after seeding. 
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Hormonal induction was initiated two days after seeding by replacing the basal medium with 
induction medium (basal medium with 1 µM insulin, 0.1 µM corticosterone, 0.5 mM IBMX, 
and 60 µM indomethacin [30,31]. The time point of induction was referred to as day 0 
throughout all experiments. At day 2, the medium was exchanged with differentiation 
medium (basal medium, 1 µM insulin). Subsequently, cells were fed by changing the 
differentiation medium every other day up to day 8. Cells were incubated in a humidified 
atmosphere at 37°C and 5% CO2 during the complete culture period. 
3.1.2. Isolation, expansion, and differentiation of ADSCs 
ADSCs were isolated from human subcutaneous adipose tissue obtained during abdominal 
plastic surgery from healthy women or men aged 17 - 69 years as previously described in 
chapter 3 (Page 47). Briefly, adipose tissue was extensively washed in PBS. After removal of 
connective tissue and blood vessels, minced adipose tissue was subjected to enzymatic 
digestion using a 0.1% collagenase solution at 37°C for 4 hours on an orbital shaker 
(150 rpm) in order to obtain a single-cell suspension. Lipoaspirates were directly transferred 
to the collagenase solution containing 1 mg/ml collagenase NB4, 15 mg/ml bovine serum 
albumin, 100 mM 2-[-4-(2-hydroxyethyl)1-piperazinyl]-ethan-sulfonic acid (HEPES), pH 7.4, 
120 mM NaCl, 50 mM KCl, 1 mM CaCl2, and 5 mM glucose. The suspension was filtrated 
twice through a 100 µm nylon filter (BD Biosciences, San Jose, CA, USA) and centrifuged at 
700 g for 7 minutes. The resulting pellet, termed the stromal vascular fraction (SVF), was 
resuspended in basal medium consisting of DMEM/DMEM Ham’sF12-Medium (1:1), 10% 
FBS, penicillin (100 U/ml), streptomycin (100 µg/ml), 1 µM insulin, 2 µg/ml transferrin, 
1 µM biotin, 17 µM pantothenate, and 3 ng/ml bFGF [38]. Cells were seeded in T75 culture 
flasks and cultured in a humidified atmosphere at 37°C and 5% CO2 or were cryopreserved in 
liquid nitrogen. Cryopreservation medium consisted of basal medium supplemented with 10% 
DMSO. In the case of following cultivation, cells were allowed to adhere to the substratum 
for one day. The flasks were rinsed twice with PBS in order to remove erythrocytes and other 
non-adherent cells. Cells were expanded (proliferation phase) in basal medium up to 
passage 3. Cyropreserved cells were similarly expanded up to passage 3 after thawing. 
For experiments, cells were seeded in basal medium into tissue-culture polystyrene well 
plates (Corning, Bodenheim, Germany) at a density of 30,000 cells/cm2. At confluence, cells 
were induced to undergo adipogenesis by supplementing basal media (without FBS) with 
100 nM cortisol, 500 µM IBMX, 1 nM triiodothyronine, 500 nM troglitazone, and 3 ng/ml 
bFGF named as induction medium [38]. The time point of induction was referred to as day 0 
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throughout all experiments. At day 2, the medium was exchanged with differentiation 
medium (basal medium without FBS, 100 nM cortisol, 1 nM triiodothyronine, 500 nM 
troglitazone, and 3 ng/ml bFGF). During the entire culture period, medium was exchanged 
every two days and cells were incubated in a humidified atmosphere at 37°C and 5% CO2. 
3.2. Microscopical analysis of treated cells 
Differentiated adipocytes were incubated with varying concentrations of Lipostabil®, PC, DC, 
buflomedil, and pentoxifyllin. Afterwards, microscopical bright field pictures of treated cells 
were acquired at 20x magnification using a CCD camera (DS-5M, Nikon, Düsseldorf, 
Germany) attached to an inverted microscope (Leica DM IRB, Leica Microsystems, Wetzlar, 
Germany) or at 63x magnification using a Zeiss Axiovert 200 M microscope equipped with a 
Zeiss AxioCam HRc camera and the software LSM Image Browser (Carl Zeiss MicroImaging 
GmbH, Jena, Germany). 
3.3. Measurement of lipolysis 
The hydrolysis of triglycerides into glycerol and free fatty acids is defined as lipolysis. This 
reaction is mainly catalyzed by the hormone-sensitive lipase and the adipose-triglyceride-
lipase. The lipolytic activity of cells can be determined based on the measurement of the 
developed glycerol during lipolysis which is secreted by cells into the medium. Subsequently, 
glycerol is metabolized to glycerol-1-phosphate and following dihydroxyacetone phosphate 
caused by enzymatic reactions. Thereby, hydrogen peroxides are produced which can be 
quantified through a peroxidase-coupled reaction. The produced quinoneimine dye shows an 
absorbance maximum at 540 nm. The increase in absorbance at 540 nm is directly 
proportional to the free glycerol concentration of the sample. The lipolytic activities of the 
investigated substances are compared with the basal lipolytic activity of the cells cultured in 
differentiation medium and with lipolysis stimulated via the β-adrenergic receptor. 
Isoproterenol is a known agonist of the β-adrenergic receptor and is commonly used 
experimentally to induce lipolysis [31]. 
At day 8 after initiation of adipogenesis, the cells were washed with serum-free medium and 
then maintained in the same medium for 2 hours to avoid interference with serum factors. 
Subsequently, medium was replaced by PBS supplemented with 3% fatty acid-free bovine 
serum albumin (BSA) and the experimental substances with varying concentrations and 
10 µM isoproterenol, respectively. After incubation for 4 hours, the conditioned buffer was 
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centrifuged (13,200 rpm, 5 minutes, 4°C) and then frozen at -20°C until the enzyme coupled 
enzymatic serum triglyceride determination kit from Sigma-Aldrich (Taufkirchen, Germany) 
was conducted according to the manufacturer’s instructions. Briefly, the samples were mixed 
with GPO-Trinder A, an enzyme that produces quinoneimine dye from glycerol in several 
steps. The quinoneimine dye was photometrically measured at 540 nm and the absorbance 
was directly proportional to the glycerol content. The amount of glycerol per well was 
calculated and normalized to the cell number per sample as determined by the DNA assay.  
3.4. Determination of cell viability with MTT assay 
Adipogenically differentiated 3T3-L1 were treated at day 8 with indicated concentrations of 
the reagents for 4 hours at 37°C before determination of cell viability using the MTT assay. In 
this assay, yellow tetrazolium salts are metabolized by intact mitochondria and produce a 
color change to blue when bioreduced to formazan derivatives. The treated cells were 
incubated in differentiation medium containing 0.5 mg/ml MTT for 4 hours at 37°C. 
Subsequently, the supernatant was removed and the produced formazan derivatives were 
dissolved by 10% SDS/0.01 M HCl. Cell viability was analyzed photometrically (570-
590 nm). The intensity of the blue color correlates with the metabolic activity of living cells. 
Cells treated with 1% Triton X-100 were used to determine maximally reduced cell viability.  
3.5. Determination of the DNA content with DNA assay 
After washing with PBS, 3T3-L1 were harvested in lysis buffer (50 mM Tris, 1 mM EDTA, 
1 mM 2-mercaptoethanol, pH 7.5) and sonicated with a digital sonifier (Branson Ultrasonic 
Corporation, Danburg, CT, USA). Aliquots of the cell lysates were digested with papainase 
(3.2 U/ml in 0.1 M Na2HPO4 buffer, pH 6.5 containing 1 mM Na2EDTA and 2.5 mM 
cysteine) for 16 hours at 60°C, and the DNA content was determined using the intercalating 
Hoechst 33258 dye (0.1 µg/ml in 0.1 M NaCl containing 1 mM Na2EDTA, 10 mM Tris, pH 
7.4) [39]. Fluorescence intensities were determined at 365 nm excitation wavelength and 
458 nm emission wavelength on a LS 55 Fluorescence Spectrometer (PerkinElmer, 
Wiesbaden, Germany) and correlated to DNA contents using standard dilutions of double-
stranded DNA (from calf thymus). 
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3.6. Determination of membrane integrity with propidium iodide staining 
Propidium iodide (PI) intercalates into double-stranded nucleic acids. Under normal 
condition, PI is excluded by viable cells but it is ingested by dying or dead cells [40,41]. In 
our experiments, staining was used to evaluate the cell membrane integrity of the exposed 
cells. Cells were treated with varying concentrations of Lipostabil®, PC or DC for 4 hours at 
37°C, 5% CO2. Subsequently, cells were stained with 5 µg/ml PI added to medium for 
5 minutes. Then, medium was replaced by fresh medium without PI and experimental agents. 
Cells treated with 1% Triton X-100 served as a positive control. PI has an absorption 
maximum at 535 nm and a fluorescence emission maximum at 617 nm and can be excited 
with an argon-ion laser. Microscopical fluorescence pictures were acquired at 63x 
magnification using a Zeiss Axiovert 200 M microscope equipped with a Zeiss AxioCam HRc 
camera and the software LSM Image Browser (Carl Zeiss MicroImaging GmbH, Jena, 
Germany). 
3.7. Statistics 
All quantitative results are presented as mean values ± standard deviation. Statistical analyses 
were determined using GraphPadPrism v.5 (GraphPad Software, La Jolla, CA, USA). 
Differences between multiple groups were analyzed for significance using one-way analysis 
of variances (ANOVA) with subsequent multiple comparisons according to Tukey’s post hoc 
test. A value of p<0.05 was regarded as statistically significant.  
4. Results 
4.1. Cytotoxic effects of the different substances on 3T3-L1 
First, we evaluated the concentrations at which the substances PC, DC, and the combined 
formula of Lipostabil® affected adipocytes in vitro by use of the murine 3T3-L1 preadipocyte 
cell line.  
4.1.1. Effect of doses and exposure times of DC on 3T3-L1 
3T3-L1 were hormonally induced to undergo adipogenesis. At day 8 after induction, the 
adipocytes were incubated with varying concentrations of DC to identify the effective range 
of the substance in vitro. In the first experiment, concentrations of 0.001 mg/ml to 10 mg/ml 
were used. For comparison, the Lipostabil® formulation which is applied for injection 
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lipolysis contains 12.65 mg/ml DC. We observed that the lowest concentration of 
0.001 mg/ml did not affect cells, whereas concentrations higher than 0.5 mg/ml were toxic 
resulting in completely dead cell population (data not shown). Therefore, in the following 
experiment, the concentration range was limited from 0.01 mg/ml to 0.1 mg/ml DC. 
Differentiated 3T3-L1 were incubated with the indicated concentrations of DC for 4 hours 
and subsequently analyzed under the microscope (Figure 1 A).  
  
Figure 1: Incubation of 3T3-L1 with varying concentrations of DC. 3T3-L1 were induced by a 
hormonal cocktail to undergo adipogenic differentiation. A) At day 8 after induction, the differentiated 
adipocytes were treated with 0.01 mg/ml (b), 0.05 mg/ml (c) or 0.1 mg/ml (d) DC for 4 hours. 
Untreated differentiated adipocytes served as control (a). Black arrows designate cells with disrupted 
cell membranes. B) PI staining of differentiated 3T3-L1 after treatment with DC. At day 8 after 
induction, the differentiated adipocytes were treated with 0.01 mg/ml (c), 0.05 mg/ml (d) or 
0.1 mg/ml (e) DC. Untreated differentiated adipocytes served as negative control (a), whereas 
adipocytes treated with 1% Triton X-100 were used as positive control (b). After 4 hours, cells were 
stained with 5 µg/ml PI and, subsequently, inspected under the confocal laser scanning microscope. In 
the upper row (a-e), PI-stained cells are presented in red on the fluorescence images. The lower row 
(a’-e’) shows an overlap of the fluorescence images with the corresponding phase-contrast images. 
Bar=20 µm.  
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The low concentration of 0.01 mg/ml DC did not have effects on 3T3-L1 adipocytes. The 
cells were vital with intact cell membranes similar to non-treated control cells (Figure 1 A, a 
and b). An increasing concentration of 0.05 mg/ml DC caused changes in cell morphology 
indicated by disrupted cell structures and membranes (Figure 1 A, c). This effect was stronger 
with higher concentration (Figure 1 A, d).  
In the following, the previous observations were verified by PI staining (Figure 1 B). PI is a 
DNA-intercalating agent which is not able to penetrate cells with intact cell membranes. 
Therefore, this dye is used for staining of necrotic cells with interrupted membranes after 
treatment with DC. Differentiated 3T3-L1 adipocytes were treated with the same 
concentrations of DC as described above. After an incubation period of 4 hours, cells were 
stained with 5 µg/ml PI for 5 minutes and analyzed under the confocal laser scanning 
microscope (Figure 1 B). PI exposure was kept short otherwise cells would be affected by PI 
over time. PI-stained cells showed a red fluorescence. Triton X-100 was used as positive 
control due to its detergent action which causes cell membrane lysis. As shown in 
Figure 1Figure 1 B, b, Triton X-100 led to disruption of the cell membranes resulting in 
penetration of PI into the cells and following red staining of the nucleus. In presence of DC, 
PI-stained cells were also obvious and the number of stained cells was augmented with 
increasing concentrations. Consistent with previous results, the dose of 0.01 mg/ml DC did 
not influence cell integrity (Figure 1 B, c), only few cells were stained by PI which was also 
the case in the control group (Figure 1 B, a). Enhancement of the concentration to 0.05 mg/ml 
DC elicited a clear increase of PI-stained adipocytes (Figure 1 B, d). As expected, the number 
of PI-stained adipocytes indicating necrotic cells further increased with higher DC 
concentrations (Figure 1 B, e). This experiment verified the effective concentrations of DC. 
The concentration of 0.05 mg/ml DC was identified as the lowest effective one as shown by 
brightfield images (Figure 1 A) and fluorescence images (Figure 1 B).  
In addition, exposure time of DC was investigated. For this purpose, differentiated 3T3-L1 
were incubated with various concentrations of DC and cell behavior was observed at different 
times over a period of 24 hours (Figure 2). For the determined period, no time-dependent 
effect of DC was detected. 3T3-L1 incubated with DC for two hours behaved comparable to 
cells which were exposed to DC for a longer time. The lysis of cell membranes which was 
observed before (Figure 1) was confirmed in this experiment. Disruption of cells started at the 
concentration of 0.05 mg/ml and the toxic effect was enhanced with increasing 
concentrations. These results approved that an incubation period of 4 hours as already used in 
the previous experiments (Figure 1) was sufficient for identification of toxicity of the 
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substances. Therefore, we maintained the incubation time of 4 hours in the subsequent 
experiments. 
  
Figure 2: Incubation of 3T3-L1 with varying concentrations of DC over a period of 24 hours. 3T3-L1 
were induced by a hormonal cocktail to undergo adipogenic differentiation. At day 8 after induction, 
the differentiated adipocytes were treated with 0.05 mg/ml (b), 0.1 mg/ml (c) or 0.5 mg/ml (d) DC. 
The effect of DC on adipocytes was analyzed after 2 hours (a, b, c, d), after 6 hours (a’, b’, c’, d’), and 
after 24 hours (a’’, b’’, c’’, d’’). Untreated differentiated adipocytes served as control (a). 
Bar=100 µm. 
In the following experiment, the viability of cells after treatment with DC was determined by 
the MTT assay (Figure 3). The MTT assay represents an alternative quantitative method to 
the previously performed PI staining. In this assay, it was identified which concentration of 
DC affected the metabolism of 3T3-L1 adipocytes.  
The absorption of the control was normalized to 100% which represented a vital and 
metabolic active cell population. The cytotoxic detergent Triton X-100 caused a decrease of 
the viability of adipocytes to 40% which was used as positive control. Low DC concentrations 
up to 0.025 mg/ml did not significantly influence the cell viability. Only at higher 
concentration of 0.5 mg/ml DC, the number of viable cells was reduced to about 40% 
comparable to the positive control. The determined toxic concentrations were higher than the 
doses identified by microscopic inspection. In contrast to microscopic analysis in which we 
determined membrane-damaged cells, the MTT assay detected metabolic active cells. The 
disruption of cell membranes is an early event of cell damage finally resulting in the failure of 
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cell metabolism. Therefore, even if the cell membrane was affected, the cells were able to 
metabolize. Accordingly, this explains the decrease of the cell viability at higher DC 
concentrations measured by the MTT assay. The assay was performed exemplarily with 3T3-
L1 treated with DC. The following investigation of the other substances like PC and 
Lipostabil® were done without the additional measurement using MTT assay.  
  
Figure 3: MTT assay of differentiated 3T3-L1 after treatment with DC. 3T3-L1 were induced by a 
hormonal cocktail to undergo adipogenic differentiation. At day 8 after induction, the differentiated 
adipocytes were treated with 0.05 mg/ml, 0.1 mg/ml, 0.25 mg/ml or 0.5 mg/ml DC. Untreated 
differentiated adipocytes served as negative control, whereas adipocytes treated with 1% Triton X-100 
were used as positive control. After incubation for 4 hours, the MTT assay was performed (n=3). Two 
independent cell culture experiments were done; representative data from one experiment are shown.  
* indicates statistically significant differences to the control group (p<0.05).  
4.1.2. Effect of varying concentrations of PC on 3T3-L1 
Analog DC, 3T3-L1 adipocytes were treated with increasing concentrations of PC for 4 hours 
and, subsequently, analyzed microscopically (Figure 4 A). The effect of PC was further 
verified by PI staining of the adipocytes after treatment (Figure 4 B).  
Neither low, nor high concentrations of PC affected the 3T3-L1 adipocytes. The morphology 
of treated cells did not differ from the non-treated control cells. Accordingly, the treated 
adipocytes were not stained with PI (Figure 4 B). This revealed that PC did not have toxic 
effects in vitro. Even the highest PC dose of 15 mg/ml did not induce cytotoxicity 
(Figure 4 B, e) in contrast to DC which caused distinct lysis of the cell membranes.  
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Figure 4: Incubation of 3T3-L1 with varying concentrations of PC. 3T3-L1 were induced by a 
hormonal cocktail to undergo adipogenic differentiation. A) At day 8 after induction, the differentiated 
adipocytes were treated with 1 mg/ml (b), 5 mg/ml (c) or 10 mg/ml (d) PC for 4 hours. Untreated 
differentiated adipocytes served as control (a). B) PI staining of differentiated 3T3-L1 after treatment 
with PC. At day 8 after induction, the differentiated adipocytes were treated with 5 mg/ml (c), 
10 mg/ml (d) or 15 mg/ml (e) PC. Untreated differentiated adipocytes served as negative control (a), 
whereas adipocytes treated with 1% Triton X-100 were used as positive control (b). After 4 hours, 
cells were stained with 5 µg/ml PI and, subsequently, inspected under the confocal laser scanning 
microscope. In the upper row (a-e), PI-stained cells are presented in red on the fluorescence images. 
The lower row (a’-e’) shows an overlap of the fluorescence images with the corresponding phase-
contrast images. Bar=20 µm.  
4.1.3. Effect of varying concentrations of Lipostabil® on 3T3-L1 
After investigation of the effective concentration range of DC and PC which are the main 
components of Lipostabil®, further studies were performed with Lipostabil® itself. Firstly, 
effective in vitro doses had to be identified for this substance according to DC and PC. It was 
assumed that Lipostabil® has similar effects on cells compared to the single components. 
Based on the previously determined effective DC concentrations (Figure 1), we used doses of 
Lipostabil® corresponding to DC concentrations between 0.005 mg/ml and 0.5 mg/ml, 
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resulting in PC concentrations between 0.01 mg/ml and 1 mg/ml. The used PC concentration 
did not have effects when applied as single substance (Figure 4).  
  
Figure 5: Incubation of 3T3-L1 with varying concentrations of PC and DC from Lipostabil®. 3T3-L1 
were induced by a hormonal cocktail to undergo adipogenic differentiation. A) At day 8 after 
induction, the differentiated adipocytes were treated with 0.1 mg/ml (b), 0.25 mg/ml (c) or 
0.5 mg/ml (d) PC in combination with 0.05 mg/ml (b), 0.125 mg/ml (c) or 0.25 mg/ml (d) DC for 
4 hours. Untreated differentiated adipocytes served as control (a). Black arrows designate cells with 
disrupted cell membranes. B) PI staining of differentiated 3T3-L1 after treatment with Lipostabil®. At 
day 8 after induction, the differentiated adipocytes were treated with 0.1 mg/ml (c), 0.25 mg/ml (d) or 
0.5 mg/ml (e) PC in combination with 0.05 mg/ml (c), 0.125 mg/ml (d) or 0.25 mg/ml (e) DC. 
Untreated differentiated adipocytes served as negative control (a), whereas adipocytes treated with 1% 
Triton X-100 were used as positive control (b). After 4 hours, cells were stained with 5 µg/ml PI and, 
subsequently, inspected under the confocal laser scanning microscope. In the upper row (a-e), PI-
stained cells are presented in red on the fluorescence images. The lower row (a’-e’) shows an overlap 
of the fluorescence images with the corresponding phase-contrast images. Bar=20 µm.  
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The lowest concentration of PC and DC did not have effects on cell morphology 
(Figure 5 A, b), whereas the PI staining showed slight cytotoxic effects (Figure 5 B, c). 
Increasing concentrations of DC and PC enhanced the effect and caused cell damages 
(Figure 5 A and B). Lipostabil® with concentrations of 0.5 mg/ml PC and 0.25 mg/ml DC 
provoked tremendous cell destruction resulting in cell death (Figure 5 B, e). The effective 
concentration range of Lipostabil® was comparable to the concentrations which were used for 
studies with DC as single component (Figure 1). 0.05 mg/ml DC was identified as initial 
concentration which caused membrane damages. PC as single substance did not cause such 
effects (Figure 4). These results suggested that DC is the active substance in the Lipostabil® 
compound being responsible for cell disruption (Figure 1 and 5).  
Later, the role of PC in the compound was further investigated with regard to protective 
effects (see 4.3).  
4.1.4. Effect of buflomedil and pentoxifyllin on 3T3-L1 
In injection lipolysis therapy, Lipostabil® has been used with various additives such as 
vasodilators which are assumed to increase the efficacy of the formula [20]. Buflomedil and 
pentoxifyllin which are commercially available as Loftyl® and Trental® are used as 
vasodilators in the compound for injection lipolysis. In the following experiments, the effect 
of both substances on adipocytes was tested in vitro. Differentiated 3T3-L1 adipocytes were 
incubated with different concentrations of buflomedil and pentoxifyllin, respectively. 
Following 24 hours incubation time, cells were inspected microscopically (Figure 6). 
Adipocytes which were incubated with low concentrations of buflomedil were similar to non-
treated cells (Figure 6 A, a-c). The cells were vital with intact cell membranes. Increasing 
concentrations of 2 – 15 mg/ml resulted in cytotoxic effects including membrane damages 
(Figure 6 A, d-f). Similar observations were made in presence of pentoxifyllin (Figure 6 B). 
This vasodilator had also a toxic effect on adipocytes starting at a concentration of 2 mg/ml 
(Figure 6 B, d-f).  
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Figure 6: Incubation of 3T3-L1 with varying concentrations of buflomedil and pentoxifyllin. 3T3-L1 
were induced by a hormonal cocktail to undergo adipogenic differentiation. A) At day 8 after 
induction, the differentiated adipocytes were treated with 0.1 mg/ml (b), 1 mg/ml (c), 2 mg/ml (d), 
10 mg/ml (e) or 15 mg/ml (f) buflomedil for 24 hours. B) At day 8 after induction, the differentiated 
adipocytes were treated with 0.1 mg/ml (b), 1 mg/ml (c), 2 mg/ml (d), 5 mg/ml (e) or 10 mg/ml (f) 
pentoxifyllin for 24 hours. Untreated differentiated adipocytes served as control (A and B, a). 
Subsequently, cells were analyzed under the light microscope. Black arrows designate cells with 
disrupted cell membranes and cell fragments, respectively, whereas white arrows show isolated lipid 
droplets. Bar=50 µm.  
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After investigating the effective in vitro concentration range of the different substances of the 
compound for injection lipolysis, the identified in vitro concentrations were compared with 
the concentrations applied for injection lipolysis in vivo.  
The toxic concentration of DC as single substance or in Lipostabil® in vitro is decreased about 
two orders of magnitude compared to the concentration applied for injection lipolysis. In 
contrast, PC does not affect adipocytes in vitro, even not at concentrations comparable to the 
in vivo applied concentration of 50 mg/ml. Thus, it is assumed that this agent does not cause 
cell damages in vivo, whereas the DC concentration used for injection lipolysis likely acts as 
detergent on the in vivo tissue resulting in cell lysis. Regarding buflomedil and pentoxifyllin, 
the concentrations employed for injection lipolysis therapy are far below the effective doses 
which were identified in vitro. In vivo, 0.25 mg/ml buflomedil and 0.5 mg/ml pentoxifyllin 
are applied, whereas in vitro clearly higher doses have to be used to cause cytotoxic effects. 
Therefore, it is supposed that the concentrations of the vasodilators in the compound for 
injection lipolysis are not toxic in vivo. 
4.2. Lipolytic effect of DC, PC, and Lipostabil® on 3T3-L1 
 
  
Figure 7: Lipolysis assay with 3T3-L1. 3T3-L1 were induced by a hormonal cocktail to undergo 
adipogenic differentiation. At day 8 after induction, the differentiated adipocytes were incubated with 
varying concentrations of the substances. A) Cells were treated with 0.01 mg/ml, 0.05 mg/ml or 
0.1 mg/ml DC added to 3% BSA/PBS. B) Cells were treated with 5 mg/ml, 10 mg/ml or 20 mg/ml PC 
added to 3% BSA/PBS. C) Cells were treated with 0.1 mg/ml, 0.5 mg/ml or 1 mg/ml PC in 
combination with 0.05 mg/ml, 0.25 mg/ml or 0.5 mg/ml DC added to 3% BSA/PBS. Untreated 
differentiated adipocytes served as control for basal lipolytic activity, whereas adipocytes treated with 
10 µM isoproterenol were used as positive control for stimulated lipolysis. After incubation for 
4 hours, the lipolysis assay was performed (n=3). * indicates statistically significant differences to the 
untreated control group (p<0.05). 
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At day 8 after adipogenic induction, the lipolytic cell response of differentiated 3T3-L1 
adipocytes was assessed by measuring the amount of glycerol release into the incubation 
buffer under control conditions and after treatment with Lipostabil®, PC, and DC (Figure 7). 
The stimulation of lipolysis using the receptor agonist isoproterenol resulted in an eight-fold 
increase of the lipolytic activity compared to the basal level. The exposure of the cells to DC 
or PC as single substances did not stimulate lipolysis (Figure 7 A and B). The measured 
glycerol content was similar to the amount released by the non-treated cells. The decreasing 
lipolytic activity detected at a concentration of 0.1 mg/ml DC is possibly due to the extreme 
cytotoxic effect caused by DC as detected microscopically in previous experiments (see 
4.1.1). Unlike the single substances, incubation of the cells with higher concentrations of 
Lipostabil® caused a slight increase of the lipolytic activity compared to the basal lipolysis 
(Figure 7 C).  
4.3. Protective effect of PC against the toxicity caused by DC  
During previous studies, we observed protective properties of PC against the toxic effect of 
high ethanol concentrations. Subsequently, we hypothesized that PC is also able to 
protectively counteract the toxic effect of DC. Protective effects of PC were already discussed 
in literature. Tsuboi et al. reported that lecithins protected from damages of the bile duct by 
antagonizing the cytotoxic effects of bile salts [42].  
To investigate our hypothesis, differentiated 3T3-L1 adipocytes were treated with two 
different concentrations of DC in combination with increasing PC concentrations. Concerning 
DC, concentrations of 0.1 mg/ml and 0.5 mg/ml were chosen due to their high cytotoxicity as 
analyzed previously (see 4.1.1). These samples were supplemented with 5 mg/ml, 10 mg/ml 
or 15 mg/ml PC. After 4 hours, the treated cells were stained with 5 µg/ml PI followed by 
analysis under the confocal laser scanning microscope (Figure 8).  
Both 0.1 mg/ml and 0.5 mg/ml DC damaged the cell membranes resulting in permeation of PI 
into the cell nucleus and intercalation with DNA (Figure 8, A and B, a). With increasing PC 
concentrations the membrane destabilizing effect of DC was reduced which was recognized 
by decreased number of PI-stained adipocytes with increasing doses of PC (Figure 8, A and 
B, b-d).  
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Figure 8: PI staining of differentiated 3T3-L1 after treatment with DC combined with PC. 3T3-L1 
were induced by a hormonal cocktail to undergo adipogenic differentiation. At day 8 after induction, 
the differentiated adipocytes were treated with 0.1 mg/ml (A) or 0.5 mg/ml (B) DC in combination 
with 5 mg/ml (b), 10 mg/ml (c) or 15 mg/ml (d) PC. After incubation for 4 hours, cells were stained 
with 5 µg/ml PI and, subsequently, inspected under the confocal laser scanning microscope. In the 
upper row (a-d), PI-stained cells are presented in red on the fluorescence images. The lower row (a’-
d’) shows an overlap of the fluorescence images with the corresponding phase-contrast images. 
Bar=20 µm. 
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4.4. Cytotoxic effects of the different substances on human ADSCs 
As an approach to human conditions, the following studies were performed with human 
ADSCs as model system. ADSCs were isolated from human subcutaneous adipose tissue as 
described previously (see 3.1.2).  
4.4.1. Effect of varying concentrations of DC on human ADSCs 
  
Figure 9: Incubation of ADSCs with varying concentrations of DC. ADSCs were induced by a 
hormonal cocktail to undergo adipogenic differentiation. A) At day 14 after induction, cells were 
treated with 0.01 mg/ml (b), 0.05 mg/ml (c) or 0.1 mg/ml (d) DC for 4 hours. Untreated ADSCs 
cultured in differentiation medium served as control (a). Black arrows designate cells with disrupted 
cell membranes. B) PI staining of differentiated ADSCs after treatment with DC. At day 14 after 
induction, the differentiated adipocytes were treated with 0.05 mg/ml (c), 0.1 mg/ml (d) or 
0.5 mg/ml (e) DC. Untreated ADSCs cultured in differentiation medium served as negative control (a), 
whereas adipocytes treated with 1% Triton X-100 were used as positive control (b). After 4 hours, 
cells were stained with 5 µg/ml PI and, subsequently, inspected under the confocal laser scanning 
microscope. In the upper row (a-e), PI-stained cells are presented in red on the fluorescence images. 
The lower row (a’-e’) shows an overlap of the fluorescence images with the corresponding phase-
contrast images. Bar=20 µm.  
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To investigate the effect of DC on ADSCs, the cells were hormonally induced to undergo 
adipogenesis. At day 14 after induction, the differentiated ADSCs were treated with various 
concentrations of DC. The concentration range was similar to the one which was identified to 
be effective on 3T3-L1 cells. After an incubation time of 4 hours, the ADSCs were analyzed 
under the confocal microscope (Figure 9 A). The membrane-lysing action of DC was verified 
by PI staining of the cells in additional experiments (Figure 9 B).  
The low DC concentration of 0.01 mg/ml did not affect cell morphology and viability 
(Figure 9 A, b). No differences compared to the control group were visible. The ADSCs were 
vital with an intact cell membrane structure. An increase of the concentration to 0.05 mg/ml 
DC resulted in slight damages of the membranes as shown by few PI-stained cells 
(Figure 9 B, c). The cell lysis progressed with higher concentrations of DC (Figure 9 A      
and B, d). Serious cell damages were observed after treatment with 0.5 mg/ml DC. The 
degree of the damage was comparable to the positive control (Figure 9 B, b and e). The effect 
of DC on ADSCs was not different to that on 3T3-L1 and moreover, identical dose-response 
relationships were characterized. 0.05 mg/ml DC was determined as the lowest concentration 
that affected cells and 0.5 mg/ml DC was a highly cytotoxic concentration. 
4.4.2. Effect of varying concentrations of PC on human ADSCs 
In the following studies, the effect of PC on ADSCs was investigated. ADSCs were induced 
to differentiate into the adipogenic lineage. After differentiation of 14 days, the cells were 
treated with varying concentrations of PC for 4 hours. Microscopic inspection including PI 
staining was performed afterwards (Figure 10). 
As observed for 3T3-L1, PC did not have any cytotoxic effects on the human cell system. 
Even at the highest PC concentration of 15 mg/ml, the cells were vital and did not show any 
morphological changes (Figure 10 A, d). Cells which were treated with 1% Triton X-100 
were extensively stained red by DNA-intercalating PI (Figure 10 B, b), whereas PC treated as 
well as non-treated cells showed no PI-stained cells (Figure 10 B, a, c, d, e). 
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Figure 10: Incubation of ADSCs with varying concentrations of PC. ADSCs were induced by a 
hormonal cocktail to undergo adipogenic differentiation. A) At day 14 after induction, cells were 
treated with 1 mg/ml (b), 5 mg/ml (c) or 15 mg/ml (d) PC for 4 hours. Untreated ADSCs cultured in 
differentiation medium served as control (a). B) PI staining of differentiated ADSCs after treatment 
with PC. At day 14 after induction, the differentiated adipocytes were treated with 5 mg/ml (c), 
10 mg/ml (d) or 15 mg/ml (e) PC. Untreated ADSCs cultured in differentiation medium served as 
negative control (a), whereas adipocytes treated with 1% Triton-X 100 were used as positive control 
(b). After 4 hours, cells were stained with 5 µg/ml PI and, subsequently, inspected under the confocal 
laser scanning microscope. In the upper row (a-e), PI-stained cells are presented in red on the 
fluorescence images. The lower row (a’-e’) shows an overlap of the fluorescence images with the 
corresponding phase-contrast images. Bar=20 µm.  
4.4.3. Effect of varying concentrations of Lipostabil® on human ADSCs 
ADSCs were hormonally induced to undergo adipogenesis and after 14 days, the cells were 
treated with Lipostabil®. Resulting concentrations of DC between 0.025 mg/ml and 0.5 mg/ml 
have been shown to be effective when applied as single substance, whereas concentrations of 
PC between 0.05 mg/ml and 1 mg/ml did not cause any effect. Treated cells were analyzed 
microscopically after 4 hours incubation with Lipostabil® (Figure 11 A). Using PI staining, 
the cytotoxic effect of Lipostabil® was verified (Figure 11 B). 
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Figure 11: Incubation of ADSCs with varying concentrations of PC and DC from Lipostabil®. ADSCs 
were induced by a hormonal cocktail to undergo adipogenic differentiation. A) At day 14 after 
induction, cells were treated with 0.1 mg/ml (b), 0.25 mg/ml (c) or 0.5 mg/ml (d) PC in combination 
with 0.05 mg/ml (b), 0.125 mg/ml (c) or 0.25 mg/ml (d) DC for 4 hours. Untreated ADSCs cultured in 
differentiation medium served as control (a). Black arrows designate cells with disrupted cell 
membranes. B) PI staining of differentiated ADSCs after treatment with PC and DC from Lipostabil®. 
At day 14 after induction, the differentiated adipocytes were treated with 0.1 mg/ml (c), 
0.25 mg/ml (d) or 0.5 mg/ml (e) PC in combination with 0.05 mg/ml (c), 0.125 mg/ml (d) or 
0.25 mg/ml (e) DC. Untreated ADSCs cultured in differentiation medium served as negative control 
(a), whereas adipocytes treated with 1% Triton X-100 were used as positive control (b). After 4 hours, 
cells were stained with 5 µg/ml PI and, subsequently, inspected under the confocal laser scanning 
microscope. In the upper row (a-e), PI-stained cells are presented in red on the fluorescence images. 
The lower row (a’-e’) shows an overlap of the fluorescence images with the corresponding phase-
contrast images. Bar=20 µm.  
As shown in Figure 11 A and B, concentrations of 0.1 mg/ml PC combined with 0.05 mg/ml 
DC did not affect the cell membrane in contrast to the following increased concentration of 
0.25 mg/ml PC and 0.125 mg/ml DC. The toxicity was more enhanced with increasing 
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concentrations of the substances (Figure 11 A, d and B, e). The effective concentration range 
correlated to the concentrations which were identified to be toxic to 3T3-L1. However, human 
ADSCs seem to be more resistant to the substances than 3T3-L1. Exemplarily, comparison of 
the two cell types after treatment with 0.5 mg/ml PC in combination with 0.25 mg/ml DC 
revealed that 3T3-L1 were affected more seriously (Figure 5 and 11). 
5. Discussion 
Injection of Lipostabil® referred to as injection lipolysis has been reported to reduce localized 
fat accumulation [21]. Lipostabil® is mainly composed of PC and DC, of which the latter is 
used for phospholipid solubilization in water. PC has been used for several indications 
including prevention of fat embolism and fibrosis in damaged liver as well as reduction of 
hyperlipidemia by decreasing serum triglycerides [5,12,21,43]. Furthermore, subcutaneously 
injected PC was used for reduction of adipose tissue volume [1,4-6,26,44,45]. The underlying 
mechanisms of fat reduction after injection of Lipostabil® have not been identified so far. It is 
controversially discussed which component of Lipostabil® is the crucial agent. Some 
investigators hypothesized that PC is responsible for the reduction of adipose tissue. They 
hypothesized that PC bursts the cell membranes of adipocytes due to its bipolar character 
resulting in the induction of lipase activity. The released lipases produce a local breakdown of 
fat that is then metabolized via beta-oxidation in the liver [1,46]. In contrast to this 
hypothesis, other investigators reported that PC is not the active substance in Lipostabil® for 
subcutaneous lipolysis [7,22,45,47]. Rotunda et al. showed that DC alone produced similar 
effects as Lipostabil® in keratinocyte cell culture in vitro [22]. They hypothesized that the cell 
destruction is previously caused by the detergent action of DC on cell membranes [22,45] 
followed by fast emulsification of the released fatty acids by means of the PC [5]. Rotunda et 
al. have also reported that after injection of isolated DC into lipomas necrosis was visible 
resulting in reduction of adipose tissue size [47]. Thus, they suggested DC as the major active 
component which caused cell lysis of various cell types due to its detergent effects [22,47].  
The results of our study correlates with the data published by Rotunda et al. [22]. We have 
shown by light microscopic analyses, PI staining and MTT assay that DC and Lipostabil® 
have cell damaging effects based on destabilization of the cell membranes. All biological cell 
membranes are composed of the same bilipid structure [48] and are, therefore, subject to 
solubilization by detergents [16,49]. The detergent is distributed between lipid bilayers which 
are subsequently destabilized and disintegrated resulting in the formation of mixed micelles 
[16,23,49]. Treatment of the adipocytes with DC and Lipostabil® resulted in a loss in cell 
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viability beginning at concentrations of 0.05 mg/ml DC (Figure 1, 5, 9 and 11, page 80, 85, 91 
and 94). Concerning PC, no cytotoxic effect was detected (Figure 4 and 10, page 84 and 93). 
The cell membranes and consequently cell viability were not affected by this agent. In our 
studies, we did not investigate the specific mechanism of cell death. It is unclear whether 
apoptotic or necrotic mechanisms are responsible for loss of cell viability. Nevertheless, the 
cell death resulted from the detergent effect of DC.  
In vitro dose-response relationships were identified for all substances. The efficient in vitro 
concentrations that we identified in our experiments were compared with the in vivo 
concentrations which were used for injection lipolysis. DC as single substance and as 
component in the Lipostabil® formula showed disrupting effects on cell membranes at 
concentrations which were decreased compared to the concentration applied in vivo. In 
contrast to this, PC did not cause any effects in vitro even not at concentrations comparable to 
the PC concentration present in Lipostabil®. Therefore, it is supposed that the applied dose of 
Lipostabil® used in vivo cause cytotoxic effects resulting from DC. Moreover, it is assumed 
that the cytotoxic property of Lipostabil® also affect various other cell types in vivo. Studies 
from Janke et al. have shown that Lipostabil® has cytolytic effects on several cell types such 
as adipocytes, preadipocytes, vascular smooth muscle cells, skeletal myotubes, and renal 
epithelial cells in vitro [25]. Furthermore, dose-response relationships were characterized for 
the vasodilators buflomedil and pentoxifyllin (Figure 6, page 87). The damaging 
concentrations of these two substances identified in vitro were much higher than the 
concentrations applied in vivo. Therefore, it is assumed that these agents do not play a role in 
injection lipolysis regarding cell damages. 
We did not investigate the effect of benzyl alcohol which is the antimicrobial in the 
Lipostabil® formula. Although this substance has been discussed to affect the fluidity of cell 
membranes [50,51], it is not a detergent and therefore, its limited quantity in the compound is 
supposed to have negligible lytic effects on cell membranes.  
Another objective of our study was to investigate whether the substances stimulates lipolysis 
in adipocytes as previously postulated [1]. We induced lipolysis by the β-agonist 
isoproterenol resulting in a significant increase of the glycerol release. In contrast, neither DC 
nor PC were able to stimulate lipolytic activity significantly (Figure 7, page 88). These results 
suggest that PC does not induce endogenous lipases and activate a lipolytic pathway as 
hypothesized by others [1,21]. Therefore, they can not be classified as lipolytic active agents. 
However, Lipostabil® caused a slight increase of the lipolytic activity. This increase was 
statistically significant at a concentration of 0.5 mg/ml PC and 0.25 mg/ml DC, whereas the 
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highest concentration of Lipostabil® did not show a significant difference to the control group. 
It has to be further investigated whether the increased lipolytic activity induced at higher 
concentrations of Lipostabil® is really present.  
In further in vitro experiments, a protective property of PC against DC was demonstrated 
(Figure 8, page 90). At higher concentrations, PC decreased the toxic effect caused by DC. As 
the protective properties of PC were just observed at high concentrations, PC presumably 
does not take protective effects in the Lipostabil® compound used for injection lipolysis 
therapy. However, the protective effect of PC against DC has to be further investigated in in 
vivo experiments. In contrast to our observation, Rotunda et al. have observed synergistic 
effects of PC and DC in the Lipostabil® formula on the cell lysis of human keratinocytes in 
vitro [22]. 
In summary, the effect of Lipostabil® used in subcutaneous injection for fat reduction is 
attributed to the detergent action of DC causing nonspecific lysis of cell membranes. Our 
findings suggest that DC is the major active component for cell lysis. In contrast, PC is 
assumed to play a minor role during injection lipolysis. A recent study also suggested that PC 
has no effect on the reduction of fat tissue volume [52]. Furthermore, the substances did not 
cause lipolysis neither as single substances nor in combination like in Lipostabil®. Therefore, 
the fat reduction after injection lipolysis is supposed to be due to the cytolytic effect caused 
by DC and not to lipolytic actions induced by the substances. Thereby, the disrupting effect is 
not restricted to adipocytes. Physicians have to be well trained and cautious when injecting 
Lipostabil®. Further investigation has to be made to study the effect under in vivo conditions 
to ensure the safety and efficacy of injection lipolysis. 
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1. Abstract 
Adipose tissue is a highly specialized connective tissue that is involved in energy metabolism 
of the organism by storing excess energy as lipid. Cellular and molecular processes of 
adipocyte development can be studied sufficiently when the in vitro adipocyte 
microenvironment resembles adipose tissue in vivo as closely as possible. Therefore, three-
dimensional (3-D) culture systems that mimic in vivo tissue environment can be used to 
further improve the understanding of cellular mechanisms and, respectively, the role of the 
extracellular matrix during the differentiation of adipocytes. In this study, the utilized 3-D 
culture system is based on the formation of spheroids. Ethyl-3,4-dihydroxybenzoate (EDHB), 
a specific inhibitor of collagen prolyl hydroxylase, was used to examine the role of collagens 
in a tissue-like context during adipogenesis of 3T3-L1 in vitro. In contrast to two-dimensional 
(2-D) culture, EDHB prevented the differentiation of adipocytes in 3-D spheroids as detected 
by oil red O staining. Accordingly, triglyceride accumulation and glycerol-3-phosphate 
dehydrogenase activity were significantly inhibited by EDHB in 3-D compared to 2-D cell 
system. Measurement of the hydroxyproline content during adipogenic differentiation 
assessed that the activity of the prolyl hydroxylases was reduced by EDHB in 3-D culture, 
whereas in 2-D culture the enzyme was still active. Further investigations of the gene 
expression of collagen prolyl-4-hydroxylase alpha 1 during adipogenesis by qRT-PCR 
analysis revealed an increase of this gene in 2-D culture in contrast to 3-D spheroids. 
Furthermore, the effect of EDHB on the adipogenesis was investigated in adipose-derived 
stem cells (ADSCs) in which EDHB prevented the differentiation in both 2-D and 3-D 
culture. In conclusion, these results demonstrate the importance of a 3-D tissue-like context 
for in vitro studies and furthermore, the importance of collagens for the adipogenesis. 
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2. Introduction 
A better understanding of the mechanism of adipose tissue differentiation is of paramount 
importance in the development of therapeutic strategies for the treatment and prevention of 
obesity and type 2 diabetes mellitus. 2-D culture of preadipocytes following differentiation 
into adipocytes is the most frequently used adipogenic model system to study adipogenesis in 
vitro. Despite of this, the 2-D culture system cannot fully capture the relevant complexity of 
the in vivo adipose tissue. White adipose tissue consists of various cell types such as 
preadipocytes, mature adipocytes, interstitial cells, and epithelial cells which are embedded in 
a highly organized extracellular matrix (ECM) composed of multiple types of collagen and 
other ECM proteins. Accordingly, many important factors such as tissue-specific architecture 
as well as cell-cell and cell-matrix communication are lost in 2-D [1-3]. Indeed, these tissue-
inherent factors are known to govern biological processes including adipocyte development 
[3-8]. Therefore, to elucidate the role of cell-matrix interactions in adipocyte biology, a 3-D 
cell system is required. Several approaches have been reported to generate 3-D constructs in 
vitro. Reconstructing the architecture of adipose tissue in vitro can be achieved by seeding 
preadipocytes either on synthetic fibrous scaffolds [3,7,9,10] or into collagen gels [6,11] 
followed by adipogenic differentiation. However, scaffold or gel-based systems also bear 
several disadvantages. Most notably, the exogenous materials prevent the formation of a 
coherent cellular context, at least at early stages of the culture. Accordingly, direct cell-cell 
and cell-matrix interactions are limited. To dissolve this problem, we used a 3-D model 
system based on the formation of cellular aggregates utilizing the liquid overlay technique 
[12,13] which was previously developed by our group [14]. 3T3-L1 preadipocytes are seeded 
onto non-adherent surfaces and, as a consequence, are forced to attach to each other and form 
multicellular aggregates. These constructs differentiate to homogeneous adipose tissue-like 
structures. The spheroid model has the great advantage that it does not require an exogenous 
scaffold. The preadipocytes aggregate after seeding and subsequently secrete their own ECM 
resulting in a coherent tissue-like context. This characteristic renders the 3-D spheroids a 
suitable model system for studying the importance of the matrix for adipocyte development.  
The ECM is more than a passive structure that fills space and offers structural support for 
cells both in vitro and in vivo. Besides the function as a structure component, the ECM is 
known to be an important factor for the regulation of different cell functions. Especially 
differentiation processes into various types of cells are regulated by cell-cell and cell-ECM 
interactions [15,16]. Previous studies showed that the ECM components play a role in 
differentiation of preadipocytes into adipocytes [17,18]. This highly controlled process has 
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been extensively characterized on cellular and molecular levels, however, the extracellular 
components involved in signaling mechanisms of adipogenesis are only marginally identified 
[19]. Changes in the composition of the ECM lead to morphological alterations and 
reorganization of the cytoskeleton in adipocytes, both important processes for the expression 
of mRNA encoding for lipogenic enzymes in adipose cells [8,20-22].  
The most abundant components of the ECM are collagens. During differentiation, the 
expression of some collagens such as collagen I, III, IV, and VI are known to vary [23]. The 
modulation of the ECM by remodeling its structure and activity has profound effects on its 
functionality and consequently on the behavior of cells residing within the matrix. The matrix 
structure can be disturbed by use of modulating inhibitors such as EDHB that inhibits 
collagen assembly [8,17,24-27]. EDHB is an inhibitor of collagen prolyl hydroxylases due to 
its analog structure of ascorbate and α-ketoglutarate which are essential cofactors for enzyme 
activity. The collagen prolyl-4-hydroxylase is specifically involved in the synthesis of 
procollagens by converting proline residues to 4(R)-hydroxyproline within the endoplasmic 
reticulum. This posttranslational modification is essential for the triple-helical assembly of 
collagens and for subsequent secretion into the extracellular space. Inhibition of the collagen 
triple helix formation leads to nonfunctional proteins which are rapidly degraded both in the 
intracellular and extracellular space [25,28].  
Previous studies have shown that EDHB affected the adipogenic development of mouse 3T3-
L1 and TA1 preadipocytes as well as bovine intramuscular preadipocytes (BIP) in 2-D culture 
[17,18,29]. However, only a partial reduction of adipogenesis was achieved in all studies. As 
the well organized matrix structure of 3-D adipose tissue seems to be an important modulator 
of adipocyte differentiation, we hypothesized that EDHB has even more profound effects on 
adipogenesis in coherent tissue-like 3-D cultures.  
Thus, the aim of this study was to examine the influence of the collagen organization on the 
adipogenic differentiation of 3T3-L1 cells in 3-D spheroids compared to 2-D culture by using 
EDHB as an inhibitor of collagen synthesis. For this, 3T3-L1 preadipocytes as well as ADSCs 
cultured in 2-D and 3-D were differentiated in the presence of EDHB and subsequently, 
adipogenic development was assessed. Even though it has been reported that EDHB indirectly 
affected the adipogenic differentiation through inhibition of collagen synthesis, the activity of 
the collagen prolyl hydroxylase was not yet investigated regarding adipogenesis. Therefore, 
we directly determined the prolyl hydroxylase activity during adipogenesis by measurement 
of the hydroxyproline content in 3-D compared to 2-D cell culture. In this context, also the 
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expression of the collagen-4-prolyl hydroxylase was investigated during adipogenic 
differentiation of both cell culture systems.  
3. Materials and Methods 
Materials 
Murine 3T3-L1 preadipocytes were obtained from ATCC (Manassas, VA, USA). ADSCs 
were isolated from human abdomen lipoaspirate obtained from cosmetic surgery as described 
in detail in chapter 3 (Page 47). Dulbecco’s Modified Eagle’s Medium (DMEM) was 
purchased from Biochrom (Berlin, Germany). Preadipocyte Basal Medium-2 (PBM-2) was 
bought from Lonza (Köln, Germany). Fetal bovine serum (FBS, Lot. No. 40A0044K), 
phosphate buffered saline (PBS), 0.25% trypsin-EDTA solution, penicillin-streptomycin 
solution, Superscript II reverse transcriptase, and SYBR Green Supermix were from 
Invitrogen (Karlsruhe, Germany). Collagenase NB4 and 3-isobutyl-methylxanthine (IBMX) 
were bought from Serva Electrophoresis (Heidelberg, Germany). Papainase was from 
Worthington (Lakewood, NJ, USA). Thesit was obtained from Gepepharm GmbH (Siegburg, 
Germany). Bovine insulin was kindly provided by Sanofi-Aventis (Frankfurt a. M., 
Germany). Minimum Essential Medium alpha modification (α-MEM), agarose, 
dexamethasone, corticosterone, indomethacin, transferrin, sodium selenite, bovine serum 
albumin, cysteine, bovine DNA, 2-mercaptoethanol, Tris base, dihydroxyacetone phosphate 
(DHAP), EDHB, and oil red O were obtained from Sigma-Aldrich (Taufkirchen, Germany). 
Hoechst 33258 dye was obtained from Polysciences (Warrington, PA, USA). Nicotinamide 
adenine dinucleotide (NADH) and random hexamer primers were from Roche (Mannheim, 
Germany). Osmium tetroxide was purchased from Carl Roth (Karlsruhe, Germany). If not 
stated otherwise, all other chemicals were from Merck KGaA (Darmstadt, Germany). 
Deionized water was obtained using a Milli-Q water purification system from Millipore 
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Methods 
3.1. 2-D cell culture 
3.1.1. 3T3-L1 
3T3-L1 is a mouse embryonic fibroblast cell line. These cells are derived from the original 
line 3T3-Swiss albino and are used as an in vitro model of adipocytes [30]. 3T3-L1 
preadipocytes were expanded in DMEM supplemented with 10% FBS, penicillin (100 U/ml), 
and streptomycin (100 µg/ml) [7,9]. For 2-D monolayer cultures, preadipocytes were seeded 
in basal medium (α-MEM, 10% FBS, penicillin (100 U/ml), and streptomycin (100 µg/ml)) 
into tissue-culture polystyrene well plates at a density of 40,000 cells/cm2. This high seeding 
density guaranteed that 2-D cultures grew to confluence within two days after seeding. 
Hormonal induction was initiated two days after seeding by exchanging half of the medium 
with induction medium (basal media with 1 µM insulin, 0.1 µM corticosterone, 0.5 mM 
IBMX, and 60 µM indomethacin (final concentration) [7,9]. The time point of induction was 
referred to as day 0 throughout all experiments. At day 2, induction medium was replaced 
with differentiation medium (basal medium, 1 µM insulin). Subsequently, cells were fed with 
differentiation medium every other day up to day 6 or 9. Feeding was performed by 
exchanging only half of the medium volume in order to treat cells in the same way as in 3-D 
culture (see 3.2.). During the adipogenic phase, induction and differentiation media were 
supplemented with different concentrations of EDHB ranging from 0 – 200 µM. Cells were 
incubated in a humidified atmosphere at 37°C and 5% CO2 during the complete culture 
period. 
3.1.2. Human adipose-derived stem cells (ADSCs) 
ADSCs were isolated from human subcutaneous adipose tissue obtained during abdominal 
plastic surgery from healthy women or men aged 17 - 69 years as previously described in 
chapter 3 (Page 47).  
For 2-D monolayer cultures, cells were seeded in basal medium (PBM-2 supplemented with 
10% FBS, penicillin (100 U/ml), and streptomycin (100 µg/ml)) at a density of 30,000 
cells/cm2. At confluence, cells were induced to undergo adipogenesis by exchanging half of 
the medium with basal media supplemented with 1.7 µM insulin, 1 µM dexamethasone, 
0.5 mM IBMX, and 200 µM indomethacin (final concentration). Different concentrations of 
EDHB (0-200 µM) were added to the medium. The time point of induction was referred to as 
day 0 throughout all experiments. Both inducers and EDHB were present during the entire 
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adipogenic period. Medium was exchanged every other day up to day 14. Feeding was 
performed by exchanging only half of the medium volume in order to treat cells in the same 
way as in 3-D culture (see 3.2.). Cells were incubated in a humidified atmosphere at 37°C and 
5% CO2. 
3.2. 3-D cell culture 
Spheroids were generated according to the liquid overlay technique (Figure 1) [13,14]. 
 
 
Figure 1: Generation of spheroids utilizing the liquid overlay technique (from Weiser B. [14]). 
Initially, 3T3-L1 preadipocytes were expanded in conventional 2-D cell culture. Then, cells were 
seeded into agarose-coated 96-well plates. Cells cannot adhere to the agarose surface, but, supported 
by the meniscus of the agarose layer and the agitation on an orbital shaker, cells accumulated in the 
center of the well, attached to each other and formed one multicellular spheroid per well. 
Tissue culture polystyrene (TCPS) 96-well plates were coated with 50 µl of 1.5% agarose in 
α-MEM per well [31]. Spheroid formation was initiated by seeding cells in basal medium 
(3.1.1 and 3.1.2) into the agarose-coated wells (Figure 1). The outermost rows and columns of 
the well plate, respectively, were not used for culture due to the increased evaporation of 
medium from the wells during prolonged culture; they were only filled with PBS 
supplemented with penicillin (100 U/ml) and streptomycin (100 µg/ml). Two days after 
seeding, cells were induced to undergo adipogenesis by exchanging half of the medium with 
induction medium (see 3.1.1 and 3.1.2). Feeding was performed by exchanging only half of 
the medium volume, otherwise spheroids would be aspirated with complete removal of the 
medium from the wells. The induction medium was applied either without or with EDHB (50, 
100, 200 µM). For 3T3-L1 preadipocytes, adipogenic induction was performed for another 
two days. Then half of the medium was exchanged with differentiation medium (see 3.1.1). 
This medium exchange was performed three times to further reduce the concentrations of 
inducers. Because ADSCs were cultured in the presence of inducers during the entire 
adipogenic phase, this washing step was not necessary. For either cell type, subsequently, 
cells were fed by exchanging half of the medium with differentiation medium every other day 
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(see 3.1.1 and 3.1.2). Spheroid cultures were incubated in a humidified atmosphere at 37°C 
and 5% CO2 on an orbital shaker at 60 rpm (Heidolph, Schwabach, Germany). 
During the present study, the 3-D spheroids of ADSCs consisted of 3000 cells per aggregate. 
Notably, the size of the 3-D spheroids of 3T3-L1 was changed. The initial experiments for 
studying the effect of EDHB on adipogenesis as well as the cytotoxicity caused by EDHB 
were performed with spheroids consisting of 750 cells per aggregate (Figure 3, 4, 7, and 8, 
Page 116, 117, 120 and 121). Previous studies showed that this cell aggregate size ensured the 
generation of homogeneous adipocyte constructs due to a sufficient supply of nutrients, 
oxygen, and adipogenic inducers. However, this small spheroid size generates disadvantages 
especially concerning the practical handling. For certain analyses, a higher cell number is 
necessary for quantification. Hence, in the following experiments (Figure 9, Page 123) larger 
spheroids were generated by seeding 3000 cells per well. In Figure 2, spheroids consisting of 
750 or 3000 cells per construct are compared. Spheroids grew significantly up to day 9 and 
the relative increase in spheroid size was comparable in both groups (Figure 2 A). Adipogenic 
maturation of the cells occurred homogeneously throughout both spheroids until day 9 after 
induction as detected by oil red O staining (Figure 2 B). A gradient in cellular TG 
accumulation from the outside to the center area of the spheroids was not observed. Small and 
large spheroids did not differ in the TG content per cell (Figure 2 B). For the spheroids 
consisting of 750 cells per aggregate, a reducing effect of EDHB on spheroid volume was 
described (Figure 3 A and C, Page 116). This effect was also observed with the spheroids 
composed of 3000 cells. In presence of 100 µM EDHB, the increase of the spheroid volume 
was suppressed (Figure 2 C).  
In conclusion, these results revealed that the adipogenic development was independent from 
spheroid size. Furthermore, the larger spheroids did not alter the effect of EDHB and 
therefore, the change of the use of spheroids consisting of 3000 cells was uncritical.  
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Figure 2: Comparison of different sizes of 3T3-L1 spheroids with regard to morphology, TG 
accumulation and effect of EDHB at day 9 after induction. 750 and 3000 cells were seeded per 96-well 
and induced to undergo adipogenesis. A) Phase contrast images of 3-D spheroids of differentiated 
3T3-L1. On the right, kinetics of spheroid growth are displayed (n=10). B) Oil red O staining of 
intracellular lipid droplets in cryosections of 3-D spheroids. Sections from the center area are 
displayed. The intracellular TG contents were quantified (n=3) and normalized to cell numbers (on the 
right). C) Phase contrast images of 3-D spheroids treated without or with 100 µM EDHB. 
Development of spheroid sizes is shown on the right. Equivalent spheroid volumes at different time 
points of differentiation in absence or presence of EDHB were quantified morphometrically from 
n=10 randomly selected spheroids. Statistically significant differences are denoted by * (p<0.05). 
Three independent cell culture experiments were performed (A-C); representative photographs from 
one experiment are shown. Bar=100 µm. 
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3.3. Microscopical determination of spheroid growth 
Microscopical bright field pictures of spheroids were acquired using a CCD camera (DS-5M, 
Nikon, Düsseldorf, Germany) attached to an inverted microscope (Leica DM IRB, Leica 
Microsystems, Wetzlar, Germany) at 20x magnification. At specific time points, sizes of 
spheroids were determined by encircling the circumference of ten randomly selected 
spheroids and calculation of the equivalent diameter with the software Eclipse Net 
(Laboratory Imaging, Praha, Czech Republic). Spheroid volumes were calculated thereof. 
3.4. Scanning electron microscopy (SEM) 
Fixation of spheroids for SEM was performed according to the procedure described 
previously [14]. Briefly, entire spheroids were washed once with PBS and fixed in 10% PBS-
buffered formalin. In order to crosslink intracellular lipids, spheroids were incubated in 1% 
aqueous osmium tetroxide solution for 30 minutes. After extensive rinsing with double-
distilled water, spheroids were put onto aluminum stubs using conductive carbon tape and 
subjected to lyophilization (Christ Beta 2-16, Martin Christ Gefriertrocknungsanlagen; 
Osterode am Harz, Germany). Lyophilized spheroids were coated with gold-palladium and 
micrographs were obtained at 2 kV on a JEOL JSM-840 (Jeol Ltd., Tokyo, Japan).  
3.5. Oil red O staining 
In order to visualize accumulated cytoplasmic triglyceride droplets, oil red O staining was 
performed at day 9 or 14 after hormonal induction of adipogenesis. For this purpose, cells or 
entire spheroids were washed once with PBS, fixed in 10% PBS-buffered formalin overnight 
and then stained with oil red O (3 mg/ml solution in 60% isopropanol) for 4 hours [7,32]. 
Excess dye was removed by washing three times with PBS. For histological investigations, 
the stained spheroids were embedded in Tissue-Tek (Hartenstein Laborbedarf, Würzburg, 
Germany), snap frozen and finally cut into 12 µm-thick cryosections. After dissolution of 
Tissue-Tek in water, cryosections were incubated for 30 seconds in 60% isopropanol to 
remove unspecific oil red O staining, washed in water and mounted in glycerol [33]. Serial 
sections were prepared from all spheroids and sections from the center region were used for 
histological evaluation. Microscopical bright field pictures were acquired at 20x 
magnification using an inverted microscope (Leica DM IRB, Leica Microsystems, Wetzlar, 
Germany) equipped with a CCD camera (DS-5M, Nikon, Düsseldorf, Germany) and the 
software Eclipse Net (Laboratory Imaging, Praha, Czech Republic). 
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3.6. Quantitative analysis of intracellular triglyceride (TG) accumulation 
For analysis of the intracellular TG content, 2-D monolayers and 3-D spheroids were washed 
twice with PBS and harvested in 0.5% aqueous thesit solution. After sonication with a digital 
sonifier (Branson Ultrasonic Corporation, Danburg, CT, USA), the spectroscopic 
quantification of TG was performed using the enzymatic serum triglyceride determination kit 
from Sigma-Aldrich (Taufkirchen, Germany) according to the manufacturer’s instructions. 
All measurements were done in three biological replicates; one replicate was derived from 
one well for 2-D cultures and from approximately 20 spheroids for 3-D cultures, respectively. 
The amount of TG per well or per spheroid was calculated and normalized to the DNA 
content as determined by the DNA assay.  
3.7. Determination of the glycerol-3-phosphate dehydrogenase (GPDH) activity 
GPDH activity was measured according to a protocol adapted from Pairault and Green [34]. 
Briefly, after washing with PBS, cells were harvested in lysis buffer (50 mM Tris, 1 mM 
EDTA, 1 mM 2-mercaptoethanol, pH 7.5), sonicated with a digital sonifier (Branson 
Ultrasonic Corporation, Danburg, CT, USA) and centrifuged (16,000 g, 5 min). GPDH 
activity was measured by adding an aliquot of the lysate supernatant to the substrate buffer 
(0.1 M triethanolamine, 2.5 mM EDTA, 0.5 mM 2-mercaptoethanol, 0.12 mM NADH, 2 mM 
DHAP) and monitoring the consumption of NADH photometrically at 340 nm for 
4.2 minutes. Measurements were done in three biological replicates; one replicate was derived 
from one well for 2-D cultures and approximately 30 spheroids for 3-D cultures, respectively. 
GPDH activities were normalized to the DNA content of the samples as determined by the 
DNA assay. 
3.8. Determination of prolyl hydroxylase activity 
The activity of prolyl hydroxylases was quantified by measuring the amount of 
hydroxyproline, an amino acid that is genetically uncoded and exists in significant amounts in 
collagen, according to Woessner [35] with some modifications as reported previously [36] 
[37]. Briefly, after washing with PBS, cells together with surrounding matrix components 
were harvested and digested in lysis buffer (0.1 M Na2HPO4, 10 mM Na2EDTA and 2.5 mM 
cysteine, pH 6.5) for 16 hours at 60°C. Digested samples were hydrolyzed by incubation with 
6 N HCl for 16 hours at 105°C. After hydrolysis, hydrochloric acid was evaporated by heating 
up to 100°C. The dry samples were dissolved in 500 µl double-distilled water. Standard 
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dilutions of hydroxyproline were treated under the same hydrolysis conditions. Subsequent 
reactions were performed in microtiter plates. 100 µl aliquots of the samples/standards were 
oxidized by addition of 50 µl chloramine T (0.05 M in citrate buffer, pH 6) for 20 minutes. 
Afterwards, 50 µl of p-dimethylaminobenzaldehyde (15%, 4 M perchloric acid in 70% 
isopropanol/water) was added and the microtiter plate was incubated for 30 minutes at 60°C. 
The plate was cooled down to room temperature and the absorbance of the samples was 
immediately measured at 557 nm on a microplate reader (TitertekPlus-MS2 Microplate 
Reader, ICN Biomedicals, Huntsville, USA). Measurements were done in three biological 
replicates; one replicate was derived from one well for 2-D cultures and from approximately 
100 spheroids for 3-D cultures, respectively. The amount of hydroxyproline per sample was 
normalized to the DNA content of the samples as determined by the DNA assay. 
3.9. Determination of the DNA content with DNA assay 
Aliquots of cell lysates from GPDH activity measurements (see 3.7) or prolyl hydroxylase 
activity measurements (see 3.8) were digested with papainase (3.2 U/ml in 0.1 M Na2HPO4 
buffer, pH 6.5 containing 1 mM Na2EDTA and 2.5 mM cysteine) for 16 hours at 60°C, and 
the DNA content was determined using the intercalating Hoechst 33258 dye (0.1 µg/ml in 
0.1 M NaCl containing 1 mM Na2EDTA, 10 mM Tris, pH 7.4) [38]. Fluorescence intensities 
were determined at 365 nm excitation wavelength and 458 nm emission wavelength on a LS 
55 Fluorescence Spectrometer (PerkinElmer, Wiesbaden, Germany) and correlated to DNA 
contents using standard dilutions of double-stranded DNA (from calf thymus). Cell numbers 
of 3T3-L1 cells were calculated with a conversion factor of 26.1 pg of DNA per cell, which 
was determined previously [14]. 
3.10. Determination of membrane integrity with propidium iodide staining 
Propidium iodide (PI) intercalates into double-stranded nucleic acids. Under normal 
condition, PI is excluded by viable cells but it is ingested by dying or dead cells [39,40]. Cells 
were treated with EDHB during the entire adipogenic phase. One or nine days after induction 
and, thus, after addition of EDHB, cells were stained with 5 µg/ml PI added to medium for 
5 minutes. Then, medium was replaced by fresh medium without PI. Cells treated with 1% 
Triton-X served as a positive control. PI has an absorption maximum at 535 nm and a 
fluorescence emission maximum at 617 nm and can be excited with an argon-ion laser. 
Microscopical fluorescence pictures were acquired at 20x magnification using a Zeiss 
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Axiovert 200 M microscope equipped with a Zeiss AxioCam HRc camera and the software 
LSM Image Browser (Carl Zeiss MicroImaging GmbH, Jena, Germany). 
3.11. Total RNA extraction 
Prior to isolation of total RNA, 2-D monolayers as well as entire spheroids were washed once 
with PBS. Total RNA was isolated using Qiagen RNeasy Mini Kit (Qiagen, Hilden, 
Germany), based on affinity columns from either freshly isolated or frozen (-80°C) cells 
according to the manufacturer’s protocol. For one biological replicate a sufficient number of 
wells and spheroids, respectively, was pooled to yield a minimum of 1 µg total RNA per 
sample. RNA content and purity were determined spectrophotometrically at 260 nm/280 nm 
(Nanodrop Analyzer, NanoDrop, Wilmington, DE, USA). The ratio of adsorption values at 
260 nm to 280 nm was optimal at about 1.8 to 2.0 and guaranteed pure RNA. 
3.12. Quantitative real-time reverse transcription-polymerase chain-reaction 
(qRT-PCR) 
 The mRNA expression levels of selected genes (see Table 1) were analyzed with qRT-PCR 
SYBR Green assays. First strand cDNA was synthesized from 1 µg of total RNA using 
random hexamer primers and Superscript II reverse transcriptase according to the 
manufacturer’s instructions. 
Relative quantitative PCR was performed with SYBR Green Dye I with an ABI 7000 Prism 
Sequence detection system (Applied Biosystem, Darmstadt, Germany) using the following 
cycling conditions: 50°C for 2 minutes, 95°C for 10 minutes followed by 40 cycles at 95°C 
for 15 seconds and 60°C for 1 minute. Each primer was suspended in a concentration of 
0.2 µM in SYBR Green Supermix and the reaction was carried out in 96-well plates with 
10 µl diluted cDNA in a final volume of 25 µl. Experiments were performed in triplicates for 
each sample. Primers were designed with the free, open-source PerlPrimer software 
(www.perlprimer.sourceforge.net [41]) and obtained from Biomers (Ulm, Germany). Except 
for 18S rRNA, primer pairs were designed to span an intron-exon boundary (Table 1). 
Specificity of primer pairs and amplification conditions were verified by melting curve 
analysis and agarose gel electrophoresis. To determine qPCR assay efficiencies, equal 
amounts of cDNA from all conditions of the experimental setup were pooled and used in 
serial dilutions as template in qPCR measurements. A calibration curve was calculated by 
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plotting Ct values against the log of concentrations and efficiencies (E) were calculated from 
the slope (S) of the calibration curve according to the equation E = 10-1/S (Table 1).  
Table 1: Primer sequences, amplicon lengths and PCR efficiencies for SYBR Green PCR assays. 
Gene 
Forward Primer 
Sequence (5’ ➔ 3’) 
Reverse Primer 










agccaccatttcaaacccag ggataccacagggtcttcgt 100 2,02 
 
To determine gene expression levels, three biological replicates of each condition were 
analyzed in the qPCR assays. Ct values were obtained using SDS software (Applied 
Biosystems). Relative expression levels of target genes were calculated with PCR efficiency 
correction and normalized to the expression of 18S rRNA according to the equation: 
expression = EtargetCt,target/E18SCt,18S. 18S rRNA expression was evaluated not to be regulated 
between the different experimental conditions in previous experiments. Expression levels 
were further normalized to expression levels of the samples from 2-D culture at day 0. 
3.13. Statistics 
For spheroid growth, DNA assay, GPDH activity, TG and hydroxyproline accumulation, 
results are presented as mean value ± standard deviation. Significances were determined using 
GraphPadPrism v.5 (GraphPad Software, La Jolla, CA, USA). Differences between groups 
were analyzed for significance using unpaired Student’s t-test. Differences between different 
groups at specific time points or between different time points within one group were 
analyzed for significance using one-way analysis of variances (ANOVA) with subsequent 
multiple comparisons according to Tukey’s post hoc test. A value of p<0.05 was regarded as 
statistically significant.  
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4. Results 
4.1. Differential effect of EDHB on the adipogenesis of 3T3-L1 in 2-D and 3-D culture 
3T3-L1 preadipocytes cultured in 2-D monolayer or 3-D spheroids were exposed to 
increasing concentrations of EDHB (0-200 µM) during the entire adipogenic period. 
Figure 3 A shows bright field pictures of the differentiated adipocytes in 2-D and 3-D culture 
on day 9 after adipogenic induction. A clear difference can be recognized between both 
culture systems. Cells in 2-D culture were able to differentiate into adipocytes also in the 
presence of EDHB (Figure 3 A, upper row). Contrarily in 3-D culture, EDHB exerted a 
decreased adipogenesis with increasing concentrations (Figure 3 A, lower row). The EDHB 
treated spheroids were smaller in size and lipid droplets were only marginally developed. The 
adipocytes in spheroids which were cultured without EDHB developed large lipid vacuoles 
which were embedded within the ECM structures (Figure 3 B). With increasing concentration 
of EDHB the number of adipocytes with large lipid droplets decreased. Under normal 
conditions, the volume of adipogenically induced spheroids increased during differentiation 
phase up to 6-fold due to accumulation of TGs (Figure 3 C). This increase was strongly 
reduced in the presence of 50 µM EDHB and completely suppressed by higher concentrations 
of the inhibitor (Figure 3 C).  
The differential effect of EDHB on the adipogenesis in 2-D and 3-D was confirmed in further 
experiments. Histological images after oil red O staining of intracellular lipid droplets of 
differentiated adipocytes are shown in Figure 4 A. Adipocytes cultured in 2-D monolayer 
accumulated large lipid droplets both in absence or presence of EDHB. The concentration of 
the inhibitor did not play a crucial role for the differentiation rate. In contrast, cells in 3-D 
aggregates did not differentiate into adipocytes when they were treated with EDHB. The 
section of the control group presented strongly stained lipid droplets, whereas the EDHB 
treated spheroids were marginally stained. Sections of spheroids that were exposed to 200 µM 
EDHB could not be cut because of the unstable structure. Measurements of the TG content 
(Figure 4 B) and the GPDH activity (Figure 4 C) confirmed the histological observations. 
Both accumulation of TGs and increased GPDH activity are characteristics of adipogenesis 
and describe the progress of the differentiation process. The TG contents and GPDH activities 
did not vary in 2-D in the presence of EDHB at day 9, whereas in 3-D, an extensive decrease 
was determined dependent on the EDHB concentrations.  
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Figure 3: Effect of EDHB on the cell morphology of 3T3-L1 in 3-D spheroids in comparison to 2-D 
cell cultures. 3T3-L1 preadipocytes were induced to undergo adipogenesis in the absence or presence 
of EDHB at the indicated concentrations. EDHB was administered during the entire adipogenic 
period. Cell morphology was assayed at day 9 after induction. A) Phase contrast images of 3T3-L1 
cultured in 2-D cultures (upper row) and 3-D spheroids (lower row). Bar=100 µm. B) SEM 
photographs of 3T3-L1 spheroids 9 days after induction which display the microscopic morphology of 
the surface of the spheroids in presence of EDHB. Exemplarily, some lipid droplets are denoted by 
black arrows. Bar=10 µm. Three independent cell culture experiments were performed (A, B); 
representative photographs from one experiment are shown. C) Development of spheroid sizes. 
Equivalent spheroid volumes at different time points of differentiation in dependence of various 
concentrations of EDHB were quantified morphometrically from n=10 randomly selected spheroids. 
Statistically significant differences are denoted by * (p<0.05).  
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Figure 4: Effect of EDHB on the TG accumulation of 3T3-L1 in 3-D spheroids in comparison to 2-D 
cell cultures. 3T3-L1 preadipocytes were induced to undergo adipogenesis in the absence or presence 
of EDHB at the indicated concentrations. EDHB was administered during the entire adipogenic 
period. TG accumulation was determined at day 9 after induction. A) Oil red O staining of 
intracellular lipid droplets in 2-D cultures (upper row) and cryosections of 3-D spheroids (lower row). 
Sections from the center area are displayed. Three independent cell culture experiments were 
performed; representative photographs from one experiment are shown. Bar=100 µm.                         
B) Quantification of intracellular TG content (n=3). TG contents were normalized to DNA contents. 
C) Quantification of specific GPDH activity (n=3). Enzyme activity was normalized to DNA contents. 
Statistically significant differences are denoted by * (p<0.05). n.d.=not detectable.  
4.2. Inhibitory effect of EDHB on the adipogenesis of ADSCs in 2-D and 3-D culture 
Furthermore, the effect of EDHB on adipogenesis was tested in another cell system, i.e., 
ADSCs. ADSCs can differentiate into adipocytes by supplementing various inducers of 
adipogenesis into the culture medium. The effect of EDHB on the adipogenesis of these 
human stem cells was investigated by addition of the inhibitor during the adipogenic phase. 
EDHB treatment yielded a reduced differentiation rate of adipocytes both in 2-D and 3-D 
culture (Figure 5). In contrast to 3T3-L1 adipocytes, no differences could be observed 
Chapter 5  Effect of EDHB on Adipogenesis in 2-D and 3-D Culture 
- 118 - 
between the monolayer and spheroid culture system. The spheroids were unstable in presence 
of EDHB so that the volume was reduced over time (Figure 5 B). A reduced cell number was 
seen in cells treated with high concentrations. This was obvious in 2-D (Figure 5 A, upper 
row), but also in 3-D, where a decreased cell number was measured by the DNA assay (data 
not shown).  
 
 
Figure 5: Effect of EDHB on the cell morphology of ADSCs in 3-D spheroids in comparison to 2-D 
cell cultures. ADSCs were induced to undergo adipogenesis in the absence or presence of EDHB at 
the indicated concentrations. EDHB was administered during the entire adipogenic period. Cell 
morphology was assayed at day 14 after induction. A) Phase contrast images of ADSCs differentiated 
in 2-D cultures (upper row) and 3-D spheroids (lower row). Three independent cell culture 
experiments were performed; representative photographs from one experiment are shown. 
Bar=100 µm. B) Development of spheroid sizes. Equivalent spheroid volumes at different time points 
of differentiation in dependence of various concentrations of EDHB were quantified morphometrically 
from n=10 randomly selected spheroids. Statistically significant differences are denoted by * (p<0.05). 
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The differentiation of adipocytes was determined by oil red O staining as well as 
measurement of TGs and GPDH activity (Figure 6). All methods confirmed the previous 
observations that EDHB prevented adipogenesis. ADSCs were only marginally able to 
differentiate into adipocytes when EDHB was added to the culture medium. Only few 
intracellular lipid droplets were demonstrated by oil red O staining (Figure 6 A). The TG 
content was significantly decreased by EDHB in 2-D and 3-D culture and the GPDH activity 
was also reduced at a concentration of 50 µM EDHB and no longer detectable in cells treated 
with 100 µM or 200 µM EDHB (Figure 6 B and C).  
 
 
Figure 6: Effect of EDHB on the TG accumulation of ADSCs in 3-D spheroids in comparison to 2-D 
cell cultures. ADSCs were induced to undergo adipogenesis in the absence or presence of EDHB at 
the indicated concentrations. EDHB was administered during the entire adipogenic period. TG 
accumulation was determined at day 14 after induction. A) Oil red O staining of intracellular lipid 
droplets in 2-D cultures (upper row) and cryosections of 3-D spheroids (lower row). Sections from the 
center area are displayed. Three independent cell culture experiments were performed; representative 
photographs from one experiment are shown. Bar=100 µm. B) Quantification of intracellular TG 
content (n=3). TG contents were normalized to DNA contents. C) Quantification of specific GPDH 
activity (n=3). Enzyme activity was normalized to DNA contents. Statistically significant differences 
are denoted by * (p<0.05). n.d.=not detectable.  
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4.3. Reduced cell number in 3-D spheroids caused by EDHB 
During the previous experiments, it was noticed that EDHB caused a loss of cell number. This 
phenomenon was more drastic in 3-D spheroids in which it could be observed even in the 
presence of the lowest concentration of EDHB (Figure 7).  
 
 
Figure 7: Effect of EDHB on the cell number of 3T3-L1 in 3-D spheroids in comparison to 2-D cell 
cultures. 3T3-L1 preadipocytes were induced to undergo adipogenesis in the absence or presence of 
EDHB at the indicated concentrations. EDHB were administered during the entire adipogenic period. 
Cell number was determined at day 9 after induction. A) Quantification of the cell number in 2-D 
cultures (n=3). B) Quantification of the cell number per spheroid (n=3). Cell numbers (A, B) were 
determined in two independent cell culture experiments; representative data are shown. Statistically 
significant differences are denoted by * (p<0.05). 
To further investigate the effect of EDHB on the cell number of the 3T3-L1 cells, EDHB was 
added at day 0, the time point of induction and maintained in the adipogenic media until the 
adipocytes were harvested at day 9. The cell number was measured at different time points of 
the adipogenic phase by DNA assay. If the cell number decreases directly after addition of 
EDHB, a toxic effect is possible.  
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Figure 8: Effect of EDHB on the viability of 3T3-L1 in 2-D cell culture and 3-D spheroids. Cells 
were adipogenically induced and differentiated in the absence or presence of EDHB. A) Evaluation of 
cell numbers at different time points of adipocyte development in 2-D (left) and 3-D (right) culture 
(n=3). * indicates statistically significant differences between the tested groups (p<0.05).  
B) Fluorescent images of PI-stained cells at indicated times (red fluorescence) and the corresponding 
bright field images in 2-D monolayer culture (upper row) and in 3-D spheroids (lower row). The 
positive control was treated with 1% Triton-X four hours prior to staining. Bar=50 µm. 
Cells proliferated in 2-D monolayer during the days of induction (Figure 8 A, left). This is 
consistent with the clonal expansion that is a prerequisite for differentiation of 3T3-L1 
preadipocytes into adipocytes. The proliferation rate was reduced and retarded in the presence 
of 100 µM EDHB in the first days but at day 4, the cell numbers of the control and the EDHB 
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treated group were almost the same. From day 4 on, the cell number declined in both group. 
At day 9, only a marginal difference between both groups was detected with regard to the cell 
number. The capability of the cells to proliferate in the presence of EDHB indicated that the 
inhibitor did not have a toxic effect in 2-D culture. The cell number of 3-D spheroids was also 
measured. Cells that were cultured in media without EDHB proliferated until day 6  
(Figure 8 A, right). Then, a loss of cells was detected during the next three days. In 3-D 
culture with 100 µM EDHB, a continuously slight decrease of the cell number was 
determined during the entire adipogenic phase. At day 9, the cell number of EDHB treated 
cells was clearly diminished in comparison to the control. Nevertheless, the constantly slow 
reduction of cells by EDHB over an extended period of time suggests a non-toxic effect of the 
inhibitor. The loss of cells was rather attributed to the instability of the spheroids resulting 
from the modified structure of the ECM caused by EDHB.  
Additionally, to exclude that the loss of cells was caused by a possible toxic effect of EDHB, 
cells were stained with PI. PI is an intercalating agent and fluorescence dye that can be used 
to stain DNA. Because PI cannot penetrate the intact membrane of viable cells, it can be used 
for identifying dying or dead cells. PI passes the membrane of dead cells, binds to DNA and 
can be detected using a 562-588 nm band pass filter when excited by a 488 nm argon laser.  
To identify dead cells in the EDHB treated population, cells were stained with 5 µg/ml PI for 
5 minutes at different time points. As positive control, cells were treated with 1% Triton-X, a 
lethal detergent that led to an intense red staining after incubation with PI both in 2-D and 3-D 
culture (Figure 8 B). Untreated cells and cells that were treated with 100 µM EDHB were 
stained neither at day 1 nor at day 9 of treatment which means that the cells were viable and 
EDHB did not have a toxic effect.  
4.4. The role of prolyl-4-hydroxylase alpha 1 in the adipogenesis of 3T3-L1 
To investigate whether EDHB really inhibits the activity of the prolyl-4-hydroxylases in 2-D 
and 3-D, the content of hydroxyproline that was produced by cells in absence or presence of 
EDHB up to day 6 was determined (Figure 9 A). This and the following experiment were 
performed with spheroids consisting of 3000 cells due to practical handling as described in 
more detail in the methods (see 3.2, Figure 2, Page 109).  
In the presence of the inhibitor, the cells should not to be able to hydroxylate prolines due to 
the lacking activity of the enzyme. In both 2-D and 3-D cell cultures, hydroxyprolines were 
produced during the development of adipocytes, but cells in a 3-D context hydroxylated more 
prolines. When the activity of the prolyl hydroxylases was blocked by EDHB, a decreased 
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amount of hydroxyprolines was measured in 3-D spheroids, whereas in 2-D culture 
hydroxylation of prolines continued. Here, the activity of the prolyl hydroxylases seemed not 
to be affected.  
In this context, we investigated the gene expression of the collagen prolyl-4-hydroxylase 
during the development of adipocytes which has not been described yet. qRT-PCR analysis 
showed that the gene expression pattern of the α1-subunit of the prolyl-4-hydroxylase was 
different in 2-D cell culture in comparison to 3-D spheroids ( Figure 9 B). Whereas the gene 
expression of the enzyme increased strongly in 2-D up to day 6 after induction, in 3-D 
spheroids a downregulation of the expression occurred during adipogenic differentiation. 
 
 
Figure 9: Analysis of the enzyme activity and gene expression of prolyl-4-hydroxylase α1 during 
adipocyte differentiation of 3T3-L1 in 2-D and 3-D cell culture. A) Accumulation of hydroxyproline 
at day 0 to day 6 after induction (n=3). EDHB was added at the indicated concentration upon induction 
and were maintained throughout differentiation. Measurements were normalized to DNA content. 
Statistically significant differences are denoted by * (p<0.05). B) qRT-PCR measurments of prolyl-4-
hydroxylase α1 (n=2). Expression is reported as the ratio of prolyl-4-hydroxylase α1/18S. Dashes 
represent the individual values of both biological replicates.  
5. Discussion 
In general, the ECM is important for the mechanical stability of tissues, for cell adhesion as 
well as for the regulation of growth and differentiation of the residing cells [42-44]. The 
matrix contributes to the microenvironment specificity through its mechanical features and its 
molecular composition which enables binding of growth factors, enzymes, and other 
diffusible molecules [45]. These interactions along with the communication with other cells 
are of pivotal importance for normal cell differentiating and functioning [3,46]. In adipose 
tissue, the ECM microenvironment also influences adipocyte development and functionality 
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(lipolysis, lipogenesis, hormone secretion, and insulin sensitivity), but the underlying 
mechanisms are unknown [8,20,44,47,48]. It has been described that collagens play an 
essential role for the terminal differentiation of preadipocytes into adipocytes in vitro and that 
EDHB, an inhibitor of prolyl-4-hydroxylase, partially reduces the differentiation of BIP and 
adipocytes of the mouse TA1 cell line [17,18]. These results are based on 2-D culture 
experiments. However, cells behave differently in vitro when cultured in a 3-D context 
[1,2,4,5,49]. 2-D cultures do not recapitulate the unique architecture observed with adipose 
tissue in vivo in contrast to 3-D culture systems with a tissue-like geometry and 
microenvironment [3,9,46,50]. Therefore, we hypothesized that the remodeling of the 
collagen structures during adipogenic differentiation is more crucial in a 3-D tissue-like 
context and accordingly, EDHB has an even more profound impact on the adipocyte 
development of the spheroids.  
In this in vitro study, we investigated the influence of EDHB on the adipogenic differentiation 
of 3T3-L1 in a 3-D tissue-like context. We observed differential effects of EDHB in 2-D 
monolayer and 3-D spheroid culture systems. 3T3-L1 cells incorporated into spheroids were 
prevented to undergo adipogenesis in the presence of EDHB, whereas in 2-D culture 
adipogenesis was not affected after 9 days (Figure 4, Page 117)  
It is likely that the presence of EDHB prevented preadipocytes from newly organizing the 
collagen matrix in the surrounding ECM during the adipogenic development, whereas 
differentiated adipocytes in spheroids without EDHB were embedded in an organized ECM 
structure resulting in the accumulation of TGs within large lipid droplets. It is known that the 
development of adipose tissue is accompanied by alterations of the ECM architecture leading 
to an increased deposition and synthesis of certain collagens and other ECM proteins 
[8,51-54]. Moreover, collagen remodeling has been previously reported as a relevant process 
for differentiation into adipocytes. Studies identified that various collagens such as collagen 
type I, III, IV, V, and VI are involved in adipogenesis [18,23,54] and especially collagen type 
V and VI altered their network structure during the adipogenic differentiation of BIP [18].  
Furthermore, we have observed that the interrupted ECM organization caused by EDHB led 
to destabilization of the spheroid structure and subsequent detachment of the cells residing in 
the outer regions from the aggregate (Figure 3 A, Page 116). Thus, the continuous loss of 
cells in 3-D determined by measurements of the DNA content apparently arose from the 
unstable spheroid structure and not from toxic effects caused by EDHB as evidenced with 
propidium iodide staining (Figure 8, Page 121). This is well in agreement with a study 
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reported by Sasaki et al. in which EDHB did also not affect the viability, proliferative 
capacity or plating efficacy of cells [25].  
In another experiment, we directly determined the inhibitory effect of EDHB on the activity 
of prolyl hydroxylases in 3-D spheroids compared to 2-D culture. Well in agreement with the 
results showing the effect of EDHB on adipogenesis (Figure 4, Page 117), different enzyme 
activities were observed in 2-D and 3-D culture in the presence of EDHB (Figure 9 A, 
Page 123). The measured hydroxyproline content demonstrated that prolyl hydroxylases were 
still active in 2-D in presence of EDHB. In 2-D culture treated with EDHB, hydroxyprolines 
were produced from day 0 to day 6 to the same degree as non-treated adipocytes after 
induction. In contrast, production of hydroxylated prolines was significantly reduced by 
EDHB in 3-D spheroids. We hypothesize that the differential activities of prolyl hydroxylases 
in 2-D and 3-D cell cultures after EDHB treatment resulted from the different gene expression 
pattern of the collagen prolyl-4-hydroxylase in the two systems (Figure 9 B, Page 123). The 
gene expression of the α-subunit of collagen prolyl-4-hydroxylase increased during transition 
from preadipocytes to adipocytes in 2-D, whereas in 3-D a comparable increase was not 
observed. Thus, despite of the inhibition through EDHB, enough α-subunits might have been 
available in 2-D which could assemble and form active enzymes. In 3-D spheroids, prolyl-4-
hydroxylases were expressed to a lower extent so that EDHB apparently suppressed enzyme 
activity effectively resulting in inhibition of the collagen synthesis and subsequent adipogenic 
differentiation. This hypothesis has to be further investigated in future studies.  
However, notably, EDHB is not specific for collagen prolyl-4-hydroxylase but it is an 
inhibitor for the complete family of prolyl hydroxylases. All prolyl hydroxylases belong to the 
group of 2-oxoglutarate coupled dioxygenases that require Fe2+, 2-oxoglutarate, O2, and 
ascorbate for their activity. Distinct members of this family are the prolyl hydroxylase 
domain-containing enzymes (PHDs); PHDs are responsible for hydroxylation of hypoxia 
inducible factor 1 alpha (HIF-1α), a regulator of the transcription of hypoxia-regulated genes 
[8,55]. Floyd et al. investigated if the inhibition of adipogenesis in the presence of PHD 
inhibitors such as EDHB is correlated with HIF-1α indeed, but they were not able to show a 
connection [29]. In their study, Floyd et al. also demonstrated that the expression of PHDs 
increased during stages of adipogenesis and that it was downregulated by EDHB [29]. 
However, this downregulation provided no evidence for the correlation between the PHD 
activity and the formation of adipocytes. It is also possible that another factor relevant for 
adipogenesis, presumably collagen prolyl-4-hydroxylase, was inhibited by EDHB and the low 
expression level of PHDs was a consequence of the preadipose state. Unfortunately, Floyd et 
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al. did not discuss any possible role of collagens in the differentiation process of adipocytes. 
However, we assume that the effect of EDHB on adipogenesis was indeed based on the failed 
collagen synthesis as collagens are the most abundant proteins in animal tissue with the 
highest hydroxyproline content [56]. Nevertheless, the role of PHDs and other subtypes of 
2-oxoglutarate coupled dioxygenases, e.g., the lysyl hydroxylase, in adipogenesis should be 
investigated in further experiments. 
Regarding the effect of EDHB on adipogenesis in 2-D monolayer culture, our results were 
differential to studies of Floyd et al., Ibrahimi et al., and Nakajima et al. in which treatment 
with EDHB reduced the adipogenic differentiation of 3T3-L1, BIP, and TA1 preadipose cells 
[17,18,29]. Regarding Ibrahimi and Nakajima, one could assume that the different cell 
sources which were used in the respective studies were responsible for this discrepancy. 
Preadipocytes from different cell source vary in their responsiveness to specific substances 
[46] as we have also demonstrated in our studies with ADSCs which were not able to 
differentiate into adipocytes in the presence of EDHB (Figure 6, Page 119).  
However, Floyd et al. have observed a reducing effect on the adipogenesis of 3T3-L1 cells 
under the same EDHB concentrations as we used, whereas in our 2-D experiments, EDHB did 
not affect the formation of adipocytes. In the following, possible reasons for this discrepancy 
are discussed. First, one reason could be the different medium exchange. The 3-D culture 
demanded a procedure where only half of the medium was exchanged; otherwise spheroids 
would be aspirated with complete removal of the medium from the wells. For comparability, 
2-D monolayer cultures were equally treated. The correct final concentrations of the inducers 
were obtained by duplicating their quantities. However, this type of medium exchange did not 
influence the effect caused by EDHB. Even with complete removal of the medium, EDHB did 
not inhibit the differentiation of 3T3-L1 adipocytes in 2-D cell culture (data not shown). A 
second possible reason for the discrepant results is the distinct composition of the induction 
medium. The induction medium used in our studies was α-MEM supplemented with 1 µM 
insulin, 0.1 µM corticosterone, 0.5 mM IBMX, and 60 µM indomethacin [7], whereas Floyd’s 
medium consisted of DMEM with 1.7 µM insulin, 1 µM dexamethasone, and 0.5 mM IBMX 
[29]. After 48 h, the medium was replaced by differentiation medium. In contrast to Floyd, 
insulin was added during the entire differentiation phase of our experiments. Therefore, we 
tested the influence of the distinct media compositions on the efficiency of EDHB by 
inducing adipogenesis with the two different media supplemented with 100 µM EDHB. 
Under Floyd’s differentiation conditions we also observed a decreased number of adipocytes 
in the presence of 100 µM EDHB as detected by oil red O (Figure 10, Page 127). 
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Figure 10: The effect of EDHB on the adipogenesis of 3T3-L1 cells subjected to various 
differentiation media. 3T3-L1 preadipocytes were adipogenically induced with two different induction 
cocktails. Induction medium 1 consisted of α-MEM supplemented with 1 µM insulin, 0.1 µM 
corticosterone, 0.5 mM IBMX, and 60 µM indomethacin [7], whereas the induction medium 2 was 
composed of DMEM with 1.7 µM insulin, 1 µM dexamethasone, and 0.5 mM IBMX [29]. EDHB was 
added at the indicated concentration upon induction and were maintained throughout differentiation. 
Intracellular lipid droplets were stained with oil red O in 2-D culture. Two independent cell culture 
experiments were performed; representative photographs from one experiment are shown. 
Bar=100 µm. 
In the present study, it seemed that the used inducers stimulated the adipocyte differentiation 
more potently as those in Floyd’s induction cocktail. One difference between the two media 
compositions was the addition of different glucocorticoids, corticosterone and 
dexamethasone, respectively, which may have been effective in different ways. Differential 
effects of corticosterone and dexamethasone have been already described in other cell 
functions, for example, in hippocampal neurogenesis or in muscle wasting responses in 
cultured L6 and C2C12 myotubes [57,58]. Furthermore, the presence of indomethacin in our 
induction cocktail was also different to the cocktail used in Floyd’s study. It has been also 
described that indomethacin stimulated the differentiation of the mouse adipogenic TA1 cell 
line even more rapidly and completely than dexamethasone [59]. The permanent 
administration of insulin during the entire adipogenic differentiation phase did not affect the 
differentiation rate (data not shown). Another important difference of the two media 
compositions was the basal medium itself which could also have an influence on the 
differentiation of adipocytes. The cultivation of cells in α-MEM yielded enhanced TG storage 
as compared to DMEM [60]. Thereby, the most interesting point appears to be that DMEM 
lacks ascorbic acid which is a cofactor for prolyl hydroxylase activity. It was reported that the 
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inhibitory effect of EDHB on enzyme activity can be compensated by addition of high 
concentrations of ascorbic acid [61]. Thus, it is hypothesized that ascorbic acid contained in 
α-MEM was responsible for EDHB not affecting the adipogenesis in 2-D culture. Further 
experiments have to be conducted to verify this hypothesis. 
 
In conclusion, the current results suggest a complex relationship between prolyl hydroxylase 
activity, collagens and adipogenesis which is more essential in a coherent 3-D tissue-like 
context. The activity of prolyl hydroxylases is important for collagen assembly and 
accordingly, it is assumed that remodeling of the collagen structures influences adipocyte 
development. This study underlines the importance of a 3-D cell model for further 
investigations of cell-matrix interactions to approach in vivo adipose architecture as closely as 
possible.
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1.  Abstract 
Adipocytes are surrounded by a unique extracellular matrix (ECM) which provides 
mechanical support and participates in a variety of signaling events. Collagens are important 
components of the ECM environment and are regulated during adipose conversion. However, 
the collagen network and its remodeling during adipocyte development are not well 
characterized. FACITs (fibril-associated collagens with interrupted triple helices) such as 
collagen XVI are adapter molecules that arrange the structural integrity of the ECM and, 
therefore, may be involved in adipose conversion. So far, the expression and the role of 
collagen XVI in adipogenesis have not been elucidated. In this in vitro study, we 
demonstrated a downregulation of collagen type XVI during hormonally induced 
adipogenesis in 2-D and 3-D adipocyte culture. When confluent 3T3-L1 preadipocytes or 
human adipose-derived stem cells from adipose tissue (ADSCs) were stimulated with 
adipogenic medium, a significant decrease of procollagen XVI(α1) mRNA was found which 
was associated with a decrease in protein expression of collagen XVI as detected by qRT-
PCR and Western blot analyses. In 3-D spheroid culture with 3T3-L1, the decrease of 
collagen XVI protein expression was additionally visualized by immunostaining. Further 
studies identified corticosterone as an inducing substance that provoked the downregulation 
of procollagen XVI(α1) mRNA. A functional role of collagen XVI in adipogenesis can be 
elucidated by using cellular overexpression of collagen XVI or exogenous addition of 
recombinant collagen XVI protein. Whereas recombinant collagen XVI did not affect the 
adipogenic differentiation of 3T3-L1 in 2-D culture, preliminary overexpression experiments 
showed that collagen XVI overexpressing 3T3-L1 cells failed to differentiate into adipocytes 
after hormonal induction in contrast to non-transfected cells in 2-D culture suggesting a 
possible functional role of collagen XVI in in vitro adipogenesis of 3T3-L1. For the first time, 
this study associates collagen XVI expression with adipogenesis and contributes to the 
emerging picture of the complexity and the role of the ECM in adipose tissue. 
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2. Introduction 
Adipose tissue is a connective tissue composed of adipocytes that functions as a key regulator 
of systemic energy homeostasis. Adipocytes are responsible for the synthesis, storage, and 
hydrolysis of nutritional energy in form of triglycerides. Many studies focused on 
characterizing the development of preadipocytes into mature adipocytes on the cellular and 
molecular levels [1-4]. This differentiation process involves a coordinated progression of the 
expression of various proteins and their cognate mRNAs. The changes of the expression 
pattern directly related to the increase in lipid synthesis are not limited to intracellular 
mechanisms; alterations also occur in the intercellular space during adipocyte differentiation. 
An important component of the adipocyte microenvironment is the ECM, a complex of 
versatile proteins and polysaccharides, secreted and assembled by different surrounding cells. 
The macromolecules interact with cells and are able to regulate cell behavior indirectly or 
directly through receptor-mediated interactions. The ECM components are associated with the 
cytoskeleton via receptors, such as integrins, playing an important role in the morphological 
changes of the preadipocytes into mature adipocytes [5,6]. These complex cell-cell and cell-
ECM interactions which are present within in vivo fat tissue can not be captured by 
conventional 2-D monolayer cultures which are commonly used for investigation of 
adipogenic differentiation in vitro [7-11]. In order to enable studies on adipocyte function and 
development within an environment more resembling in vivo conditions, we recently 
established a coherent tissue-like 3-D model system utilizing 3T3-L1 and also human ADSCs 
which is based on the formation of spheroids. The 3-D tissue-like context of the spheroids 
enables the investigation of interactions among adipose cells and their ECM [12,13]. 
So far, only few studies focused on the components of the ECM that are associated with the 
development of the adipocyte phenotype and many discrepancies are found in the literature. 
The development of adipocytes is accompanied by perpetual changes in the level and type of 
ECM components [14]. During development, the ECM is continually reorganized by 
proteolytic degradation and assembly of de novo matrix. Degradation action is mainly 
modulated by matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) [14-17]. The 
first ultrastructural changes in the differentiation of adipose cells are marked by the increase 
of laminins, entactin, and glycosaminoglycans [18-21]. Additionally, a decline in cell-
associated fibronectin was detected during differentiation of 3T3-F442A and 3T3-L1 [5,22]. 
Collagens, the most ubiquitous and best-characterized proteins of the ECM, have also been 
implicated in the differentiation of adipocytes. Green et al. demonstrated that collagens were 
synthesized at substantial levels in 3T3-L1 preadipocytes [23]. Upon differentiation of 3T3-
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L1 preadipocytes into adipocytes, the gene expression of fibrillar collagens such as type I and 
III declined [21], whereas basement membrane collagen type IV accumulated [19,21]. In 
addition, Nakajima et al. reported that upon differentiation into adipocytes, the mRNA 
expression of collagen type I, II, III, IV, V, and VI as well as laminin and fibronectin 
increased three- to sixfold in bovine intramuscular preadipocytes (BIP) [24]. Nevertheless, the 
organization of the collagen network through interactions of the molecules during 
adipogenesis is not well characterized. FACITs are important components for connection of 
the ECM network. Members of the FACIT family (collagen type IX, XII, XIV, XVI, XIX, 
XX, XXI, XXII) are localized on the surface of major collagen fibrils and act as molecular 
bridges that arrange the structural integrity of the ECM. So far, FACITs were not investigated 
during adipocyte development. 
Collagen XVI, one member of the FACIT group, is a homotrimeric molecule composed of 
three 220-kDa α1(XVI) chains [25]. The structure of collagen XVI is characterized by 10 
collagenous domains, which are interrupted by 11 non-collagenous domains (Figure 1). The 
high thermal stability of the homotrimer in the form of disulfide bonds arises from 32 cysteine 
residues which are almost all located in the non-collagenous domains at the junction with the 
precedent collagenous regions [26]. The terminal non-collagenous NC11 consists mainly of a 
200-residue motif referred to as proline-arginine-rich protein (PARP) in various other 
collagen types. This motif is responsible for the binding of certain integrins [27].  
 
Figure 1: The domain structure of collagen XVI [28]. 
Collagen XVI is widely distributed in the heart, intestine, kidney, testis, ovary, eye, arterial 
wall, and smooth muscle cells of adult mice. In human, collagen XVI is predominantly 
expressed in skin and cartilage, where it is integrated into tissue specific aggregates [29,30], 
and it has been further detected in the nervous system [31]. Pathophysiologically, a 
dysregulation of collagen XVI was observed recently. It was demonstrated that collagen XVI 
is upregulated in glioblastoma as a part of tumor-specific remodelling of the ECM [32]. 
Furthermore, a role in the remodelling of the matrix in Crohn’s disease was described [33]. 
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However, the physiological function of this type of collagen is not well understood so far. 
Eble et al. detected collagen XVI in fat tissue around adipocytes, but neither a regulation nor 
a role of this collagen type has been described in adipocyte development so far [27]. 
Therefore, in the current study, we investigated the expression of collagen XVI during the in 
vitro adipogenesis of 3T3-L1 preadipocytes and ADSCs in 2-D and 3-D culture. The 
adipogenic differentiation was induced by a hormonal cocktail consisting of insulin, a 
glucocorticoid, IBMX, and indomethacin. We determined the gene and protein expression of 
collagen XVI at different differentiation stages of 3T3-L1 and ADSCs by qRT-PCR and 
Western blot analyses. Further studies revealed the influence of the adipogenic inducers on 
gene expression of collagen XVI. Finally, preliminary experiments were performed to 
examine a possible functional role of collagen XVI in in vitro adipogenesis. 
3. Materials and Methods 
Materials 
Murine 3T3-L1 preadipocytes were obtained from ATCC (Manassas, VA, USA). Human 
ADSCs were bought from Promocell (Heidelberg, Germany). Dulbecco’s Modified Eagle’s 
Medium (DMEM) was purchased from Biochrom (Berlin, Germany). Preadipocyte Basal 
Medium-2 (PBM-2) was bought from Lonza (Köln, Germany). Fetal bovine serum (FBS, Lot. 
No. 40A0044K), phosphate buffered saline (PBS), 0.25% trypsin-EDTA solution, penicillin-
streptomycin solution, 4’,6-diamidino-2-phenylindole (DAPI), Superscript II reverse 
transcriptase, SYBR Green Supermix, and Lipofectamine 2000 were from Invitrogen 
(Karlsruhe, Germany). 3-isobutyl-methylxanthine (IBMX), Coomassie Blue G250, 
bisacrylamide, bromphenol blue, SDS, Tris, and Tween 20 were bought from Serva 
Electrophoresis (Heidelberg, Germany). Papainase was from Worthington (Lakewood, NJ, 
USA). Bovine insulin was kindly provided by Sanofi-Aventis (Frankfurt a. M., Germany). 
Minimum Essential Medium alpha modification (α-MEM), agarose, dexamethasone, 
corticosterone, indomethacin, bovine serum albumin (BSA), cysteine, bovine DNA, 2-
mercaptoethanol, bisphenol A diglycidyl (BADGE), Ponceau S, and oil red O were obtained 
from Sigma-Aldrich (Taufkirchen, Germany). Thesit was purchased from Gepepharm GmbH 
(Siegburg, Germany) and collagen I was from Cardiovascular Sciences GmbH (Hamburg, 
Germany). Hoechst 33258 dye was obtained from Polysciences (Warrington, PA, USA). 
Complete Mini and random hexamer primers were from Roche (Mannheim, Germany). 
TEMED and dry milk powder were purchased from Carl Roth (Karlsruhe, Germany). Normal 
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goat serum and fluorescence mounting medium were bought from Dako (Glostrup, Denmark). 
Puromycin 2HCl was obtained from Biomol (Hamburg, Germany). If not stated otherwise, all 
other chemicals were from Merck KGaA (Darmstadt, Germany). Deionized water was 
obtained using a Milli-Q water purification system from Millipore (Schwalbach, Germany). 
All cell culture plastics were purchased from Corning (Bodenheim, Germany). Recombinant 
collagen XVI, the expression vector pCEP-PU-BM40SP-colXVI and all antibodies were 
kindly provided by the Department of Experimental Orthopedics, University Hospital of 
Regensburg (Regensburg, Germany) [30]. 
Methods 
3.1. Cell culture methods 
3.1.1. 2-D cell culture 
3T3-L1 
3T3-L1 is a mouse embryonic fibroblast cell line. These cells are derived from the original 
line 3T3-Swiss albino and are used as an in vitro model of adipocytes [23]. 3T3-L1 
preadipocytes were expanded in DMEM supplemented with 10% FBS, penicillin (100 U/ml), 
and streptomycin (100 µg/ml) [34,35]. For 2-D monolayer cultures, preadipocytes were 
seeded in basal medium (α-MEM, 10% FBS, penicillin (100 U/ml), and streptomycin 
(100 µg/ml)) into tissue-culture polystyrene well plates at a density of 40,000 cells/cm2. This 
high seeding density guaranteed that 2-D cultures grew to confluence within two days after 
seeding. Hormonal induction was initiated two days after seeding by exchanging half of the 
medium with induction medium (basal media with 1 µM insulin, 0.1 µM corticosterone, 
0.5 mM IBMX, and 60 µM indomethacin (final concentration) [34,35]. The time point of 
induction was referred to as day 0 throughout all experiments. At day 2, induction medium 
was replaced with differentiation medium (basal medium, 1 µM insulin). Subsequently, cells 
were fed with differentiation medium every other day up to day 6. Feeding was performed by 
exchanging only half of the medium volume in order to treat cells in the same way as in 3-D 
culture (see 3.1.2.). Cells were incubated in a humidified atmosphere at 37°C and 5% CO2 
during the complete culture period. 
 
Human adipose-derived stem cells (ADSCs) 
For 2-D monolayer cultures, cells were seeded in basal medium (PBM-2 supplemented with 
10% FCS, penicillin (100 U/ml), and streptomycin (100 µg/ml)) at a density of 30,000 
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cells/cm2. At confluence, cells were induced to undergo adipogenesis by exchanging half of 
the medium with basal medium supplemented with 1.7 µM insulin, 1 µM dexamethasone, 
0.5 mM IBMX, and 200 µM indomethacin (final concentration). The time point of induction 
was referred to as day 0 throughout all experiments. The inducers were present during the 
entire adipogenic period. Medium was exchanged every other day up to day 10. Feeding was 
performed by exchanging only half of the medium volume in order to treat cells in the same 
way as in 3-D culture (see 3.1.2.). Cells were incubated in a humidified atmosphere at 37°C 
and 5% CO2. 
3.1.2. 3-D cell culture 
Spheroids were generated according to the liquid overlay technique as already described in 
Chapter 5 (Page 101) [36,37]. Briefly, tissue culture polystyrene (TCPS) 96-well plates were 
coated with 50 µl of 1.5% agarose in α-MEM per well [38]. Spheroid formation was initiated 
by seeding 3,000 cells per well in basal medium (see 3.1.1) into the agarose-coated well. The 
outermost rows and columns of the well plate, respectively, were not used for culture due to 
the increased evaporation of medium from the wells during prolonged culture; they were only 
filled with PBS supplemented with penicillin (100 U/ml) and streptomycin (100 µg/ml). Two 
days after seeding, cells were induced to undergo adipogenesis by exchanging half of the 
medium with induction medium (see 3.1.1). Feeding was performed by exchanging only half 
of the medium volume, otherwise spheroids would be aspirated with complete removal of the 
medium from the wells. For 3T3-L1 preadipocytes, adipogenic induction was performed for 
another two days. Then half of the medium was exchanged with differentiation medium (see 
3.1.1). This medium exchange was performed three times to further reduce the concentrations 
of inducers. Because ADSCs were cultured in the presence of inducers during the entire 
adipogenic phase, this washing step was not necessary. For either cell type, subsequently, 
cells were fed by exchanging half of the medium with differentiation medium every other 
day. Spheroid cultures were incubated in a humidified atmosphere at 37°C and 5% CO2 on an 
orbital shaker at 60 rpm (Heidolph, Schwabach, Germany). 
3.1.3. Stable transfection with Lipofectamine 2000 
The expression vector pCEP-PU-BM40SP-colXVI for stable transfection of 3T3-L1 with 
collagen XVI was kindly provided by the Department of Experimental Orthopedics, 
University Hospital of Regensburg (Regensburg, Germany) (Figure 2).  
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Figure 2: Expression vector pCEP-PU-BM40SP 
This vector is based on a previous commercially available expression vector pCEP-Pu from Invitrogen 
(Karlsruhe, Germany). The vector has been modified by insertion of a BM40 signal peptide and 
several tag sequences [39-41] and recombinant expression of collagen XVI with this vector has been 
established previously [26]. The restriction sites Not I and Nhe I within the multiple cloning site are 
framed. The black area refers to the coding sequence of the BM40 signal peptide (BM40SP). The 
vector contains an ampicillin resistance for selection in prokaryotes and a puromycin resistance for 
selection in mammalian cells. 
Plasmid DNA was isolated by using a silica membrane system commercially available from 
Peqlab (Erlangen, Germany). According to the manufacturer’s protocol for Spin Miniprep kits 
5 ml of bacteria suspension were initially applied. Higher volumes up to 50 ml were purified 
with Qiagen Midiprep kit (Hilden, Germany) yielding up to 500 µg plasmid DNA.  
Transfection was carried out using Lipofectamine 2000, a lipid-based transfection reagent. 
Cells were seeded at a density of 20,000 cells/cm2 in a 12-well plate. Firstly, 2 µl 
Lipofectamine 2000 and 48 µl culture medium without FBS were mixed and incubated for 
5 minutes. DNA (2 µg/reaction) was separately prepared with FBS-free medium up to a 
volume of 50 µl. Lipofectamine and DNA solutions were gently mixed and incubated for 
20 minutes at room temperature. Afterwards, the reaction volume was added to the cells 
together with usually applied culture medium and the cells were incubated for 8 hours at 37°C 
and 5% CO2. After this time, medium was replaced by serum-containing medium. Selection 
medium containing puromycin in a final concentration of 15 µg/ml as previously determined 
in a kill curve for non-transfected cells (see 3.1.4) was applied 48 hours after transfection 
procedure. By the time all non-transfected cells were eliminated upon antibiotic application, 
Chapter 6  Regulation of Collagen Type XVI during in vitro Adipogenesis 
- 141 - 
resistant clones were transferred to larger flasks and further cultivated. Finally, cells were 
harvested by trypsin digestion and used for analyses. 
3.1.4. Titration of antibiotic stocks (kill curve) 
Prior to application of puromycin in order to establish stable cell lines, selection agent stocks 
had to be titrated to determine the optimal concentration for selection with the chosen cell 
line. 20,000 non-transfected cells per cm2 were plated in 12-well plates containing the culture 
medium plus increasing amounts of puromycin (0, 2.5, 5.0, 7.5, 10.0, 15.0, and 25.0 µg/ml). 
The cells were incubated for 10 days to 14 days and the selection medium was replaced every 
three days. For selecting stable transfectants, the lowest concentration that induces massive 
cell death in about 5 days and kills all the cells within two weeks was used.  
3.1.5. Coating of well plates with proteins 
48-well plates were coated with collagen I (10 µg/ml) and recombinant collagen XVI 
(10 µg/ml) overnight at 4°C [26]. Unspecific binding sites were blocked with 1% (w/v) BSA 
solution for 2 hours at room temperature. The plates were washed two times with PBS and 
stored at 4 °C until usage. Collagen IV-coated well plates were purchased from BD 
Biosciences (Heidelberg, Germany). 
3.2. Analysis of triglyceride (TG) accumulation 
3.2.1. Oil red O staining 
In order to visualize accumulated cytoplasmic TG droplets, oil red O staining was performed 
at day 6 after hormonal induction of adipogenesis. For this purpose, cells or entire spheroids 
were washed once with PBS, fixed in 10% PBS-buffered formalin overnight and then stained 
with oil red O (3 mg/ml solution in 60% isopropanol) for 4 hours [34,42]. Excess dye was 
removed by washing three times with PBS. For histological investigations, the stained 
spheroids were embedded in Tissue-Tek (Hartenstein Laborbedarf, Würzburg, Germany), 
snap frozen and finally cut into 12 µm-thick cryosections. After dissolution of Tissue-Tek in 
water, cryosections were incubated for 30 seconds in 60% isopropanol to remove unspecific 
oil red O staining, washed in water and mounted in glycerol [43]. Serial sections were 
prepared from all spheroids and sections from the center region were used for histological 
evaluation. Microscopical bright field pictures were acquired at 20x magnification using an 
inverted microscope (Leica DM IRB, Leica Microsystems, Wetzlar, Germany) equipped with 
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a CCD camera (DS-5M, Nikon, Düsseldorf, Germany) and the software Eclipse Net 
(Laboratory Imaging, Praha, Czech Republic). 
3.2.2. Quantitative analysis of intracellular TG accumulation 
For analysis of the intracellular TG content, 2-D monolayers were washed twice with PBS 
and harvested in 0.5% aqueous thesit solution. After sonication with a digital sonifier 
(Branson Ultrasonic Corporation, Danburg, CT, USA), the spectroscopic quantification of TG 
was performed using the enzymatic serum triglyceride determination kit from Sigma-Aldrich 
(Taufkirchen, Germany) according to the manufacturer’s instructions. Measurements were 
done in three biological replicates; one replicate was derived from one well for 2-D cultures. 
The amount of TG was calculated and normalized to the cell number per sample as 
determined by the DNA assay.  
3.3. Determination of the DNA content with DNA assay 
After washing with PBS, cells were harvested in lysis buffer (50 mM Tris, 1 mM EDTA, 
1 mM 2-mercaptoethanol, pH 7.5) and sonicated with a digital sonifier (Branson Ultrasonic 
Corporation, Danburg, CT, USA). Aliquots of the cell lysates were digested with papainase 
(3.2 U/ml in 0.1 M Na2HPO4 buffer, pH 6.5 containing 1 mM Na2EDTA and 2.5 mM 
cysteine) for 16 hours at 60°C, and the DNA content was determined using the intercalating 
Hoechst 33258 dye (0.1 µg/ml in 0.1 M NaCl containing 1 mM Na2EDTA, 10 mM Tris, pH 
7.4) [44]. Fluorescence intensities were determined at 365 nm excitation wavelength and 
458 nm emission wavelength on a LS 55 Fluorescence Spectrometer (PerkinElmer, 
Wiesbaden, Germany) and correlated to DNA contents using standard dilutions of double-
stranded DNA (from calf thymus). Cell numbers of 3T3-L1 cells were calculated with a 
conversion factor of 26.1 pg of DNA per cell, which was determined previously [37]. 
3.4. Molecular biology methods 
3.4.1. Total RNA extraction 
Prior to isolation of total RNA, 2-D monolayers as well as entire spheroids were washed once 
with PBS. Total RNA was isolated using Qiagen RNeasy Mini Kit (Qiagen, Hilden, 
Germany), based on affinity columns from either freshly isolated or frozen (-80° C) cells 
according to the manufacturer’s protocol. For one biological replicate a sufficient number of 
wells and spheroids, respectively, was pooled to yield a minimum of 1 µg total RNA per 
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sample. RNA content and purity were determined spectrophotometrically at 260 nm/280 nm 
(Nanodrop Analyzer, NanoDrop, Wilmington, DE, USA). The ratio of adsorption values at 
260 nm to 280 nm was optimal at about 1.8 to 2.0 and guaranteed pure RNA. 
3.4.2. Microarray Analysis: RNA transcription, hybridization, and data acquisition 
For microarray analysis, integrity of total RNA was verified by electrophoresis using an 
Agilent Bioanalyzer 2100 (Agilent Technologies, Waldbronn, Germany). All following 
procedures, i.e., RNA transcription, fragmentation, hybridization, scanning, and data 
processing were performed according to the manufacturer’s instructions (Agilent 
Technologies, One-Color Microarray-Based Gene Expression Analysis Protocol, G4140-
90040). 1 µg of total RNA per sample was transcribed into cyanine 3 (Cy3)-labeled cRNA 
using the Low RNA input Fluorescent Linear Amplification Kit (Agilent Technologies). 
Labeled cRNAs were purified using RNeasy Mini Kit (Qiagen, Hilden, Germany) and quality 
parameters (cRNA yield > 1.5 µg and Cy3-incorporation rate > 9 pmol/µg RNA) were 
assessed spectrophotometrically (NanoDrop Analyzer). Using the Gene Expression 
Hybridization Kit (Agilent Technologies) 1.5 µg of cRNA was fragmented (60°C, 
30 minutes) and hybridized (60°C for 17 hours) to 44K Whole Mouse Genome Oligo 
Microarrays (G4122F, 4x44K slide format, Agilent Technologies). Each array contains 
41,534 60-mer oligonucleotide probes representing approximately 41,000 mouse genes and 
transcripts. After washing, microarrays were scanned with a DNA Microarray Scanner 
(Agilent Technologies) and background corrected spot intensities were acquired using Feature 
Extraction Software (Version 9.1.1.1, FE Extraction Protocol: GE1-v5_91_0806, grid: 
014868_D_20060807, Agilent Technologies). RNA transcription, hybridization, and scanning 
of the microarrays were performed by the Kompetenzzentrum für Fluoreszente Bioanalytik 
(Regensburg, Germany). Resulting data were imported into GeneSpring GX software 
(Version 7.3.1, Agilent Technologies) and spot intensities of collagen type XVI alpha 1 
(GenBank accession number NM_028266) were normalized to the median of all spot 
intensities of the respective chip (median normalization). For each experimental condition two 
biological replicates were analyzed.  
3.4.3. Quantitative real-time reverse transcription-polymerase chain-reaction (qRT-PCR) 
To validate results from microarray analysis and for further experiments, mRNA expression 
levels of collagen XVI(α1) (see Table 1) was analyzed with qRT-PCR SYBR Green assays. 
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First strand cDNA was synthesized from 1 µg of total RNA using random hexamer primers 
and Superscript II reverse transcriptase according to the manufacturer’s instructions. 
Relative quantitative PCR was performed with SYBR Green Dye I with an ABI 7000 Prism 
Sequence detection system (Applied Biosystem, Darmstadt, Germany) using the following 
cycling conditions: 50°C for 2 minutes, 95°C for 10 minutes followed by 40 cycles at 95°C 
for 15 seconds and 60°C for 1 minute. Each primer was suspended in a final concentration of 
0.2 µM in SYBR Green Supermix and the reaction was carried out in 96-well plates with 
10 µl diluted cDNA in a final volume of 25 µl. Experiments were performed in triplicates for 
each sample. Primers were designed with the free, open-source PerlPrimer software 
(www.perlprimer.sourceforge.net [45]) and obtained from Biomers (Ulm, Germany). 
Specificity of primer pairs and amplification conditions were verified by melting curve 
analysis and agarose gel electrophoresis.  
Table 1: Primer sequences and amplicon lengths for SYBR Green PCR assays. 
Gene 
Forward Primer 
Sequence (5’ ➔ 3’) 
Reverse Primer 






mouse      
col XVI(α1) 
tacctccaggatgcagttcc cacctttggtaccaggcagt NM_028266 181 
human     
col XVI(α1) 
gcctggtaccaaaggtgaaa catagcctggaggaccttga M92642 97 
 
To determine gene expression levels, three biological replicates of each condition were 
analyzed in the qPCR assays. Ct values were obtained using SDS software (Applied 
Biosystems). For absolute quantification a standard curve of serially diluted plasmids of 
known copy number (10 up to 10x107) was plotted and sample Ct values were used to 
determine the exact copy numbers of the genes of interest.  
3.5. Protein biochemical methods 
3.5.1. Protein isolation, precipitation, and quantification 
For detection of secreted proteins in 2-D culture, the supernatant per well was taken. In 3-D 
culture, the culture medium of 100-200 spheroids collected in one 96-well was used. In order 
to concentrate proteins, the solution was incubated on ice for 20 minutes with a final 
concentration of 0.14% (w/v) Triton X-100 and 15.5% (w/v) trichloric acid (TCA). 
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Centrifugation with 18,000 x g for 20 minutes at 4°C resulted in a protein pellet that was 
washed two times with pre-chilled acetone. After air-drying, the pellet was resuspended in an 
appropriate volume of sample buffer. 
For detection of proteins within the cell, cells were washed with PBS, harvested in lysis 
buffer (3.5 mM SDS, 8.3 mM Tris ad 250 ml, pH 7.4, adding protease inhibitor (complete 
mini)) and sonicated with a digital sonifier (Branson Ultrasonic Corporation, Danburg, CT, 
USA). Protein content was determined using the Bradford method [46]. Measurements were 
done in three biological replicates; one replicate was derived from one well for 2-D cultures 
and a number of approximately 200 spheroids at day 0 and 3 and of 100 spheroids at day 6 
and 10, respectively, for 3-D cultures. 
3.5.2. SDS-PAGE according to Laemmli 
 
Table 2: Buffer concentrations for SDS-PAGE according to Laemmli. 
Solutions Concentration of ingredients 
Resolving gel buffer 
1.5 M Tris/HCl, pH 8.8 
0.4% (w/v) SDS 
Stacking gel buffer 
0.5 M Tris/HCl, pH 6.8 
0.4% (w/v) SDS 
Acrylamide stock solution 30% (w/v) bisacrylamide 
TEMED 100% triethylmethylethylendiamine 
APS 10% (w/v) ammonium persulfate in water 
Sample loading buffer 
0.1 M Tris/HCl, pH 6.8 
1% (w/v) SDS  
20% (v/v) glycerol 
5% (v/v) ß-mercaptoethanol 
0.01% (w/v) bromphenol blue 
 
The discontinuous sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
according to Laemmli [47] was used to discriminate heterogeneous protein samples 
comprising different protein fractions. After addition of sample loading buffer to the protein 
samples, they were denatured for 5 minutes at 95°C and added into a 4.5% to 15% gradient 
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resolving gel with a 4.5% stacking gel. Collagen XVI was detected by Western blot of 20 µg 
total protein. Concentrations of the ingredients are listed in Table 2. The gel run was 
performed at a maximum current of 20 mA. A pre-stained protein marker was always co-
separated to determine the molecular weight of the sample (Precision Plus™ Protein All Blue 
Standard, BioRad, München, Germany). 
3.5.3. Western blot analysis 
 
Table 3: Buffer concentrations for Western blot analysis. 
Solutions Concentration of ingredients 
Blotting buffer 50 mM Tris  
380 mM glycine  
0.1% (w/v) SDS  
10% (v/v) methanol 
1x TBST 140 mM NaCl 
15 mM Tris/HCl 
5 mM EDTA  
0.1% (v/v) Tween 20 in TBS 
Blocking solution  5% (w/v) dry milk powder in 1xTBST  
 
Proteins were electrotransferred to a nitrocellulose membrane (Protran, Schleicher & Schuell, 
Germany) with the BioRad Mini Trans Blot Electrophoretic Cell (BioRad, München, 
Germany) in a sandwich of three layers whatman paper (BioRad, München, Germany), 
nitrocellulose membrane, polyacrylamide gel and again three layers of whatman paper. Per 
cm² of nitrocellulose membrane 0.8 mA current was applied for 60 to 75 minutes according to 
the fragment size of the protein. Prior to transfer, whatman paper and nitrocellulose 
membrane were soaked in blotting buffer (Table 3). After blotting, transfer of proteins was 
confirmed by a reversible Ponceau red staining of the membrane with a 0.2% (w/v) Ponceau S 
solution in 3% (v/v) TCA. After removal of the Ponceau red staining with water, unspecific 
binding sites were blocked with blocking solution (Table 3) for 1.5 hours at room 
temperature. After a short washing step in Tris-buffered saline Tween 20 (TBST), the 
membrane was incubated at 4°C overnight with the polyclonal guinea pig-anti-colXVI 
antibody (1:1,000) in blocking solution. Unspecificly bound antibody was removed in three 
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washing steps for 20 minutes each in TBST. The secondary goat-anti-guinea pig peroxidase-
conjugated antibody was diluted 1:30,000 in blocking solution and the membrane was 
incubated for 60 minutes at room temperature. Washing steps were repeated as described for 
the primary antibody. Protein bands were detected by incubating the membrane with Super 
Signal West Femto Trial ECL reagent (Thermo Scientific, Rockford, IL, USA) for 1 minute. 
Wrapped in clear foil, the luminescent signal was detected by application of an x-ray film for 
10 seconds to 5 minutes (Amersham, UK).  
3.5.4. Immunofluorescence 
Cells grown on coverslips (Sarstedt, Nümbrecht, Germany) or entire spheroids were washed 
once with PBS, fixed in 4% (w/v) paraformaldehyde (PFA) in PBS overnight and washed 
thoroughly in PBS. The spheroids were embedded in Tissue-Tek (Hartenstein Laborbedarf, 
Würzburg, Germany), snap frozen and finally cut into 12 µm-thick cryosections. Serial 
sections were prepared from all spheroids and sections from the center region were used for 
histological evaluation. After dissolution of Tissue-Tek in water, cryosections were fixed in 
ice-cold acetone for 10 minutes at 4°C. Further procedures were performed with both cells in 
monolayer and cryosections of spheroids. Unspecific binding sites were blocked with 5% 
(v/v) normal goat serum, 1% (w/v) BSA and protease inhibitor (complete mini, 1:5) in PBS 
for 60 minutes at 37°C. Guinea pig-anti-colXVI primary antibody was diluted 1:100 in 
blocking buffer and incubated at 4°C overnight. After washing with PBS, the goat-anti-guinea 
pig Alexa Fluor® 555 antibody diluted in PBS at a final concentration of 5 µg/ml was applied 
and incubated at 37°C for 1 hour. Nuclei were counterstained with 300 nM DAPI for 
10 minutes and the slides were washed again with PBS before they were mounted with 
fluorescence mounting medium. All histological incubation steps were performed in humid 
chambers. The stained structures were visualized with confocal laser scanning microscopy 
(C1 confocal microscope, C4 camera and software Nikon, Germany). 
3.6. Statistics 
For TG accumulation, DNA measurements and qRT-PCR data, results are presented as mean 
values ± standard deviation. Statistical analyses were determined using GraphPadPrism v.5 
(GraphPad Software, La Jolla, CA, USA). Differences between two groups were analyzed for 
significance using the unpaired Student’s t-test. Differences between multiple groups were 
analyzed for significance using one-way analysis of variances (ANOVA) with subsequent 
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multiple comparisons according to Tukey’s post hoc test. A value of p<0.05 was regarded as 
statistically significant. For microarray analysis, the mean value and the values of both 
replicates are depicted. 
4. Results 





Figure 3: Gene expression of collagen XVI(α1) in 3T3-L1 in 2-D and 3-D cultures. 
A) Microarray analysis (n=2) of collagen XVI(α1) after adipogenic induction in 2-D cultures and 3-D 
spheroids. Bars represent the mean value of the median-normalized spot intensities. Dashes represent 
the individual values of both biological replicates. B) Microarray analysis was verified by qRT-PCR 
measurements (n=3). Collagen XVI(α1) gene expression during differentiation of 3T3-L1. C) qRT-
PCR measurements of the collagen XVI(α1) gene expression in uninduced 3T3-L1 (n=3). Expression 
is reported as exact copy numbers of the collagen XVI(α1) gene per µg RNA (B, C). * indicates 
statistically significant differences to the corresponding group at day 0 (p<0.05). 
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3T3-L1 preadipocytes were adipogenically induced in 2-D and 3-D cell culture and RNA 
samples were taken at day 0, 3, and 6. The gene expression of collagen XVI(α1) was firstly 
identified by microarray analysis (Figure 3 A) and the result was further ascertained by qRT-
PCR analyses in independent cell culture experiments (Figure 3 B). In 2-D as well as in 3-D 
culture, collagen XVI gene expression was clearly downregulated after adipogenic induction 
observed both in microarray analysis and qRT-PCR measurements. In contrast, when 
preadipocytes were not induced to undergo adipogenesis, the gene expression of collagen 
XVI(α1) was not decreased until day 6 after induction in 2-D and 3-D culture (Figure 3 C). In 
fact, in 3-D culture, collagen XVI expression was clearly increased. 
4.2. Protein expression of collagen XVI during adipogenesis of 3T3-L1 in 2-D and 3-D  
To confirm the qRT-PCR results on the protein level, we examined the expression pattern of 
collagen XVI during adipogenesis of 3T3-L1 in 2-D cell culture and 3-D spheroids by 
Western blotting analyses. Cell extracts for analysis of intracellular collagen XVI were 
prepared and culture medium for detection of secreted collagen XVI at different stages of 
differentiation was additionally collected. Moreover, the expression of preadipocytes which 
were not adipogenically induced by a hormonal cocktail was determined. An equal amount of 
protein was loaded onto each lane and blotted on a nitrocellulose membrane, as confirmed by 
Ponceau S staining (Figure 4). By Western blotting, we mostly detected proteolytically 
processed fragments of collagen XVI as already reported for smooth-muscle cells, dermal 
fibroblasts, and intestinal subepithelial myofibroblasts [25,33]. The shown Western blots 
demonstrated the presence of five different-sized polypeptides (Figure 4) with about 210 kDa, 
180 kDa, 130 kDa, 80 kDa, and 60 kDa. Most of the bands correspond to the recombinant 
collagen XVI fragments after proteolytic degradation as previously described by Kassner et 
al. [26]. The ~210 kDa band represents the full-length collagen XVI protein (Figure 1), 
whereas the ~180 kDa fragment shows the collagen XVI molecule lacking almost the entire 
NC11 domain. The ~130 kDa fragment results from elimination of parts of the C-terminal 
domains and the ~80 kDa polypeptide corresponds to the C-terminal part of collagen XVI 
starting at amino acid 941 harboring the non-collagenous domains 1-4 and the collagenous 
domains 1-3. However, the polypeptide with the molecular mass of 60 kDa was not detected 
in HEK 293 EBNA cells transfected with recombinant collagen XVI by Kassner et al. [26], 
thus, it seems to be a proteolytic fragment typical for 3T3-L1. Tillet et al. have also detected 
this 60 kDa polypeptide in transfected human embryonic kidney cell clones and they assumed 
that this fragment corresponds to the largest collagenous domain Col2 (Figure 1) [48].  
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The results of the Western blot analyses demonstrated that collagen XVI was highly 
expressed on day 0 in undifferentiated 3T3-L1 and gradually decreased from day 3 to day 6 of 
differentiation (Figure 4 A). At day 6 after induction, no collagen XVI protein was detectable 
in both 2-D and 3-D cultures. Notably, collagen XVI was more abundant in 3-D culture at 
day 0 and the downregulation was more obvious in 3-D culture compared to 2-D culture. The 
clearly reduced protein expression of collagen XVI was not detected in the preadipocytes 
cultured for 6 days without the addition of the adipogenic inducers, neither in 2-D nor in 3-D 
cell culture (Figure 4 B).  
 
 
Figure 4: Protein expression of collagen XVI in 3T3-L1 in 2-D and 3-D cultures. 
Cell extracts as well as culture medium of induced or uninduced 3T3-L1 were isolated at day 0, 3, and 
6. 20 µg total protein per group were separated by SDS-PAGE and transferred to a nitrocellulose 
membrane. The blots were probed with anti-collagen XVI antibody. A) Western blot of cellular 
collagen XVI after adipogenic induction in 2-D cultures and 3-D spheroids. B) Western blot of cellular 
collagen XVI in 3T3-L1 that were not induced in 2-D and 3-D cultures. C) Western blot of secreted 
collagen XVI after adipogenic induction in 2-D cultures and 3-D spheroids. D) Western blot of 
secreted collagen XVI in 3T3-L1 which were not induced in 2-D and 3-D cultures. Ponceau S staining 
is shown as control for protein loading. Three independent cell culture experiments were performed; 
representative data from one experiment is shown (A-D). Abbreviation: ColXVI=collagen XVI. 
Additionally, the secretion of collagen XVI into the culture medium was analyzed in 2-D and 
3-D (Figure 4 C and D). A small content of secreted protein was detected in 2-D cell culture 
at day 0 and no secretion was found at later stages of differentiation (Figure 4 C). In contrast, 
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cells incorporated in spheroids secreted much more collagen XVI at day 0 compared to 2-D 
culture, but the amount of secreted protein was also diminished during adipose conversion 
(Figure 4 C). Non-induced preadipocytes also secreted more collagen XVI into the medium in 
3-D culture. The secretion gradually decreased up to day 6 of culture in 3-D, whereas in 2-D a 
slight upregulation was detected (Figure 4 D).  
Additionally to the Western blot analyses, the decreased collagen XVI protein expression was 
confirmed with immunofluorescence staining in 3-D culture. The staining did not work in 2-D 
due to autofluorescence of the cells in 2-D monolayer culture in contrast to 3-D sections. 3T3-
L1 spheroids were induced to differentiate into adipocytes and at day 0, 3, and 6 after 
induction, cryosections of 3-D spheroids were stained with Alexa Fluor® 555 antibody linked 
to the anti-collagen XVI antibody. Cryosections of the central region of the spheroid showed 
a homogeneous distribution of collagen XVI at day 0 which was drastically reduced during 




Figure 5: Distribution of collagen XVI in 3-D spheroids during differentiation of adipocytes detected 
by immunofluorescence. Cryosections from spheroids were stained with anti-collagen XVI antibody 
(red fluorescence) and additionally counterstained with DAPI (blue fluorescence). Sections from the 
center area are displayed. Bar=50 µm. 
4.3. Gene and protein expression of collagen XVI(α1) during adipogenesis of ADSCs 
in 2-D and 3-D 
In further experiments, we investigated whether the reduced expression of collagen XVI 
during adipogenic differentiation in vitro was specific for 3T3-L1 or was also observed in 
other adipogenic cell systems such as human ADSCs. Therefore, the gene and protein 
expression of collagen XVI in adipogenically induced ADSCs were analyzed in 2-D and 3-D 
cell culture. RNA samples were prepared at day 0, 3, and 10 and the gene expression of 
collagen XVI(α1) was determined by qRT-PCR analyses (Figure 6 A). A clear 
Chapter 6  Regulation of Collagen Type XVI during in vitro Adipogenesis 
- 152 - 
downregulation of collagen XVI(α1) gene expression after adipogenic induction was not 
detected in 2-D culture of ADSCs in contrast to 3T3-L1, in which this gene was decreased in 
both 2-D and 3-D (Figure 6 and 3). However, a significantly reduced gene expression of 
collagen XVI was evident in 3-D spheroids at day 10 after induction compared to day 0 
(Figure 6 A). The observation made in 3-D was verified on protein level by Western blot 
analyses (Figure 6 C). In 2-D, Western blot technique also showed a slight downregulation of 
collagen XVI at day 10, which was less obvious than in 3-D. Another difference to 3T3-L1 
was the finding that collagen XVI proteins were more abundant in 2-D culture compared to 
3-D at all time points (Figure 6 C, D). When ADSCs were not induced to undergo 
adipogenesis the gene as well the protein expression of collagen XVI did not decrease in 2-D 
culture up to day 10 of cultivation (Figure 6 B, D). The same was observed for protein 
expression in 3-D culture (Figure 6 D). Only the collagen XVI(α1) gene expression in 3-D 
was reduced at day 10 (Figure 6 B).  
 
 
Figure 6: Gene and protein expression of collagen XVI in ADSCs in 2-D and 3-D cultures. 
A) qRT-PCR measurements (n=3) of collagen XVI(α1) after adipogenic induction in 2-D cultures and 
3-D spheroids. B) qRT-PCR measurements of the collagen XVI(α1) gene expression in uninduced 
ADSCs (n=3). Expression is reported as exact copy numbers of the collagen XVI(α1) gene per µg 
RNA (A, B). C) Western blot of cellular collagen XVI after adipogenic induction in 2-D cultures and 
3-D spheroids. D) Western blot of cellular collagen XVI in ADSCs that were not induced in 2-D and 
3-D cultures. Ponceau S staining is shown as control for protein loading. Three independent cell 
culture experiments were performed; representative data from one experiment is shown (C, D).           
* indicates statistically significant differences to the corresponding group at day 0 (p<0.05). 
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Figure 7: Influence of the adipogenic inducers on gene expression of procollagen XVI(α1). 3T3-L1 
preadipocytes were adipogenically induced with differently composed induction cocktails. A) qRT-
PCR measurements (n=3) of procollagen XVI(α1) at day 3 after induction. * indicates statistically 
significant differences to the uninduced preadipocytes at day 0 (p<0.05). B) Oil red O staining of lipid 
droplets within adipocytes 6 days after adipogenic induction. Bar=100 µm. Three independent cell 
culture experiments were performed; representative images from one experiment are shown. 
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To study whether one of the adipogenic inducers has a direct influence on collagen XVI 
expression, we stimulated the differentiation of 3T3-L1 preadipocytes with different induction 
media. The control induction medium consisted of the generally used adipogenic cocktail 
containing insulin, indomethacin, IBMX, and corticosterone. In further experiments, always 
one of the inducers was eliminated from the medium. At day 3 after induction, qRT-PCR 
analysis demonstrated that the cocktails containing corticosterone induced a decrease of 
procollagen XVI(α1) gene expression (Figure 7 A) which was accompanied by adipogenesis 
as shown by oil red O staining (Figure 7 B, a-d). In contrast, cells induced without 
corticosterone (i.e., only with insulin, indomethacin, and IBMX) did not downregulate 
procollagen XVI(α1) mRNA. Adipogenic differentiation was strongly affected in this group 
(Figure 7 B, e). Therefore, subsequently, preadipocytes were incubated in presence of 
corticosterone alone. These preadipocytes showed a reduced procollagen XVI(α1) gene 
expression without differentiating into adipocytes (Figure 7 A and B, f). Finally, bisphenol A 
diglycidyl ether (BADGE), which is an antagonist of peroxisome proliferator-activated 
receptor γ (PPARγ), was added to the conventionally used induction medium consisting of the 
four inducers. BADGE has been experimentally used to inhibit hormone-induced 
differentiation of 3T3-L1 preadipocytes [49]. Preadipocytes which were incubated with 
BADGE showed a reduced procollagen XVI(α1) gene expression and did not differentiate 
into adipocytes (Figure 7 A and B, g).  
It can be deduced that downregulation of collagen XVI was not sufficient to result in 
adipogenic differentiation. Nevertheless, from these results, it is still possible that collagen 
XVI has a functional role in adipogenesis and has to be downregulated in order that adipocyte 
development proceeds.  
4.5. Differentiation of 3T3-L1 on different collagen substrata 
A possible functional role of collagen XVI on in vitro adipogenesis was initially investigated 
by the exogenous addition of recombinant collagen XVI protein. Adipogenic differentiation 
of 3T3-L1 cells was compared for different collagen substrata, i.e., collagen I, collagen IV, 
and collagen XVI relative to BSA-coated tissue-culture plastic as control. Collagen I and IV 
were also used as controls to eliminate unspecific effects of collagens. Collagen IV is the 
most abundant collagen in adipocytes and is known to be increased during adipogenesis 
[19,21]. In contrast, collagen I is downregulated during adipogenic differentiation [21]. Our 
coating experiments revealed that the extent of adipogenesis after induction with the usual 
hormonal cocktail was independent of the composition of the substrate. In all groups, 
Chapter 6  Regulation of Collagen Type XVI during in vitro Adipogenesis 
- 155 - 
differentiation was evident in the accumulation of TG within intracellular lipid droplets as 
detected by oil red O staining (Figure 8 A) and TG measurements (Figure 8 B). 
 
 
Figure 8: Differentiation of 3T3-L1 on different collagen substrata in 2-D culture. Preadipocytes were 
seeded on different collagen-coated plates: collagen I, IV, and XVI. BSA-coated plastics served as 
control. TG accumulation was determined at day 6 after adipogenic induction. A) Oil red O staining of 
lipid droplets within adipocytes 6 days after adipogenic induction. Bar=100 µm. Two independent cell 
culture experiments were performed; representative images from one experiment are shown.               
B) Quantification of intracellular TG content (n=3). TG contents were normalized to cell numbers. 
4.6. Effect of collagen XVI(α1) overexpression on in vitro differentiation of 3T3-L1 
preadipocytes 
To further investigate if collagen XVI has a functional role in the adipogenesis of 3T3-L1 
preadipocytes, we generated a stably transfected 3T3-L1 cell line overexpressing human 
collagen XVI(α1). We hypothesized that the downregulation of collagen XVI is essential for 
the adipogenic process and, thus, the overexpression of this ECM component would prevent 
the differentiation into adipocytes. 3T3-L1 preadipocytes were transfected with the vector 
pCEP-PU-BM40SP modified by insertion of collagen XVI(α1) [26] using the Lipofectamine 
2000 reagent and transfectants were selected with puromycin. The success of the transfection 
procedure was verified by qRT-PCR measurements. In cells overexpressing collagen 
Col I Control Col XVI Col IV
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XVI(α1), six-fold increased mRNA levels were monitored by qRT-PCR as compared to non-
transfected cells referred to as control (Figure 9 A).  
In the following, we performed first experiments to investigate a possible effect of the 
collagen XVI overexpression on the adipocyte differentiation in vitro. Non-transfected 3T3-
L1 referred to as control and 3T3-L1 stably overexpressing collagen XVI were induced to 
undergo adipogenesis. Six days after induction, the intracellular lipid content was higher in 
the control cells as compared to the collagen XVI(α1) overexpressing cells as detected by oil 
red O staining (Figure 9 B). Quantification of the TG content confirmed the impaired 
adipogenesis resulted from overexpression of collagen XVI (Figure 9 C).  
 
 
Figure 9: Effect of collagen XVI(α1) overexpression on in vitro differentiation of 3T3-L1 
preadipocytes. 3T3-L1 preadipocytes were stably transfected with pCEP-PU-BM40SP modified by 
insertion of human collagen XVI(α1). Non-transfected 3T3-L1 preadipocytes served as control. 
A) The overexpression of collagen XVI mRNA was verified by qRT-PCR. B) Oil red O staining of 
lipid droplets within adipocytes is shown for non-transfected preadipocytes (left) and for cells 
overexpressing collagen XVI(α1) (right) at day 6 after adipogenic induction. Bar=100 µm. Three 
independent cell culture experiments were performed; representative images from one experiment are 
shown. C) Quantification of intracellular TG content in control cells and in cells overexpressing 
collagen XVI(α1) at day 6 after adipogenic induction (n=3). TG contents were normalized to the cell 
number. * indicates statistically significant differences to the control group (p<0.05). 
5. Discussion 
Besides the changes directly related to the intracellular increase in lipid synthesis, alterations 
also occur in the ECM surrounding the cells during adipocyte differentiation. The ECM, 
whose main components are collagens, is continuously remodeled during the adipogenic 
process. Studies on collagen matrix turnover during adipose conversion have been focused on 
fibrillar collagens, i.e., type I, III, and V as well as collagen IV and VI, whose expressions are 
regulated in adipogenesis [19,21,24]. However, the association of the major matrix molecules 
like fibrillar collagens is organized by specific sets of minor components, e.g., FACIT 
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collagens. Members of this collagen family act as adapter molecules interconnecting 
macromolecular networks. The presence and distribution of FACIT in skin, cornea, and 
cartilage have been reported previously [50]. So far, FACITs are not well documented in 
adipose tissue. Apart from one study in which collagen XVI was observed around adipocytes 
by immunofluorescence staining of adult mouse skin sections [27], no reports exist 
connecting type XVI collagen and adipose tissue. Changes in collagen type XVI expression 
during adipocyte differentiation have not been described previously at all.  
In the current study, for the first time, we examined the expression of collagen type XVI 
mRNA and protein in 3T3-L1 and ADSCs during the development into adipocytes after 
adipogenic induction in vitro. 3T3-L1 preadipocytes constitutively expressed procollagen 
XVI(α1) mRNA and upon differentiation into adipocytes, the expression level distinctly 
decreased as detected by qRT-PCR analyses (Figure 3 B, Page 148). In addition, the reduction 
of procollagen XVI mRNAs was associated with parallel decrease in protein expression of 
collagen XVI shown by Western blot analyses and immunofluorescence staining (Figure 4 A 
and 5, Page 150 and 151). Cells which were not adipogenically induced did not exhibit a 
downregulation of collagen XVI (Figure 4 B, Page 150). ADSCs also showed a 
downregulation of collagen XVI during in vitro adipogenesis (Figure 6, Page 152). 
Interestingly, in ADSCs, in which adipogenesis progresses slower than in 3T3-L1, the 
collagen XVI downregulation was also observed at a later time point as compared to 3T3-L1.  
Comparing the 2-D and 3-D culture systems, differences in the expression pattern of collagen 
XVI were detected in 3T3-L1. In 3-D spheroids, collagen XVI gene expression was strongly 
diminished in preadipocytes at day 0 compared to 2-D culture (Figure 3 B, Page 148). 
Interestingly, contrary results were determined on protein level. Here, collagen XVI was more 
expressed in preadipocytes cultured in 3-D spheroids and, subsequently, the downregulation 
was more obvious in 3-D culture compared to 2-D culture (Figure 4 A, Page 150). In contrast 
to 3-D spheroids, in which the cells were in close contact from the beginning of spheroid 
formation occurring few hours after seeding, in 2-D monolayer, the cells were not confluent 
shortly after seeding, but grew to confluence within two days up to the time of induction 
(referred to as day 0). During this time, the cells proliferated more rapidly in 2-D compared to 
3-D culture (data not shown). Presumably, these different conditions influence the collagen 
XVI gene expression. Furthermore, cells in 2-D culture do not generate the complex ECM 
organization presented in a 3-D tissue-like context. Consequently, it is assumed that cells in 
2-D monolayer synthesize and secrete a limited number of matrix proteins including collagen 
XVI as detected by Western blot analyses (Figure 4 A, Page 150). The differential results in 
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2-D and 3-D point out the presence of differences between the two culture systems and the 
importance of a 3-D tissue-like model system which likely resembles in vivo conditions more 
closely for studying cell-matrix interactions. 3-D systems offer a better representation of the 
complexity of the in vivo microenvironment which influences various essential cell processes 
including adipocyte differentiation [10,35,51-53]. This microenvironment also involves cell 
adhesion complexes including several integrins which are of pivotal physiological relevance 
since they connect cells with specialized fibrils and, thus, contribute to the matrix 
organization [27]. Few studies implicated integrins in adipogenesis [54-56]. Furthermore, it 
was reported that collagen XVI interacts with integrin α1β1 and α2 β1 [27,33]. Thus, in future 
studies, it would be interesting to investigate possible molecular interactions of collagen XVI 
with integrins with regard to adipogenic differentiation, especially in a 3-D coherent tissue-
like context.  
Further experiments in this study revealed that corticosterone, one of the adipogenic inducers, 
had a reducing effect on procollagen XVI(α1) expression and apparently was responsible for 
the downregulation of this type of procollagen (Figure 7, Page 153). Pantoja et al. have 
revealed that dexamethasone, a synthetic glucocorticoid, modulated the expression of genes 
that participate in ECM processes and the transforming growth factor ß (TGF-ß), WNT 
(wingless/Int), and MAP kinase pathways [57]. Furthermore, it was reported that 
glucocorticoids inhibited the TGF-β-induced expression of ECM proteins such as fibronectin 
[58] and collagen [59,60]. It was shown that the glucocorticoid receptor repressed TGF-β 
signaling by directly targeting smad 3 and 4 proteins [61]. Smad proteins are signaling 
effectors of TGF-β and regulate the transcription by binding to DNA and interaction with 
other transcription factors. Furthermore, it was reported that collagen XVI expression was 
increased by exogenous addition of TGF-β [62]. In our study, it may be that after induction of 
3T3-Ll preadipocytes with a glucocorticoid the corresponding receptor inhibited the TGF-β 
signaling pathway by interacting with smads. In turn, it is supposed that the inhibition of the 
TGF-β signaling by glucocorticoids repressed the collagen XVI transcription. This hypothesis 
has to be further investigated in future studies.  
To date, we have not clarified the consequence of collagen XVI downregulation on 
adipogenesis. From the experiments with differently composed induction media (Figure 7, 
Page 153), it can be deduced that downregulation of collagen XVI was not sufficient to result 
in adipocyte differentiation. It is possible that the collagen XVI downregulation introduced by 
adipogenic signals is a side effect of induction which does not influence the adipogenic 
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process. Thus, it would be interesting to examine whether collagen XVI is downregulated 
during adipocyte differentiation which is induced independently of any glucocorticoids. 
Nevertheless, it is very well still possible that collagen XVI plays a functional role in 
adipogenesis and has to be downregulated for adipocyte maturation. A possible functional 
role of the downregulation of collagen XVI in adipogenesis was investigated by 
overexpression studies as well as exogenous addition of collagen XVI. The exogenous 
addition of collagen XVI by coating the bottom of culture plates did not influence the 
morphology and development of adipocytes (Figure 8, Page 155). Qualitative and quantitative 
assessment using oil red O staining and measurements of the TG content showed that 
preadipocytes grown on collagen XVI coated or on uncoated plates differentiated into 
adipocytes at the same rate. Collagen I and IV substrates served as controls, but again, no 
significant changes in the differentiation rate were detectable. The effect was not amplified by 
an increase in coating density (50 µg/ml) of the single collagen types (data not shown). It is 
assumed that the used hormonal induction cocktail was sufficient to induce adipocyte 
differentiation so that the differentiation of 3T3-L1 adipocytes always proceeded to maximal 
level. Thereby, responses of cells to altered conditions such as different coating substrates 
were potentially impaired. For this reason, we also investigated adipogenic self-induction of 
the preadipocytes which occurs spontaneously, i.e., without adding any inducing substances 
when confluent cells are further cultured. However, also under these conditions, exogenous 
collagen XVI did not influence adipocyte differentiation (data not shown). Thus, the abundant 
presence of collagen XVI in the surrounding of the cells did not influence adipocyte 
differentiation. Presumably, the matrix protein has to be correctly inserted into the ECM 
network in order to cause significant effects. 
In overexpression studies, 3T3-L1 preadipocytes were stably transfected with collagen 
XVI(α1). Collagen XVI(α1) overexpression in 3T3-L1 preadipocytes had a considerable 
effect on their differentiation into mature adipocytes. It was shown that only a minor fraction 
of the cells were able to differentiate into adipocytes compared to non-transfected cells 
(Figure 9 B, Page 156). In further experiments it has to be investigated whether the reduced 
adipocyte differentiation was caused by the overexpression of collagen XVI(α1) or if it was a 
phenomenon of the transfection procedure or the vector itself. In this study, we used non-
transfected cells as control, however, the transfection using an empty vector as control is 
inevitable to exclude that the effect resulted from the transfection procedure, even if we do 
not expect it to affect the results. Many published overexpression studies have shown that 
various vectors did not impact the differentiation of 3T3-L1 preadipocytes into adipocytes 
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including the activation of key transcription factors [63-66]. If in experiments with an empty 
vector control it can be verified that expression of collagen XVI prevents adipocyte 
development, in further experiments the nature of the functional role of collagen XVI in 
adipogenesis, i.e., in intracellular or extracellular events, may be investigated.  
In summary, this study showed for the first time that collagen XVI was regulated in 
hormonally induced adipogenesis. Thereby, corticosterone induced a downregulation of 
procollagen XVI(α1). Preliminary overexpression experiments suggest a possible functional 
role of collagen XVI in in vitro adipogenesis of 3T3-L1. Further analyses will be required for 
a better understanding of the underlying mechanism of regulation and its biological 
significance to clarify the role of this FACIT collagen member in adipogenesis. 
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1. Abstract 
Adipose tissue engineering is a promising strategy to augment soft tissue defects in many 
reconstructive, corrective, and cosmetic indications. Successful engineering of adipose tissue 
requires suitable biomaterials that guarantee adipocyte function and differentiation. For these 
purposes, our group recently developed in situ forming, poly(ethylene glycol) (PEG)-based 
hydrogels that can be easily functionalized with degradation sites and various other factors, 
such as adhesion peptides or growth factors.  
In the present study, the suitability of the developed hydrogels for adipose tissue engineering 
was investigated by seeding them with 3T3-L1 preadipocytes. By determining the 
intracellular triglyceride (TG) content, we investigated the influence of substrate stiffness, 
adhesiveness, and degradability on the differentiation of adipocytes. Compared to 
conventional two-dimensional (2-D) cell culture, the adipocytes encapsulated in hydrogels 
accumulated higher TG amounts. Further increasing the gel strength resulted in reduced TG 
accumulation; gel functionalization with the laminin-derived adhesion peptide Cys-Asp-Pro-
Gly-Tyr-Ile-Gly-Ser-Arg (YIGSR) enhanced the lipid synthesis of encapsulated adipocytes. 
Long-term in vitro studies revealed that enzymatically degradable hydrogels promoted the 
formation of coherent adipose tissue-like structures characterized by many mature unilocular 
adipocytes.  
In conclusion, the developed biomimetic PEG hydrogels provide an appropriate environment 
for 3T3-L1 cells to differentiate into adipocytes and are, therefore, suggested as a promising 
new biomaterial for adipose tissue engineering.  
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2. Introduction 
Adipose tissue engineering aims at the reconstruction of adipose tissue by generating suitable 
grafts, which must be equivalent to native adipose tissue regarding its composition and 
biological function. Engineered adipose tissue equivalents are increasingly acknowledged as a 
possible alternative in plastic and reconstructive surgery to augment soft tissue defects after 
tumor resection, deep burns, severe trauma or congenital defects. However, despite the 
increasing clinical demand for suitable tissue substitutes, none of the current approaches has 
proven to be ideal for adipose tissue reconstruction. Low graft survival and necrosis due to 
insufficient vascularization accompanied with fibrous tissue invasion and formation of fatty 
cysts are widely observed problems [1-3]. To overcome these limitations and guarantee a 
successful adipose tissue development, the scaffold is an essential factor and has to be 
optimized. An appropriate scaffolding material must be biocompatible, support the formation 
of functional tissue, and demonstrate considerable mechanical stability to allow for successful 
integration of the newly formed tissue into the surrounding host tissue [4]. Thereby, the 
mechanical properties of the scaffold should resemble in vivo adipose tissue as closely as 
possible. Thus, very rigid scaffolds are not suitable materials to augment soft tissues. 
However, PEG-based hydrogels are proposed to be an appropriate alternative for adipose 
tissue engineering [5-11]. These hydrophilic polymer networks absorb large amounts of water 
enabling the unrestricted diffusion of low molecular weight nutrients and metabolites [12]. 
Furthermore, the biocompatible hydrogels provide tissue-forming adipocytes with an 
environment mimicking the native extracellular matrix (ECM) [8,13-16]. Another important 
characteristic of scaffolding materials are their degradability. Current tissue engineering 
strategies are based on biodegradable cell carriers which provide transient mechanical support 
until cells have produced their own ECM and developed new tissue structures that are ideally 
integrated into the host tissue. Thus, the degradation rate has to be adapted to the progression 
of tissue formation [14,17]. Since the most synthetic hydrogels are biologically inert, the 
incorporation of certain peptide sequences, such as collagenase-sensitive peptides, is required 
to render the resulting hydrogels susceptible to proteolytic breakdown. Lutolf and coworkers 
prepared such biomimetic PEG hydrogels by cross-linking vinylsulfone terminated PEG 
macromers with cysteine-containing matrix metalloproteinase (MMP)-sensitive peptides 
[18,19]. These in situ forming gels were degraded by cell-secreted and cell-activated 
proteases and proved to be suitable for the repair of bone and cartilage defects [20,21]. In 
another approach, amine-reactive PEG monoacrylates were reacted with collagenase-sensitive 
peptides (Gly-Gly-Leu↓Gly-Pro-Ala-Gly-Gly-Lys) and integrin-binding domains (Tyr-Ile-
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Gly-Ser-Arg) resulting in triblock copolymers terminated by acrylate groups. These 
copolymers were photopolymerized to form hydrogels that promoted viability, adhesion, and 
proliferation of preadipocytes [9]. 
But despite these promising results, direct transfer into clinical practice could be a challenge. 
The radical cross-linking scheme often results in cytotoxic byproducts, such as unreacted 
monomers or degradation products of the polymers, which have to be removed prior to their 
implantation [22]. To cope with the problems associated with radical cross-linking, our group 
developed injectable, biomimetic hydrogels that are prepared without the use of free-radical 
initiators (Figure 1) [12,23]. For the preparation of enzymatically degradable hydrogels, 
branched PEG-amines were modified with collagenase-sensitive peptides and cross-linked 
with branched PEG-succinimidyl propionates. Alanin-modified PEG-amines were used for 
non-degradable hydrogels.  
 
 
Figure 1: Principle of injectable, biomimetic hydrogels for adipose tissue engineering. A) For gel 
preparation, branched PEG-succinimidyl propionates are cross-linked with branched, amino acid-
modified PEG-amines. B) The collagenase-sensitive peptide sequence Ala-Pro-Gly↓Leu allows for 
enzymatic gel degradation. C) The integrin-binding motif Tyr-Ile-Gly-Ser-Arg is reacted with 
branched PEG-succinimidyl propionates and mediates cell adhesion. Reprinted with permission from 
Brandl et al. [23]. ©2010 Elsevier B.V. 
The use of these hydrogels as injectables directly applied into the soft tissue defect and cross-
linked in vivo may facilitate the treatment in a minimally invasive and less painful way [24]. 
Additionally, the developed hydrogels can be further optimized by functionalization with 
adhesion molecules or growth factors to promote cell adhesion, migration, proliferation, and 
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differentiation [14,17,24]. Thus, the newly developed hydrogels were functionalized with the 
synthetic nonapeptide YIGSR, which has been identified as the major cell binding site in the 
B1 chain of laminin and mediates cell adhesion [9,25-27].  
The present in vitro studies investigate the efficiency of the newly developed PEG-based 
hydrogels as scaffold material for adipose tissue engineering. 3T3-L1 preadipocytes, a 
commonly used model system for studying adipocyte biology, were encapsulated into the 
hydrogels and subsequently differentiated into mature adipocytes. We tested the effects of 
substrate stiffness, adhesiveness, and degradability on adipocyte development by quantifying 
the intracellular TG accumulation and compared the adipogenic differentiation capacity with 
the outcome of 2-D cell culture. Finally, we investigated the influence of biodegradability on 
the formation of adipose tissue-like structures in an in vitro long-term study.  
3. Materials and Methods 
Materials 
Murine 3T3-L1 preadipocytes were obtained from ATCC (Manassas, VA). Dulbecco’s 
Modified Eagle’s Medium (DMEM) was purchased from Biochrom (Berlin, Germany). Fetal 
bovine serum (FBS, Lot. No. 40A0044K), 0.25% trypsin-EDTA solution, penicillin-
streptomycin solution, and phosphate buffered saline (PBS) were from Invitrogen GmbH 
(Karlsruhe, Germany). Hoechst 33258 dye was obtained from Polysciences (Warrington, PA) 
and bovine insulin was kindly provided by Sanofi-Aventis (Frankfurt am Main, Germany). 3-
isobutyl-methylxanthine (IBMX) was bought from Serva Electrophoresis (Heidelberg, 
Germany). Corticosterone, cysteine, DNA from calf thymus, indomethacin, the laminin 
fragment YIGSR, Minimum Essential Medium alpha modification (α-MEM), oil red O, and 
Sigmacote® were purchased from Sigma-Aldrich (Taufkirchen, Germany). Papainase was 
bought from Worthington (Lakewood, NJ). Thesit was obtained from Gepepharm GmbH 
(Siegburg, Germany). All other chemicals were of analytical grade and obtained from Merck 
KGaA (Darmstadt, Germany). Deionized water was obtained using a Milli-Q water 
purification system from Millipore (Schwalbach, Germany). All cell culture plastics were 
purchased from Corning (Bodenheim, Germany). 
Amine-reactive polymers (4armPEG10k-SPA), collagenase-sensitive polymers (4arm-
PEG10k-LGPA), and non-degradable polymers (4arm-PEG10k-Ala) were kindly provided by 
Ferdinand Brandl, Department of Pharmaceutical Technology, University of Regensburg 
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(Regensburg, Germany). The synthesis of these polymers is described in detail by Brandl et 
al. [23]. 
Methods 
3.1. Cell seeding and cell culture 
3T3-L1 preadipocytes were plated in T150 culture flasks and expanded in DMEM 
supplemented with 10% FBS, penicillin (100 U/ml), and streptomycin (100 μg/ml). At 
confluence, the 3T3-L1 cells were harvested using trypsin-EDTA, centrifuged to a pellet 
(1200 rpm, 5 minutes) and washed with PBS. 
For the preparation of hydrogels, accurately weighed amounts of 4armPEG10k-LGPA 
(degradable gels) or 4armPEG10k-Ala (non-degradable gels) were dissolved in phosphate 
buffer (50 mM, pH 7.4) at 125 mg/ml. A solution of YIGSR (c = 10 μmol/ml) or phosphate 
buffer was added, so that the final polymer concentrations were 100 mg/ml. In a similar 
manner, accurately weighed amounts of 4armPEG10k-SPA were dissolved in water at 
100 mg/ml. All polymer solutions were kept on ice until use. For cell seeding, the prepared 
3T3-L1 preadipocytes were suspended in the amino component (4armPEG10k-LGPA or 
4armPEG10k-Ala). Subsequently, an equal volume of 4armPEG10k-SPA was added. After 
vortexing, 50 μl of the polymer-cell solution were cast into cylindrical glass molds (5 mm 
inner diameter) that had been treated with Sigmacote®. The final polymer concentration was 
10% (w/v) and the cell number 100,000 cells per hydrogel construct. For long-term cell 
culture 5,000,000 cells were used. After 30 minutes of gelation at 37°C, the glass rings were 
removed. Each gel sample was transferred into one well of 24-well plates and covered with 
2 ml of basal medium (α-MEM supplemented with 10% FBS, 100 U/ml penicillin, and 
100 μg/ml streptomycin). For standard 2-D cell culture, 100,000 3T3-L1 cells were seeded in 
24-well plates and covered with 2 ml of basal medium. Two days after cell seeding, 
adipogenesis was induced by applying induction medium (basal medium supplemented with 
1 μM insulin, 0.1 μM corticosterone, 0.5 mM IBMX, and 60 μM indomethacin). The time 
point of induction was referred to as day 0. At day 2, the induction medium was replaced by 
differentiation medium (basal medium supplemented with 1 μM insulin). The hydrogel 
constructs were dynamically cultured on an orbital shaker at 60 rpm (Heidolph Instruments, 
Schwabach, Germany) in a humidified atmosphere at 37°C and 5% CO2. The culture medium 
was exchanged every two days. 
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3.2. Oil red O staining 
In order to visualize cytoplasmic lipid droplets, the hydrogel constructs were washed with 
PBS, fixed in formalin (10% in PBS) overnight, and stained with oil red O (3 mg/ml in 60% 
isopropanol) for 12 hours [28]. Excessive dye was removed by washing three times with PBS. 
Microscopical phase contrast images were acquired at 20× magnification using a Zeiss 
Axiovert 200 M microscope equipped with a Zeiss AxioCam HRc camera and the software 
ZEN 2008 (Carl Zeiss MicroImaging GmbH, Jena, Germany). 
3.3. Quantitative analysis of intracellular TG accumulation 
Nine days after induction, the intracellular TG content was quantified using a serum 
triglyceride determination kit (Sigma-Aldrich, Taufkirchen, Germany). After washing with 
PBS, the hydrogel constructs were harvested in 0.5% thesit solution, disintegrated using a 
micropistill (Hartenstein Laborbedarf, Würzburg, Germany) and sonicated (Branson 
Ultrasonic Corporation, Danbury, CT). The spectroscopic quantification of TGs was 
performed according to the manufacturer’s instructions. All measurements were done in three 
biological replicates. The amount of TGs per hydrogel construct was calculated and 
normalized to the cell number of the respective sample as determined by the DNA assay. 
3.4. Determination of the cell number with DNA assay 
Aliquots of disintegrated and sonicated hydrogel constructs were completely digested with 
papainase (3.2 U/ml in 0.1 M Na2HPO4 buffer, pH 6.5 containing 1 mM Na2EDTA and 
2.5 mM cysteine) for 16 hours at 60°C, and the DNA content was determined using the 
intercalating Hoechst 33258 dye (0.1 μg/ml in 0.1 M NaCl containing 1 mM Na2EDTA and 
10 mM Tris, pH 7.4) [29]. Fluorescence intensities were determined at 365 nm excitation 
wavelength and 458 nm emission wavelength on a LS 55 Fluorescence spectrometer 
(PerkinElmer, Wiesbaden, Germany) and correlated to DNA contents using standard dilutions 
of double-stranded DNA (from calf thymus). Cell numbers were calculated with a conversion 
factor of 26.1 pg of DNA per cell, which was determined previously [30]. 
3.5. Statistics 
All quantitative results are presented as mean values ± standard deviation. Statistical analyses 
were determined using GraphPadPrism v.5 (GraphPad Software, La Jolla, CA, USA). 
Differences between two groups were analyzed for significance using the unpaired Student’s 
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t-test. Differences between multiple groups were analyzed for significance using one-way 
analysis of variances (ANOVA) with subsequent multiple comparisons according to Tukey’s 
post hoc test. A value of p<0.05 was regarded as statistically significant.  
4. Results 
4.1. Effect of hydrogel strength on 3T3-L1 adipocytes in vitro  
The strength of the PEG-based hydrogels increased with rising polymer concentrations [23]. 
To find an optimal gel strength supporting adipocyte proliferation and adipogenesis in vitro, 
biodegradable hydrogels with polymer contents ranging from 5% - 20% were seeded with 
3T3-L1 preadipocytes at a cell density of 100,000 cells per hydrogel. Two days after seeding, 
the cell-polymer constructs were adipogenically induced with a hormonal cocktail composed 
of insulin, corticosterone, indomethacin, and IBMX. Nine days after induction, the cell 
number per gel and the intracellular TG content per cell were determined. Microscopic 
inspection of the differentiated cell-hydrogel constructs revealed a homogeneous cell 
distribution within the hydrogel regardless of the initial polymer concentrations (Figure 2 A). 
Differentiated lipid-loaded adipocytes appeared as dark dots in the microscopic photographs 
(Figure 2 A). In hydrogels prepared from 5% or 10% polymer, many differentiated adipocytes 
were visible. However, the number of cells generally decreased with increasing polymer 
concentrations. This observation was also confirmed by quantifying the cell number per 
hydrogel construct (Figure 2 B). The determined cell number was generally lower than the 
seeded cell number of 100,000 cells. Apparently the cells did not proliferate within the 
hydrogels. Regarding adipogenesis, the intracellular TG accumulation was comparable for 
adipocytes encapsulated in hydrogels prepared from 5%, 10% and 15% polymer. In contrast 
to that, significant lower values were observed for cells cultured in gels prepared from 20% 
polymer (Figure 2 C). The microscopic picture confirmed the reduced number of adipocytes 
in the 20% hydrogel. Almost no lipid-filled adipocytes were detectable (Figure 2 A).  
Altogether, the PEG-based hydrogels seemed to provide an appropriate environment for 3T3-
L1 preadipocytes to differentiate into adipocytes. In particular, the hydrogels containing 10% 
polymer showed the most promising results with regard to cell number and adipogenic 
differentiation capacity and we, therefore, used these hydrogels for all further experiments.  
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Figure 2: Effect of hydrogel strength on cell number and adipogenic differentiation of 3T3-L1 
preadipocytes encapsulated within degradable gels prepared from different polymer concentrations. 
The 3T3-L1 preadipocytes were seeded at a density of 100,000 cells per hydrogel; two days after 
seeding, the obtained three-dimensional (3-D) cell constructs were adipogenically induced with a 
hormonal cocktail. At day 9 after induction, the differentiated cell-hydrogel constructs were analyzed. 
A) Phase contrast images of differentiated cell-hydrogel constructs. Three independent cell culture 
experiments were performed; representative photographs from one experiment are shown. 
Bar=500 µm. B) Quantification of the cell number per hydrogel (n=3). C) Quantification of 
intracellular TG accumulation (n=3). TG contents were normalized to cell numbers. Statistically 
significant differences are denoted by * (p<0.05). 
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4.2. Adipogenic differentiation of 3T3-L1 cells cultured within hydrogels and under 
standard 2-D cell conditions 
In this experiment, we compared the cell number and adipogenic differentiation of 3T3-L1 
preadipocytes cultured either in conventional monolayer cell culture (2-D cell culture) or 
within hydrogels (degradable and non-degradable cells, 3-D cell culture) at day 9 after 
induction (Figure 3).  
 
 
Figure 3: Comparison of 2-D and 3-D cell culture. In 2-D culture, 3T3-L1 preadipocytes were seeded 
at a density of 100,000 cells in a 24-well plate, whereas in 3-D culture, the same number of 
preadipocytes was encapsulated into degradable or non-degradable hydrogels (50 µl). Two days after 
seeding, the cells were adipogenically induced with a hormonal cocktail. At day 9 after induction, the 
adipocytes were analyzed. A) Phase contrast images of differentiated adipocytes cultured under 2-D 
(left) and 3-D conditions (right). Three independent cell culture experiments were performed; 
representative photographs from one experiment are shown. Bar=100 µm and 200 µm, respectively. 
B) Quantification of the cell number per hydrogel (n=3). C) Quantification of intracellular TG 
accumulation (n=3). TG contents were normalized to cell numbers. Statistically significant differences 
are denoted by * (p<0.05). 
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In 2-D culture, the seeded 3T3-L1 cells proliferated during the initial culture period; at day 9 
after induction, approximately 260,000 cells per well were detected by DNA assay 
(Figure 3 B). Compared to this data, the number of cells found within hydrogels was clearly 
reduced after the same culture period. The determined cell number of about 80,000 cells per 
degradable hydrogel corresponded to the initial cell number quantified immediately after gel 
preparation in separate experiments (Figure 4). This indicates that the proliferation of 3T3-L1 
cells was suppressed when cultured within hydrogels.  
 
 
Figure 4: Determination of the cell number within degradable gels immediately after gel preparation 
and at day 9 after induction (n=3). 
Regarding adipogenesis, 3T3-L1 preadipocytes were able to differentiate after adipogenic 
induction in 2-D as well as in 3-D culture systems resulting in lipid-filled adipocytes 
(Figure 3 A). Under 2-D culture conditions, the differentiated 3T3-L1 cells had a well spread 
morphology and contained a large number of small lipid droplets. Within 3-D hydrogels, 
however, the adipocytes had a rounded shape probably resulting from the large lipid vacuoles 
(Figure 3 A). Quantification of the intracellular TG content verified the increased TG 
accumulation in adipocytes encapsulated within hydrogels (Figure 3 C). The degradability of 
the gel did not influence the adipogenic differentiation of the cells compared to the non-
degradable system.  
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Figure 5: Effect of YIGSR on the proliferation and adipogenic differentiation of 3T3-L1 cells which 
were encapsulated within degradable and non-degradable hydrogels. 3T3-L1 preadipocytes were 
seeded at a density of 100,000 cells into the different hydrogels. Two days after seeding, the cells were 
adipogenically induced with a hormonal cocktail. At day 9 after induction, the adipocytes were 
analyzed. A) Phase contrast images of differentiated adipocytes cultured in degradable hydrogels 
without YIGSR (right) and with 1 µmol/ml YIGSR (left). Bar=200 µm. B) Phase contrast images of 
differentiated adipocytes cultured in non-degradable hydrogels without YIGSR (right) and with 
1 µmol/ml YIGSR (left). Bar=200 µm. Three independent cell culture experiments were performed; 
representative photographs from one experiment are shown (A, B). C) Quantification of the cell 
number per hydrogel (n=3). D) Quantification of intracellular TG accumulation (n=3). TG contents 
were normalized to cell numbers. Statistically significant differences are denoted by * (p<0.05). 
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To enable cell adhesion, which is critical for cell viability and function, the virtually non-
adhesive PEG gels have been modified by incorporation of various adhesion ligands [9,31]. In 
the present study, we tested the effect of the laminin-derived peptide YIGSR on the 
proliferation and adipogenic differentiation of 3T3-L1 cells. For this purpose, degradable and 
non-degradable cell-hydrogel constructs were prepared either without YIGSR or with 
1 µmol/ml YIGSR. Two days after seeding, the gel samples were hormonally induced to 
undergo adipogenesis. At day 9 after induction, the cell-laden hydrogels were analyzed for 
their cell number and their intracellular TG content (Figure 5). 
Isolated adipocytes were homogeneously distributed throughout the hydrogels (Figure 5 A 
and B). In comparison to gels containing no YIGSR, adipocytes cultured in hydrogels with 
1 µmol/ml YIGSR seemed to accumulate more lipids resulting in larger droplets (Figure 5 A 
and B). This observation was verified by quantifying the intracellular TG content 
(Figure 5 C). In degradable hydrogels containing YIGSR, the TG amount was significantly 
increased in comparison to gels without YIGSR. A similar trend was observed in non-
degradable constructs. Regarding the cell number, no differences were detected between gel 
samples containing YIGSR and those without (Figure 5 D). Again, degradable and non-
degradable systems did not influence the proliferative behavior of 3T3-L1 cells (see section 
4.2 for comparison).  
4.4. Effect of the substrate degradability on adipose tissue development in vitro 
To investigate the effect of substrate degradability on adipose tissue development in vitro, 
degradable and non-degradable hydrogels were seeded with 5,000,000 preadipocytes per 
construct and cultured over a period of 6 weeks. At day 42 after adipogenic induction, the two 
groups were analyzed microscopically (Figure 6). 
The capability of non-degradable and degradable hydrogels to support the development of 
adipose tissue-like structures varied dramatically. 3T3-L1 preadipocytes encapsulated within 
non-degradable hydrogels differentiated into adipocytes with multiple intracellular lipid 
droplets (Figure 6 A and B, left). However, the isolated adipocytes were not able to form 
coherent, tissue-like structures within these gels. In contrast, preadipocytes cultured within 
degradable hydrogels matured to unilocular adipocytes with a single large lipid droplet that 
occupied most of the cytoplasm (Figure 6 A and B, right). Under these conditions, the 
differentiated adipocytes were able to form adipose tissue-like structures; single cells could no 
longer be detected. 
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Figure 6: Effect of the substrate degradability on adipose tissue development in vitro. 3T3-L1 
preadipocytes were seeded at a density of 5,000,000 cells into degradable and non-degradable 
hydrogels. Two days after seeding, the cells were adipogenically induced with a hormonal cocktail. At 
day 42 after induction, the adipocytes were microscopically analyzed. A) Phase contrast images of 
differentiated adipocytes cultured in non-degradable (left) and degradable (right) hydrogels. 
Bar=100 µm. B) Oil red O staining of intracellular lipid droplets within differentiated adipocytes 
cultured in non-degradable (left) and degradable (right) hydrogels. Bar=100 µm. 
5. Discussion 
Current tissue engineering approaches include the use of various natural, synthetic, and hybrid 
scaffolding materials to correct soft tissue deficits. However, rigid materials such as 
poly(lactic-co-glycolic) acid (PLGA) are not appropriate for adipose tissue engineering. In 
contrast, in situ forming PEG-based hydrogels have been proposed as suitable scaffold 
systems for this application because of their mechanical and elastic properties. Furthermore, 
these hydrogels can be modified by incorporation of cell-specific degradation sites and 
adhesion ligands resulting in a suitable environment that supports adipose tissue development 
[9]. However, the previously reported PEG hydrogels were prepared by photopolymerization 
which often leads to cytotoxic byproducts. Therefore, our group developed an alternative, 
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non-radical cross-linking approach that allows for the preparation of injectable, biomimetic 
hydrogels.  
In this study, we analyzed the utility of these biomimetic PEG-based hydrogels for adipose 
tissue engineering. 3T3-L1 preadipocytes were encapsulated within degradable and non-
degradable PEG-based hydrogels and, subsequently, differentiated into adipocytes within this 
3-D environment. The developed gel systems appeared to provide a suitable environment for 
preadipocyte differentiation in vitro. However, the gel strength, which can be influenced by 
the polymer concentrations [23], affected the adipogenic differentiation of 3T3-L1 
preadipocytes (Figure 2 A and C, Page 173). Up to a polymer concentration of 15%, the gels 
supported the adipogenic differentiation of seeded preadipocytes; in gels containing 20% 
polymer, adipogenic differentiation was obviously suppressed. Possibly, the high mechanical 
strength of these hydrogels prevented entrapped adipocytes from expanding, which is a 
prerequisite for the accumulation of lipid droplets. Similar findings have also been reported in 
literature. Khan et al. found that with increasing rigidity of the surrounding ECM the 
expansion of adipocytes was more and more restricted due to the massive pressure on their 
cell membrane [32]. Additionally, we detected decreased cell numbers in gels with polymer 
concentrations of 15% and 20% (Figure 2 B, Page 173). Although the polymers were shown 
to be non-toxic on cells [33], high concentrations may affect the cell viability due to osmotic 
effects or the detergent character of the polymers. It has to be further investigated whether this 
cell loss is really caused by cell death or by detachment of cells from the gel. In general, the 
detected cell numbers were decreased compared to the initially seeded cell numbers. It is 
assumed that this phenomenon is associated with the preparation of the samples for DNA 
measurements and resulted from insufficient digestion of the adipocytes within the gels.  
After evaluation of the optimal polymer concentrations (10% initial polymer concentration), 
we compared the proliferation and differentiation capacity of the adipocytes within the 3-D 
gel construct with conventional 2-D monolayer culture. In 2-D culture, the 3T3-L1 
preadipocytes proliferated during the initial period of two days, until induction forced the 
preadipocytes to undergo growth arrest. In contrast, cells within the hydrogels were not able 
to expand during this time (Figure 3 B, Page 174). It is supposed that the growth phase of two 
days was not sufficient for significant cell proliferation within the stiff gel structure. The 
hydrogels do not provide the additional space required for the morphological changes during 
cell proliferation and prevents, therefore, the spreading and expansion of the cells [9]. 
Furthermore, it is possible that the PEG polymers elicited an anti-proliferative effect on the 
preadipocytes.  
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With regard to the adipocyte differentiation, the opposite trend was observed (Figure 3 A and 
C, Page 174). Here, more intracellular TGs were found in cell-containing hydrogels than in 
2-D cell culture. In 3-D cell constructs, the preadipocytes differentiated into mature 
adipocytes with multiple large lipid droplets in their intracellular space resulting in a spherical 
cell shape. In 2-D culture, the lipid vacuoles were smaller and the cells were well spread. It is 
known from the literature that the morphology of differentiating adipocytes shifts from a 
fibroblast-like phenotype to a more rounded shape due to the accumulation of lipids [34,35]. 
It has been furthermore shown that adipogenesis of preadipocytes was inhibited when cells 
were attached on strongly adhesive, fibronectin coated substrates preventing morphological 
changes of the cells [36,37]. Keeping the cells in a rounded configuration, e.g., by disrupting 
the cytoskeleton, reversed the inhibitory effect of fibronectin on adipogenic differentiation 
[36,37]. The differences between 2-D and 3-D culture detected in our study are probably 
caused by similar effects. In 2-D culture, the preadipocytes strongly adhered on the 
polystyrene substrate which presumably prevented morphological changes. In contrast, PEG-
based hydrogels are completely inert so that the embedded preadipocytes did only loosely 
interact with the gel network. Together with the elasticity of the hydrogel scaffold, these loose 
interactions are thought to enable morphological changes that finally support adipogenic 
differentiation [34]. This illustrates the complex interplay of substrate mechanics and 
adipocyte function. Therefore, suitable scaffolds for adipose tissue engineering have to meet 
demands on differentiation, cell attachment, and cell spreading [37].  
In a further experiment, we investigated the influence of the substrate adhesiveness on 
adipogenic differentiation by functionalizing the PEG-based hydrogels with the laminin-
derived cell adhesion motif YIGSR (Figure 5, Page 176). Patel et al. have reported that 
incorporation of YIGSR into photopolymerizable hydrogels promoted adhesion of 
preadipocytes to the virtually non-adhesive PEG gels [9]. We showed that addition of YIGSR 
resulted in an increased intracellular TG accumulation accompanied by the development of 
adipocytes with enlarged lipid vacuoles (Figure 5 A and B, Page 176). Obviously, the 
increased adhesiveness significantly enhanced the differentiation of preadipocytes in vitro. 
Regarding the cell proliferation, we could not detect any effects of YIGSR on the growth of 
3T3-L1 preadipocytes (Figure 5 C, Page 176). Patel et al. found enhanced proliferation of 
preadipocytes within degradable PEG hydrogels in the presence of YIGSR [9]. However, the 
detected differences were significant only on day 6 after cell seeding. In the present study, the 
seeded preadipocytes were forced to undergo growth arrest at the time point of induction 
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(day 2 after seeding). During these two days, no significant cell proliferation had occurred, 
which is in accordance to Patel et al. [9].  
A key feature of the prepared hydrogels is their degradability by cell-secreted enzymes, such 
as MMPs. The cell carrier is expected to provide initial mechanical support for the developing 
adipose tissue. Simultaneously, the hydrogel scaffold is degraded over time. In our in vitro 
studies, degradable and non-degradable systems were compared with respect to the adipocyte 
development. We hypothesized that the degradability presumably promote the generation of a 
coherent adipose tissue-like context. The biodegradable mechanics of the gels enables 
adipocyte enlargement as well as cell-cell and cell-matrix interactions which are important for 
adipocyte function [38-40]. However, no significant differences between degradable and non-
degradable hydrogels were observed in our short-term cell culture experiments (Figure 3 and 
5, Page 174 and 176). During this culture period, it seems that the cells did not secrete a 
sufficient amount of enzymes which are responsible for degradation of the hydrogels. 
Accordingly, the differentiating adipocytes were not able to generate adipose tissue-like 
structures (Figure 2, 3 and 5, Page 173, 174 and 176) and only isolated cells were found. 
Additionally, it has to be noted that the seeded cell number of 100,000 cells per hydrogel 
obviously was not sufficient for the development of coherent tissue. Therefore, higher 
numbers of 3T3-L1 cells were encapsulated into the hydrogels and their ability for adipose 
tissue development was investigated in an in vitro long-term study over 6 weeks (Figure 6, 
Page 178). In this experiment, the degradability of the gels clearly influenced the formation of 
adipose tissue-like structures. Within non-degradable hydrogels, the cells were not able to 
generate a coherent tissue-like context and only single, multilocular adipocytes were found. In 
contrast to that, coherent adipose tissue-like structures with many unilocular fat cells were 
observed in enzymatically degradable gels after 6 weeks of culture. The polymer network of 
these gels was obviously broken down by adipocyte-derived enzymes, which presumably 
facilitated the development of coherent adipose tissue-like structures. 
In summary, we successfully developed a 3-D in vitro model for adipose tissue engineering 
based on 3T3-L1 preadipocytes embedded in a new type of PEG-based hydrogels which are 
non-radically cross-linked. The developed hydrogels represented mechanical properties 
resembling adipose tissue and additional functionalization of the gels with adhesion peptides 
or degradation sites provided a suitable 3-D environment for adipocyte differentiation and the 
development of coherent tissue-like structures. Future experiments may include the use of 
different cell densities, extended culture periods, and the incorporation of various angiogenic 
and adipogenic growth factors as well as hormones in PEG-based hydrogels to optimize 
Chapter 7  PEG-based Hydrogels for Adipose Tissue Engineering 
- 182 - 
adipocyte development. Ultimately, in vivo testing is essential to prove the suitability of the 
developed scaffold for clinical applications. 
 
Chapter 7  PEG-based Hydrogels for Adipose Tissue Engineering 
- 183 - 
References 
1.  Smahel J. Adipose tissue in plastic surgery. Ann.Plast.Surg. 1986; 16: 444-453.  
2.  Beahm E K, Walton R L, Patrick C W, Jr. Progress in adipose tissue construct 
development. Clin.Plast.Surg. 2003; 30: 547-58.  
3.  Abberton K M, Bortolotto S K, Woods A A, Findlay M, Morrison W A, Thompson E 
W, Messina A. Myogel, a novel, basement membrane-rich, extracellular matrix 
derived from skeletal muscle, is highly adipogenic in vivo and in vitro. Cells 
Tissues.Organs 2008; 188: 347-358.  
4.  Rahaman M N, Mao J J. Stem cell-based composite tissue constructs for regenerative 
medicine. Biotechnol.Bioeng. 2005; 91: 261-284.  
5.  Patrick C W, Jr. Tissue engineering strategies for adipose tissue repair. Anat.Rec. 
2001; 263: 361-366.  
6.  Weiser B, Neubauer M, Goepferich A, Blunk T. Tissue Engineering, Fat. In: 
Encyclopedia of Biomaterials and Biomedical Engineering 1 edition 2005.  
7.  Hemmrich K, von Heimburg D. Biomaterials for adipose tissue engineering. 
Expert.Rev.Med.Devices 2006; 3: 635-645.  
8.  Alhadlaq A, Tang M, Mao J J. Engineered adipose tissue from human mesenchymal 
stem cells maintains predefined shape and dimension: implications in soft tissue 
augmentation and reconstruction. Tissue Eng 2005; 11: 556-566.  
9.  Patel P N, Gobin A S, West J L, Patrick C W, Jr. Poly(ethylene glycol) hydrogel 
system supports preadipocyte viability, adhesion, and proliferation. Tissue Eng 2005; 
11: 1498-1505.  
10.  Patel P N, Smith C K, Patrick C W, Jr. Rheological and recovery properties of 
poly(ethylene glycol) diacrylate hydrogels and human adipose tissue. 
J.Biomed.Mater.Res.A 2005; 73: 313-319.  
11.  Vashi A V, Keramidaris E, Abberton K M, Morrison W A, Wilson J L, O'Connor A J, 
Cooper-White J J, Thompson E W. Adipose differentiation of bone marrow-derived 
mesenchymal stem cells using Pluronic F-127 hydrogel in vitro. Biomaterials 2008; 
29: 573-579.  
12.  Brandl F, Kastner F, Gschwind R M, Blunk T, Tessmar J, Goepferich A. Hydrogel-
based drug delivery systems: comparison of drug diffusivity and release kinetics. 
J.Control Release 2010; 142: 221-228.  
13.  Lee K Y, Mooney D J. Hydrogels for tissue engineering. Chem.Rev. 2001; 101: 1869-
1879.  
14.  Drury J L, Mooney D J. Hydrogels for tissue engineering: scaffold design variables 
and applications. Biomaterials 2003; 24: 4337-4351.  
15.  Nguyen K T, West J L. Photopolymerizable hydrogels for tissue engineering 
applications. Biomaterials 2002; 23: 4307-4314.  
16.  Burdick J A, Anseth K S. Photoencapsulation of osteoblasts in injectable RGD-
modified PEG hydrogels for bone tissue engineering. Biomaterials 2002; 23: 4315-
4323.  
17.  Lutolf M P, Hubbell J A. Synthetic biomaterials as instructive extracellular 
microenvironments for morphogenesis in tissue engineering. Nat.Biotechnol. 2005; 
23: 47-55.  
Chapter 7  PEG-based Hydrogels for Adipose Tissue Engineering 
- 184 - 
18.  Lutolf M P, Hubbell J A. Synthesis and physicochemical characterization of end-
linked poly(ethylene glycol)-co-peptide hydrogels formed by Michael-type addition. 
Biomacromolecules. 2003; 4: 713-722.  
19.  Lutolf M P, Lauer-Fields J L, Schmoekel H G, Metters A T, Weber F E, Fields G B, 
Hubbell J A. Synthetic matrix metalloproteinase-sensitive hydrogels for the 
conduction of tissue regeneration: engineering cell-invasion characteristics. 
Proc.Natl.Acad.Sci.U.S.A 2003; 100: 5413-5418.  
20.  Lutolf M P, Weber F E, Schmoekel H G, Schense J C, Kohler T, Muller R, Hubbell J 
A. Repair of bone defects using synthetic mimetics of collagenous extracellular 
matrices. Nat.Biotechnol. 2003; 21: 513-518.  
21.  Park Y, Lutolf M P, Hubbell J A, Hunziker E B, Wong M. Bovine primary 
chondrocyte culture in synthetic matrix metalloproteinase-sensitive poly(ethylene 
glycol)-based hydrogels as a scaffold for cartilage repair. Tissue Eng 2004; 10: 515-
522.  
22.  Timmer M D, Shin H, Horch R A, Ambrose C G, Mikos A G. In vitro cytotoxicity of 
injectable and biodegradable poly(propylene fumarate)-based networks: unreacted 
macromers, cross-linked networks, and degradation products. Biomacromolecules. 
2003; 4: 1026-1033.  
23.  Brandl F P, Seitz A K, Tessmar J K, Blunk T, Goepferich A M. Enzymatically 
degradable poly(ethylene glycol) based hydrogels for adipose tissue engineering. 
Biomaterials 2010; 31: 3957-3966.  
24.  Shin H, Jo S, Mikos A G. Biomimetic materials for tissue engineering. Biomaterials 
2003; 24: 4353-4364.  
25.  Patrick C W, Jr., Wu X. Integrin-mediated preadipocyte adhesion and migration on 
laminin-1. Ann.Biomed.Eng 2003; 31: 505-514.  
26.  Ranieri J P, Bellamkonda R, Bekos E J, Vargo T G, Gardella J A, Jr., Aebischer P. 
Neuronal cell attachment to fluorinated ethylene propylene films with covalently 
immobilized laminin oligopeptides YIGSR and IKVAV. II. J.Biomed.Mater.Res. 
1995; 29: 779-785.  
27.  Bellamkonda R, Ranieri J P, Aebischer P. Laminin oligopeptide derivatized agarose 
gels allow three-dimensional neurite extension in vitro. J.Neurosci.Res. 1995; 41: 501-
509.  
28.  Ramirez-Zacarias J L, Castro-Munozledo F, Kuri-Harcuch W. Quantitation of adipose 
conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. 
Histochemistry 1992; 97: 493-497.  
29.  Kim Y J, Sah R L, Doong J Y, Grodzinsky A J. Fluorometric assay of DNA in 
cartilage explants using Hoechst 33258. Anal.Biochem. 1988; 174: 168-176.  
30.  Weiser B, Adipose Tissue Engineering - Precultivation Strategies towards Clinical 
Applications & A Novel 3-D Model of Adipogenesis for Basic Research. Ph.D. thesis 
2008. University of Regensburg, Regensburg, Germany.   
31.  Boateng S Y, Lateef S S, Mosley W, Hartman T J, Hanley L, Russell B. RGD and 
YIGSR synthetic peptides facilitate cellular adhesion identical to that of laminin and 
fibronectin but alter the physiology of neonatal cardiac myocytes. Am.J.Physiol Cell 
Physiol 2005; 288: C30-C38.  
32.  Khan T, Muise E S, Iyengar P, Wang Z V, Chandalia M, Abate N, Zhang B B, 
Bonaldo P, Chua S, Scherer P E. Metabolic dysregulation and adipose tissue fibrosis: 
role of collagen VI. Mol.Cell Biol. 2009; 29: 1575-1591. 
Chapter 7  PEG-based Hydrogels for Adipose Tissue Engineering 
- 185 - 
33.  Teramura Y, Kaneda Y, Totani T, Iwata H. Behavior of synthetic polymers 
immobilized on a cell membrane. Biomaterials 2008; 29: 1345-1355.  
34.  Smas C M, Sul H S. Control of adipocyte differentiation. Biochem.J. 1995; 309 ( Pt 
3): 697-710.  
35.  Gregoire F M, Smas C M, Sul H S. Understanding adipocyte differentiation. Physiol 
Rev. 1998; 78: 783-809.  
36.  Spiegelman B M, Ginty C A. Fibronectin modulation of cell shape and lipogenic gene 
expression in 3T3-adipocytes. Cell 1983; 35: 657-666.  
37.  O'Connor K C, Song H, Rosenzweig N, Jansen D A. Extracellular matrix substrata 
alter adipocyte yield and lipogenesis in primary cultures of stromal-vascular cells from 
human adipose. Biotechnology Letters 2003; 25: 1967-1972.  
38.  Fischbach C, Spruss T, Weiser B, Neubauer M, Becker C, Hacker M, Goepferich A, 
Blunk T. Generation of mature fat pads in vitro and in vivo utilizing 3-D long-term 
culture of 3T3-L1 preadipocytes. Experimental Cell Research 2004; 300: 54-64.  
39.  Kang X, Xie Y, Kniss D A. Adipose tissue model using three-dimensional cultivation 
of preadipocytes seeded onto fibrous polymer scaffolds. Tissue Eng 2005; 11: 458-
468.  
40.  Mariman E C, Wang P. Adipocyte extracellular matrix composition, dynamics and 












Chapter 8  Summary and Conclusions 
- 188 - 
1. Summary 
For both basic cell biology research and the development of new therapeutic strategies related 
to adipose tissue, in vitro adipocyte culture is helpful to understand adipocyte and adipose 
tissue development. Commonly, two-dimensional (2-D) monolayer cultures are used to study 
adipocyte biology on the cellular and molecular level. The first part of this thesis focused on 
conventional 2-D adipocyte culture to investigate the efficacy of therapeutic substances used 
for injection lipolysis (Chapter 3 and 4).  
To study the influence of the surrounding tissue architecture on adipocyte function, three-
dimensional (3-D) culture systems are required mimicking an in vivo-like adipose tissue 
context. Recently, a novel 3-D adipocyte culture system based on the formation of spheroids 
was developed by our group [1]. This spheroid model is characterized by a coherent tissue-
like context and represents a suitable model system to investigate tissue-inherent factors such 
as cell-cell and cell-matrix interactions. In the second part of this work, the influence of 
collagens, the most abundant components of the extracellular matrix (ECM), on adipocyte 
development was investigated in vitro (Chapter 5 and 6). 
Besides the benefit of 3-D adipocyte culture models in basic research, the generation of 3-D 
adipose substitutes appears desirable in tissue engineering strategies for plastic and 
reconstructive surgery to augment soft tissue defects, e.g., after deep burns or tumor 
resections [2]. The third part of this work investigated the suitability of a newly developed 
poly(ethylene glycol) (PEG)-based hydrogel for the use in adipose engineering (Chapter 7). 
1.1. 2-D culture 
1.1.1. Investigation of therapeutic substances used for injection lipolysis  
The injection of Lipostabil®, referred to as injection lipolysis, is a non-invasive aesthetic 
procedure to reduce localized fat depositions [3-5]. So far, the underlying mechanisms have 
not been fully understood. In cooperation with “Network Lipolysis”, the effect of Lipostabil® 
as well as its single substances sodium deoxycholate (DC) and phosphatidylcholine (PC) on 
mature adipocytes were investigated by using in vitro 2-D culture systems with the 3T3-L1 
cell line and human adipose-derived stem cells (ADSCs) (Chapter 4). ADSCs are a 
previously identified cell source isolated from adipose tissue and were used in this study to 
reflect a more native situation. We evaluated the isolation and culture conditions in order to 
optimize the adipogenic differentiation rate of the ADSCs (Chapter 3). The introduction of 
additional filtrations steps during the isolation procedure led to a more purified cell 
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population with higher differentiation capacity. Additionally, the supplementation of the 
culture medium with basic fibroblast growth factor (bFGF) enhanced the adipogenic 
differentiation of ADSCs. Finally, a 2-D adipogenic culture system with ADSCs was 
successfully developed and was used in further experiments to investigate the underlying 
mechanisms of injection lipolysis.  
The treatment of the differentiated cells, both 3T3-L1 and ADSCs, with DC and Lipostabil® 
clearly affected the cell membrane integrity as detected microscopically and confirmed by 
propidium iodide staining (Chapter 4). In contrast to that, PC did not have any toxic effects 
on the adipocytes. PC was identified as a partially protective substance against the cell-lysing 
effect of DC. Lipolytic activities, e.g., via adrenergic receptors, were not observed for the 
Lipostabil® formula and its single components. Therefore, it is concluded that the reduction of 
fat tissue volumes after injection of Lipostabil® is caused by disruption of the cell membrane 
integrity and not by lipolytic mechanisms. DC as a detergent substance could be identified to 
be the effective substance in the Lipostabil® compound applied for injection lipolysis.  
1.2. 3-D culture 
1.2.1.  Investigation of collagens in adipogenesis in vitro 
Collagens are important components of the ECM network and are regulated during 
adipogenesis [6-9]. The collagen network and its remodeling during adipocyte development 
are not well characterized. Since the adipose tissue architecture is better reflected in a 3-D 
context, the role of collagens during adipose conversion was investigated in 3-D spheroids in 
comparison to 2-D monolayer culture (Chapter 5 and 6). Ethyl-3,4-dihydroxybenzoate 
(EDHB), an inhibitor of collagen prolyl hydroxylase and, thus, collagen synthesis was used to 
examine the influence of the collagen organization in a tissue-like context on the adipogenesis 
of 3T3-L1 in vitro (Chapter 5). In contrast to 2-D culture, EDHB prevented the 
differentiation of adipocytes in 3-D spheroids as detected by reduced oil red O staining, 
triglyceride (TG) content and glycerol-3-phosphate dehydrogenase activity. Measurement of 
the hydroxyproline content during adipogenic differentiation showed a reduced activity of 
prolyl hydroxylases in 3-D culture, whereas in 2-D culture the enzyme was still active. 
Further investigations of the gene expression of collagen prolyl-4-hydroxylase alpha 1 during 
adipogenesis by qRT-PCR analysis revealed an increase of this gene in 2-D culture in 
comparison to 3-D spheroids. These results suggest a complex relationship between prolyl 
hydroxylase activity, collagens and adipogenesis.   
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The complex organization of the collagen network is partially arranged by a specified family 
of collagens, the FACIT (fibril-associated collagens with interrupted triple helices). Members 
of this family are localized on the surface of major collagen fibrils and contribute to the 
connection of the ECM network itself. Collagen XVI is one member of the FACIT sub-family 
and it was reported to mediate anchoring processes and remodeling of the ECM [10,11]. Since 
the matrix is remodeled during adipocyte differentiation, we hypothesized that this type of 
collagen is involved in this process. In our study, collagen XVI was identified to be highly 
expressed in 3T3-L1 preadipocytes and undifferentiated ADSCs. Upon hormonally induced 
adipogenesis, however, its gene and protein expression was strongly downregulated in 2-D 
and 3-D adipocyte culture (Chapter 6). Further studies identified corticosterone, one 
component of the adipogenic induction cocktail, as a substance inducing downregulation of 
procollagen XVI(α1) mRNA. A functional role of collagen XVI in the adipogenesis could not 
be clarified so far. However, preliminary experiments showed that 3T3-L1 cells 
overexpressing collagen XVI failed to differentiate into adipocytes after hormonal induction 
in contrast to non-transfected cells. For the first time, collagen XVI expression was associated 
with adipogenesis contributing to the emerging picture of the complexity and the role of the 
ECM in adipose tissue. To clarify the role of this FACIT in adipogenesis, further analyses are 
required to understand the underlying mechanisms. 
1.2.2. Novel hydrogels for adipose tissue engineering 
Recently, our group developed in situ forming PEG-based hydrogels that can be easily 
functionalized with degradation sites and various other factors such as adhesion peptides, 
growth factors or hormones. In the last part of this thesis (Chapter 7), the suitability of the 
developed hydrogels for fat tissue engineering was investigated by encapsulating 3T3-L1 
preadipocytes within the hydrogels. Thereby, the influence of different parameters such as 
substrate stiffness, adhesiveness, and degradability on the adipogenic differentiation was 
assessed. Compared to conventional 2-D cell culture, the entrapped adipocytes in the 
hydrogels accumulated higher intracellular TG amounts. Increasing gel strength resulted in a 
reduced TG accumulation. However, gel functionalization with the laminin-derived adhesion 
peptide YIGSR enhanced the lipid synthesis of encapsulated adipocytes. Long-term in vitro 
studies revealed that only enzymatically degradable hydrogels promoted the formation of 
coherent adipose tissue-like structures characterized by many mature unilocular adipocytes. In 
summary, the developed biomimetic PEG hydrogels provided an appropriate environment for 
3T3-L1 cells to differentiate into adipocytes and are, therefore, suggested as a promising new 
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biomaterial for adipose tissue engineering. Future in vivo testing is essential to prove the 
suitability of the developed scaffold for clinical applications.  
2. Conclusion 
This thesis presents the variability of in vitro adipocyte culture for different applications in 
basic research and developments towards clinical application. Conventional 2-D monolayer 
culture is useful for the investigation of mechanism on the cellular and molecular level. 
Thereby, the choice of the cell source is essential. The 3T3-L1 preadipocyte cell line is a well 
established culture system, but its use is limited, particularly in clinical applications. ADSCs 
are an alternative cell culture model to further approach human conditions. In this thesis, a 
standardized isolation and culture procedure of ADSCs was established leading to a highly 
differentiated adipocyte culture. By utilizing the established culture systems with 3T3-L1 and 
ADSCs, it was clarified that the fat reducing effect after injection of Lipostabil® are caused by 
cell-lysing and not receptor-mediated lipolytic actions.  
Adipocyte cell culture is particularly used in basic research. In the last decades, many 2-D in 
vitro studies contributed to the understanding of molecular mechanisms of adipogenesis. 
However, the influence of the surrounding tissue architecture on adipocyte development is not 
well characterized. In this thesis, a complex interplay of collagens and adipogenesis was 
shown. Particularly collagen XVI was downregulated during in vitro adipogenesis and it is 
supposed to play a functional role in this process. Moreover, this thesis showed the 
importance of a 3-D adipocyte culture system when investigating the surrounding 
architecture. The appropriate collagen organization appeared to be more relevant in a 3-D 
tissue-like context for adipocyte development.  
3-D adipocyte culture systems are not only essential for basic research purposes, but also for 
clinical approaches. The improvement of adipose tissue engineering for use in reconstructive 
surgery requires suitable scaffold biomaterials. A new PEG-based hydrogel developed by our 
group was suggested to be an appropriate scaffold for adipose engineering. The gel provided a 
suitable environment that directed adipocyte differentiation. Furthermore, functionalization of 
the gel with degradation sites promoted the development of coherent adipose tissue-like 
structures. Once placed at the application site, it is assumed that the gel is degraded by cell-
secreted proteases. Thereby, the degradation rate is spatially and temporarily synchronized 
with the deposition of ECM. Although future in vivo experiments have to be carried out, the 
developed gel system is proposed as a promising scaffold for a variety of applications in 
regenerative medicine.  
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In conclusion, adipocyte cell culture is an adequate tool for basic research and the 
development of clinical applications. Whereas 2-D culture is an easily accessible and widely 
used model system, 3-D cell systems open up new possibilities for future research, especially 
when a tissue-like context is of importance. 
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List of Abbreviations 
18S 18S ribosomal RNA 
2-D two-dimensional 
3-D three-dimensional 
α-MEM minimum essential medium (alpha-modification) 
AA ascorbic acid 
ADD-1 adipocyte differentiation and determination factor 1 
ADSC adipose-derived stem cell 
Ala alanine 
ANOVA analysis of variances 
APS ammonium persulfate  
Arg arginine 
Asp asparagine 
ATCC American Type Culture Collection 
ATGL adipose triglyceride lipase 
BADGE bisphenol A diglycidyl 
BAT brown adipose tissue 
bFGF basic fibroblast growth factor 
BIP bovine intramuscular preadipocytes 
BMSC bone marrow-derived stem cell 
BSA bovine serum albumin 
bp base pair 
cAMP cyclic adenosine 3',5''-monophosphate 
cDNA complementary deoxyribonucleic acid 
C/EBPα CCAAT/enhancer binding protein alpha 
CEBPβ CCAAT/enhancer binding protein beta 
cGMP cyclic guanosine 3',5''-monophosphate 
colXVI collagen type XVI 
CREB cAMP-responsive element binding protein 
Ct cycle threshold 
Cy 3 cyanine 3 
Cys cysteine 
Da dalton 
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DAPI 4',6-diamidino-2-phenylindole 
DC sodium deoxycholate 
DG diglyceride 
DHAP dihydroxyacetone phosphate 
DMEM Dulbecco's Modified Eagle's Medium 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
DTT dithiothreitol 
E efficiency 
ECM extracellular matrix 
EDHB ethyl-3,4-dihydroxybenzoate 
EDTA ethylenediamine tetraacetic acid 
e.g. exempli gratia 
EGF epidermal growth factor 
ERK extracellular-signal-regulated kinase 
EST expressed sequence tag 
et al. et alii 
FACIT fibril-associated collagens with interrupted triple helices 
FACS fluorescence-activated cell sorting 
FBS fetal bovine serum 
FCS fetal calf serum 
FDA Food and Drug Administration 
FFA free fatty acid 
GAG glycosaminoglycan 
Gly glycine 
GPDH glycerol 3-phosphate dehydrogenase 
h hours 
HA hyaluronic acid 
HEPES 2-(4-(2-Hydroxyethyl)-1-piperazinyl)-ethansulfonsäure 
HIF-1α hypoxia inducible factor 1 alpha 
HSL hormone-sensitive lipase 
IBMX 3-isobutyl-1-methylxanthine 
i.e. id est 
IFATS International Fat Applied Technology Society 
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IGF insulin-like growth factor 
Ile isoleucine 
INF-γ interferon gamma 
IRF interferon-regulatory factor 
IRS-1 insulin receptor substrate 1 




MAP mitogen-activated protein 
MCP-1 monocyte chemoattractant protein-1 
MG monoglyceride 
MMP matrix metalloproteinase 
mRNA messenger ribonucleic acid 
MSC mesenchymal stem cell 
MTT dimethyl thiazolyl diphenyl tetrazolium 
NADH nicotinamide adenine dinucleotide 
OrO oil red O 
PAGE polyacrylamide gel electrophoresis 
PAI plasminogen activator inhibitor protein 
PARP proline-arginine-rich protein 
PBM-2 preadipocyte basal medium-2 
PBS phosphate-buffered saline 
PC phosphatidylcholine 
PCR polymerase chain reaction 
PDGF platelet-derived growth factor 
PEG polyethylene glycol 
PFA paraformaldehyde 
PGA polyglycolic acid 
PHD prolyl hydroxylase domain-containing enzymes 
PI propidium iodide 
PLA polylactic acid 
PLGA poly(lactic-co-glycolic) acid 
PPARγ peroxisome proliferator-activated receptor gamma 
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Pref-1 preadipocyte factor 1 
Pro proline 
qRT-PCR quantitative reverse transcription-polymerase chain reaction 
RNA ribonucleic acid 
rpm rounds per minute 
rRNA ribosomal ribonucleic acid 
S slope 
SDS sodium dodecyl sulfate 
SEM scanning electron microscopy 
Ser serine 
SREBP-1 sterol regulatory element binding protein 1 
SVF stromal vascular fraction 
TBST Tris-buffered saline Tween 20 
TCA trichloric acid 
TCF/LEF T cell-specific transcription factor/lymphoid enhancer-binding 
factor 
TCPS tissue culture polystyrene 
TEMED triethylmethylethylendiamine 
TG triglyceride 
TGF-β transforming growth factor beta 
TIMP tissue inhibitor of metalloproteinase 




VLDL very low density lipoproteins 
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